þ Form 20-F | o Form 40-F |
o Yes | þ No |
Registered name |
Semiconductor Manufacturing International
|
Corporation (the “Company”)
|
|
Chinese
name (for identification purposes only)
|
|
Registered office | PO Box 309 |
Ugland House | |
Grand Cayman | |
KY1-1104 | |
Cayman Islands | |
Head office and place of business in PRC | 18 Zhangjiang Road |
Pudong New Area | |
Shanghai 201203 | |
PRC | |
Place of business in Hong Kong registered under | Suite 3003 |
Part XI of the Companies Ordinance | 30th Floor |
9 Queen’s Road Central | |
Hong Kong | |
Website address | http://www.smics.com |
Company secretary | Anne Wai Yui Chen |
Authorized representatives | Jiang Shang Zhou |
Anne Wai Yui Chen | |
Places of listing | The Stock Exchange of Hong Kong Limited (“HKSE”) |
New York Stock Exchange (“NYSE”) | |
Stock code | 0981 (HKSE) |
SMI (NYSE) | |
FINANCIAL CALENDAR | |
Announcement of 2009 results | April 26, 2010 |
Book closure period | May 31, 2010 to June 3, 2010, both days |
inclusive | |
Annual general meeting | June 3, 2010 |
Financial year end | December 31 |
1) | Entry of judgement and mutual release of all claims that were or could have been brought in the pending lawsuits; | |
2) | Termination of SMIC’s obligation to make remaining payments under prior settlement agreement between the parties (approximately US$40 million); | |
3) | Payment to TSMC of an aggregate of US$200 million (with US$15 million paid upon execution, funded from SMIC’s existing cash balances, and the remainder to be paid in installments over a period of four years — US$15 million payable by 31 December, 2009, US$80 million payable by 31 December, 2010, US$30 million payable by 31 December, 2011, US$30 million payable by 31 December, 2012 and US$30 million payable by 31 December, 2013); |
4) | Commitment to grant to TSMC of 1,789,493,218 shares of SMIC (representing approximately 8% of SMIC’s issued share capital as of October 31, 2009) and a warrant exercisable within three years of issuance to subscribe for 695,914,030 shares of SMIC, subject to adjustment, at a purchase price of HK$1.30 per share. Both the shares and the warrant would allow TSMC to obtain total ownership of approximately 10% of SMIC’s issued share capital after giving effect to the share issuances and are subject to receipt of required government and regulatory approvals; and | |
5) | Certain remedies in the event of breach of this settlement. |
For the year ended December 31, | |||||||||||||||
2005 | 2006 | 2007 | 2008 | 2009 | |||||||||||
(in US$ thousands, except for per share and per ADS data) | |||||||||||||||
Income Statement Data: | |||||||||||||||
Sales | $1,171,319 | $1,465,323 | $1,549,765 | $1,353,711 | $1,070,387 | ||||||||||
Cost of sales(1) | 1,105,134 | 1,338,155 | 1,397,038 | 1,412,851 | 1,184,589 | ||||||||||
Gross profit (loss) | 66,185 | 127,168 | 152,727 | (59,140 | ) | (114,202 | ) | ||||||||
Operating expenses (income): | |||||||||||||||
Research and development | 78,865 | 94,171 | 97,034 | 102,240 | 160,754 | ||||||||||
General and administrative | 35,701 | 47,365 | 74,490 | 58,841 | 215,566 | ||||||||||
Selling and marketing | 17,713 | 18,231 | 18,716 | 20,661 | 26,566 | ||||||||||
Litigation settlement | — | — | — | — | 269,637 | ||||||||||
Amortization of acquired intangible assets | 20,946 | 24,393 | 27,071 | 32,191 | 35,064 | ||||||||||
Impairment loss of long-lived assets | — | — | — | 106,741 | 138,295 | ||||||||||
Income from sale of equipment and other | |||||||||||||||
fixed assets | — | (43,122 | ) | (28,651 | ) | (2,877 | ) | 3,832 | |||||||
Total operating expenses, net | 153,225 | 141,038 | 188,659 | 317,797 | 849,714 | ||||||||||
Income (loss) from operations | (87,040 | ) | (13,870 | ) | (35,932 | ) | (376,937 | ) | (963,917 | ) | |||||
Other income (expenses): | |||||||||||||||
Interest income | 11,356 | 14,916 | 12,349 | 11,542 | 2,591 | ||||||||||
Interest expense | (38,784 | ) | (50,926 | ) | (37,936 | ) | (50,767 | ) | (24,699 | ) | |||||
Change in the fair value of commitment | |||||||||||||||
to issue shares and warrants | — | — | — | — | (30,101 | ) | |||||||||
Foreign currency exchange gain (loss) | (3,355 | ) | (21,912 | ) | 11,250 | 3,230 | 4,180 | ||||||||
Others, net | 4,462 | 1,821 | 2,238 | 7,429 | 4,626 | ||||||||||
Total other income (expense), net | (26,322 | ) | (56,101 | ) | (12,100 | ) | (28,566 | ) | (43,403 | ) | |||||
Income(Loss) before income tax | (113,362 | ) | (69,971 | ) | (48,032 | ) | (405,503 | ) | (1,007,319 | ) | |||||
Income tax benefit (expense) | (285 | ) | 24,928 | 29,720 | (26,433 | ) | 46,624 |
For the year ended December 31, | |||||||||||
2005 | 2006 | 2007 | 2008 | 2009 | |||||||
(in US$ thousands, except for per share and per ADS data) | |||||||||||
Loss from equity investment | (1,379 | ) | (4,201 | ) | (4,013 | ) | (444 | ) | (1,782 | ) | |
Net income (loss) before cumulative effect | |||||||||||
of a change in accounting principle | (115,026 | ) | (49,244 | ) | (22,324 | ) | (432,380 | ) | (962,478 | ) | |
Cumulative effect of a change in accounting | |||||||||||
principle | — | 5,154 | — | — | — | ||||||
Net income(loss) | (115,026 | ) | (44,090 | ) | (22,324 | ) | (432,380 | ) | (962,478 | ) | |
Accretion of interest to non-controlling | |||||||||||
interest | 251 | (19 | ) | 2,856 | (7,851 | ) | (1,060 | ) | |||
Income (loss) attributable to holders of | |||||||||||
ordinary shares | (114,775 | ) | (44,109 | ) | (19,468 | ) | (440,231 | ) | (963,537 | ) | |
Income (loss) per share, basic | $(0.00 | ) | $(0.00 | ) | $(0.00 | ) | $(0.02 | ) | $(0.04 | ) | |
Income (loss) per share, diluted | $(0.00 | ) | $(0.00 | ) | $(0.00 | ) | $(0.02 | ) | $(0.04 | ) | |
Shares used in calculating basic income | |||||||||||
(loss) per share(2)(3) | 18,184,429,255 | 18,334,498,923 | 18,501,940,489 | 18,682,544,866 | 22,359,237,084 | ||||||
Shares used in calculating diluted income | |||||||||||
(loss) per share(2)(3) | 18,184,429,255 | 18,334,498,923 | 18,501,940,489 | 18,682,544,866 | 22,359,237,084 |
(1) | Including amortization of deferred stock compensation for employees directly involved in manufacturing activities. | |
(2) | Anti-dilutive preference shares, options and warrants were excluded from the weighted average ordinary shares outstanding for the diluted per share calculation. For 2005, 2006, 2007, 2008 and 2009 basic income (loss) per share did not differ from diluted loss per share. | |
(3) | All share information has been adjusted retroactively to reflect the 10-for-1 share split effected upon completion of the global offering of ordinary shares in March 2004 (the “Global Offering”). |
As of December 31, | |||||||||||
2005 | 2006 | 2007 | 2008 | 2009 | |||||||
(in US$ thousands) | |||||||||||
Balance Sheet Data: | |||||||||||
Cash and cash equivalents | $585,797 | $363,620 | $469,284 | $450,230 | $443,463 | ||||||
Restricted Cash | — | — | — | 6,255 | 20,360 | ||||||
Short-term investments | 13,796 | 57,951 | 7,638 | 19,928 | — | ||||||
Accounts receivable, | |||||||||||
net of allowances | 241,334 | 252,185 | 298,388 | 199,372 | 204,290 | ||||||
Inventories | 191,238 | 275,179 | 248,310 | 171,637 | 193,705 | ||||||
Total current assets | 1,047,465 | 1,049,666 | 1,075,302 | 926,858 | 907,058 | ||||||
Land use rights, net | 34,768 | 38,323 | 57,552 | 74,293 | 78,112 | ||||||
Plant and equipment, net | 3,285,631 | 3,244,401 | 3,202,958 | 2,963,386 | 2,251,614 | ||||||
Total assets | 4,586,633 | 4,541,292 | 4,708,444 | 4,270,622 | 3,524,077 | ||||||
Total current liabilities | 896,038 | 677,362 | 930,190 | 899,773 | 1,031,523 | ||||||
Total long-term liabilities | 622,497 | 817,710 | 730,790 | 578,689 | 661,472 | ||||||
Total liabilities | 1,518,535 | 1,495,072 | 1,660,980 | 1,478,462 | 1,692,995 | ||||||
Non-controlling interest | 38,782 | 38,800 | 34,944 | 42,795 | 34,842 | ||||||
Total stockholders’ equity | $3,029,316 | $3,007,420 | $3,012,519 | $2,749,365 | $1,796,240 | ||||||
For the year ended December 31, | |||||||||||
2005 | 2006 | 2007 | 2008 | 2009 | |||||||
(in US$ thousands, except percentages and operating data) | |||||||||||
Cash Flow Data: | |||||||||||
Net income (loss) | $(111,026 | ) | $(49,244 | ) | $(22,324 | ) | $(432,380 | ) | $(962,478 | ) | |
Adjustments to reconcile net income (loss) | |||||||||||
to net cash provided by (used in) | |||||||||||
operating activities: | |||||||||||
Depreciation and amortization | 769,472 | 919,616 | 706,277 | 761,809 | 748,185 | ||||||
Net cash provided by (used in) | |||||||||||
operating activities | 648,105 | 769,649 | 672,465 | 569,782 | 283,566 | ||||||
Purchases of plant and equipment | (872,519 | ) | (882,580 | ) | (717,171 | ) | (669,055 | ) | (217,269 | ) | |
Net cash used in investing activities | (859,652 | ) | (917,369 | ) | (643,344 | ) | (761,713 | ) | (211,498 | ) | |
Net cash provided by (used in) | |||||||||||
financing activities | 190,364 | (74,440 | ) | 76,637 | 173,314 | (78,902 | ) | ||||
Net increase (decrease) in cash and | |||||||||||
cash equivalents | (21,376 | ) | (222,177 | ) | 105,664 | (19,054 | ) | (6,767 | ) | ||
Other Financial Data: | |||||||||||
Gross margin | 5.7 | % | 8.7 | % | 9.9 | % | –4.4 | % | –10.7 | % | |
Operating margin | –7.4 | % | –0.9 | % | –2.3 | % | –27.8 | % | –90.1 | % | |
Net margin | –9.8 | % | –3.0 | % | –1.3 | % | –32.5 | % | –90.0 | % | |
Operating Data: | |||||||||||
Wafers shipped (in units): | |||||||||||
Total(1) | 1,347,302 | 1,614,888 | 1,849,957 | 1,611,208 | 1,376,663 |
(1) | Including logic, DRAM, copper interconnects and all other wafers. |
1
|
Based on simplified average selling price which is calculated as total revenue divided by total shipments. |
Payments due by period Less than | ||||||||||
After | ||||||||||
Contractual obligations | Total | 1 year | 1–2 years | 3–5 years | 5 years | |||||
(consolidated, in US$ thousands) | ||||||||||
Short-term borrowings | $286,864 | $286,864 | $— | $— | $— | |||||
Long-term debt secured long-term | ||||||||||
loans | 756,437 | 205,784 | 334,995 | 215,658 | — | |||||
Operating lease obligations(1) | 5,439 | 743 | 453 | 361 | 3,882 | |||||
Purchase obligations(2) | 146,506 | 146,506 | — | — | — | |||||
Other long-term obligations(3) | 189,946 | 101,842 | 33,339 | 54,765 | — | |||||
Total contractual obligations | $1,385,192 | $741,739 | $368,787 | $270,784 | $3,882 |
(1) | Represents our obligations to make lease payments to use the land on which our fabs and other office equipment we have leased. | |
(2) | Represents commitments for construction or purchase of semiconductor equipment, and other property or services. | |
(3) | Includes the settlement with TSMC for an aggregate of $200 million payable in installments over five years and the other long-term liabilities relating to certain license agreements. |
1. | Consolidated tangible net worth of no less than US$1,200 million; | |
2. | Consolidated total borrowings to consolidated tangible net worth of: | |
(a) | no more than 60% for periods up to and including 31 December 2008; and | |
(b) | no more than 45% thereafter; | |
3. | Consolidated total borrowings to trailing preceding four quarters EBITDA not to exceed 1.50x; and | |
4. | Debt Service Coverage Ratio of no less than 1.5x. Debt Service Coverage Ratio means trailing four quarters EBITDA divided by scheduled principal repayments and interest expense for all bank borrowings (including hire purchases, leases and other borrowed monies) for the same period. |
1. | Consolidated tangible net worth of no less than US$2,300 million; | |
2. | Consolidated net borrowings to consolidated tangible net worth of: | |
(a) | no more than 50% for period up to and including 30 June 2009; | |
(b) | no more than 40% thereafter; and | |
3. | Consolidated net borrowings to trailing four quarters EBITDA of: | |
(a) | no more than 1.50x for periods up to and including 30 June 2009; and no more than 1.30x thereafter. | |
SMIC
Shanghai is exempted from the covenants by the lenders. Furthermore, the
Company is currently working with the lenders to refinance the remainder
of the USD loan and expects the completion of this restructuring in the
near future from the date of this
report.
|
1. | [Net profit + depreciation + amortization + financial expenses – (increase of accounts receivable and advanced payments + increase of inventory – increase in accounts payable and advanced receipts)]/ financial expenses 60% (when SMIC Beijing’s capacity is less than 20,000 12-inch wafers per month); and | |
2. | (Total liability – borrowings from shareholders, including principal and interest)/Total assets > 50% (when SMIC Beijing’s capacity exceeds 20,000 12-inch wafers per month). |
As of December 31, | As of December 31, | As of December 31, | ||||||||||
2009 | 2008 | 2007 | ||||||||||
(in US$ thousands) | (in US$ thousands) | (in US$ thousands) | ||||||||||
2009 | Fair Value | 2008 | Fair Value | 2007 | Fair Value | |||||||
Forward Exchange | ||||||||||||
Agreement | ||||||||||||
(Receive Eur/Pay US$) | ||||||||||||
Contract Amount | 21,265 | (390 | ) | 31,144 | (440.8 | ) | — | — | ||||
(Receive Rmb/Pay US$) | ||||||||||||
Contract Amount | (12,236 | ) | (39 | ) | 189,543 | (3,069.5 | ) | 404 | 530.4 | |||
Total Contract Amount | 9,029 | (429 | ) | 220,687 | (3,510.3 | ) | 404 | 530.4 |
As of December 31, | |||||
2010 | 2011 | 2012 | |||
(Forecast) | |||||
(in US$ thousands, except percentages) | |||||
US$ denominated | |||||
Average balance | 388,792 | 78,924 | 9,506 | ||
Average interest rate | 1.82% | 2.40% | 2.92% | ||
EUR denominated | |||||
Average balance | 29,789 | 16,201 | 3,245 | ||
Average interest rate | 1.21% | 1.56% | 1.88% | ||
Weighted average forward interest rate | 1.82% | 2.37% | 2.86% |
Name | Age | Position |
Directors | ||
Jiang Shang Zhou | 63 | Chairman, Independent Non-Executive Director |
David N.K. Wang | 63 | President, Chief Executive Officer and Executive Director |
Chen Shanzhi | 41 | Non-Executive Director |
Gao Yonggang | 45 | Non-Executive Director |
Zhou Jie | 42 | Non-Executive Director |
Tsuyoshi Kawanishi | 81 | Independent Non-Executive Director |
Lip-Bu Tan | 50 | Independent Non-Executive Director |
Wang Zheng Gang | 59 | Alternate Director to Zhou Jie |
Senior Managers | ||
Chris Chi | 59 | Chief Business Officer |
Simon Yang | 51 | Chief Operating Officer |
Gary Tseng | 53 | Chief Financial Officer |
Barry Quan | 58 | Chief Administrative Officer |
Anne Chen | 47 | Company Secretary, Hong Kong Representative and Chief |
Compliance Officer | ||
Samuel Tsou | 53 | Vice President of Corporate Human Resources |
Zhou Mei Sheng | 52 | Vice President of Technology and Operations Office |
John Peng | 45 | Associate Vice President and General Manager of China BU |
1. | Semiconductor Manufacturing International (Shanghai) Corporation* (“SMIS” or “SMIC Shanghai”) Principal place of operation: Shanghai, PRC Place of incorporation: Shanghai, PRC Legal entity: Wholly foreign-owned enterprise Total investment: US$5,200,000,000 Registered capital: US$1,740,000,000 Equity holder: the Company (100%) |
|
2. | Semiconductor Manufacturing International (Beijing) Corporation* (“SMIB” or “SMIC Beijing”) Principal place of operation: Beijing, PRC Place of incorporation: Beijing, PRC Legal entity: Wholly foreign-owned enterprise Total investment: US$3,000,000,000 Registered capital: US$1,000,000,000 Equity holder: the Company (100%) |
|
3. | Semiconductor Manufacturing International (Tianjin) Corporation* (“SMIT” or “SMIC Tianjin”) Principal place of operation: Tianjin, PRC Place of incorporation: Tianjin, PRC Legal entity: Wholly foreign-owned enterprise Total investment: US$1,100,000,000 Registered capital: US$690,000,000 Equity holder: the Company (100%) |
|
4. | Semiconductor Manufacturing International (Chengdu) Corporation* (“SMICD” or “SMIC Chengdu”) Principal place of operation: Chengdu, PRC Place of incorporation: Chengdu, PRC Legal entity: Wholly foreign-owned enterprise Total investment: US$175,000,000 Registered capital: US$60,000,000 Equity holder: the Company (66.3%, indirectly through Semiconductor Manufacturing International (AT) Corporation) |
5. | SMIC Japan Corporation* Principal country of operation: Japan Place of incorporation: Japan Authorised capital: JPY10,000,000 divided into 200 shares of a par value of JPY50,000 Equity holder: the Company (100%) |
|
6. | SMIC, Americas | |
Principal
country of operation: U.S.A. Place of incorporation: California, US |
||
Registered
capital: No registered capital, authorized to issue 50,000,000 shares of
common stock Equity holder: the Company (100%) |
||
7. | Better Way
Enterprises Limited Principal country of operation: Samoa Place of incorporation: Samoa |
|
Authorised
capital: US$1,000,000 divided into 1,000,000 shares of a par value of
US$1.00 Issued share capital: US$1.00 Equity holder: the Company (100%) |
||
8. | SMIC Europe S.R.L. | |
Principal
place of operation: Agrate Brianza (Milan), Italy Place of incorporation: Agrate Brianza (Milan), Italy Registered capital: Euros100,000 Equity holder: the Company (100%) |
||
9. | Garrison Consultants Limited | |
Principal
country of operation: Samoa Place of incorporation: Samoa |
||
Authorised
capital: US$1,000,000 divided into 1,000,000 shares of a par value of
US$1.00 Issued share capital: US$1.00 Equity holder: the Company (100%, indirectly through Better Way Enterprises Limited) |
||
10. | Semiconductor Manufacturing International (AT) Corporation (“AT”)
Principal country of operation: Cayman Islands Place of incorporation: Cayman Islands |
|
Authorised
capital: US$1,900,000 divided into 100,000,000 ordinary shares of US$0.01
each and 90,000,000 Series A preference shares of US$0.01 each Equity holder: the Company (66.3%) |
||
11. | Semiconductor Manufacturing International (Solar Cell) Corporation
Principal country of operation: Cayman Islands Place of incorporation: Cayman Islands Authorised capital: US$11,000 Equity holder: the Company (100%) |
12. | ||
SMIC
Energy Technology (Shanghai) Corporation* (“Energy Science”)
Principal place of operation: Shanghai, PRC Place of incorporation: Shanghai, PRC Legal entity: Wholly foreign-owned enterprise Total investment: US$28,935,000 Registered capital: US$12,000,000 Equity holder: the Company (100%, indirectly through SMIC Solar Cell (HK) Company Limited) |
||
13. | SMIC Commercial (Shanghai) Limited Company Principal place of operation: Shanghai, PRC Place of incorporation: Shanghai, PRC Legal entity: Wholly foreign-owned enterprise Total investment: US$1,100,000 Registered capital: US$800,000 Equity holder: the Company (100%) |
14. | ||
SMIC
Development (Chengdu) Corporation* Principal place of operation: Chengdu, PRC Place of incorporation: Chengdu, PRC Legal entity: Wholly foreign-owned enterprise Total Investment: US$12,500,000 Registered capital: US$5,000,000 Equity holder: the Company (100%) |
||
15. | Magnificent Tower Limited Principal country of operation: British Virgin Islands Place of incorporation: British Virgin Islands Authorised capital: US$50,000 Issued share capital: US$1.00 Equity holder: the Company (100%, indirectly through Better Way Enterprises Limited) |
|
16. | SMIC Shanghai (Cayman) Corporation Principal country of operation: Cayman Islands Place of incorporation: Cayman Islands Authorised capital: US$50,000 Issued share capital: US$0.0004 Equity holder: the Company (100%) |
|
* | For identification purposes only |
17. | SMIC Beijing (Cayman) Corporation Principal country of operation: Cayman Islands Place of incorporation: Cayman Islands Authorised capital: US$50,000 Issued share capital: US$0.0004 Equity holder: the Company (100%) |
|
18. | SMIC Tianjin (Cayman) Corporation Principal country of operation: Cayman Islands Place of incorporation: Cayman Islands Authorised capital: US$50,000 Issued share capital: US$0.0004 Equity holder: the Company (100%) |
|
19. | SMIC Shanghai (HK) Company Limited Principal place of operation: Hong Kong Place of incorporation: Hong Kong Authorised capital: HK$1,000 Issued share capital: HK$1.00 Equity holder: the Company (100%, indirectly through SMIC Shanghai (Cayman) Corporation) |
|
20. | SMIC Beijing (HK) Company Limited Principal place of operation: Hong Kong Place of incorporation: Hong Kong Authorised capital: HK$1,000 Issued share capital: HK$1.00 Equity holder: the Company (100%, indirectly through SMIC Beijing (Cayman) Corporation) |
|
21. | SMIC Tianjin (HK) Company Limited Principal place of operation: Hong Kong Place of incorporation: Hong Kong Authorised capital: HK$1,000 Issued share capital: HK$1.00 Equity holder: the Company (100%, indirectly through SMIC Tianjin (Cayman) Corporation) |
|
22. | SMIC Solar Cell (HK) Company Limited Principal place of operation: Hong Kong Place of incorporation: Hong Kong Authorised capital: HK$10,000 Issued share capital: HK$1.00 Equity holder: the Company (100%, indirectly through Semiconductor Manufacturing International (Solar Cell) Corporation) |
23. | SMIC AT (HK) Company Limited Principal place of operation: Hong Kong Place of incorporation: Hong Kong Authorised capital: HK$10,000 Issued share capital: HK$1.00 Equity holder: the Company (66.3%, indirectly through Semiconductor Manufacturing International (AT) Corporation) |
|
24. | Semiconductor Manufacturing International (BVI)
Corporation Principal country of operation: British Virgin Islands Place of incorporation: British Virgin Islands Authorised capital: US$10.00 Issued share capital: US$10.00 Equity holder: the Company (100%) |
|
25. | Admiral Investment Holdings Limited Principal country of operation: British Virgin Islands Place of incorporation: British Virgin Islands Authorised capital: US$10.00 Issued share capital: US$10.00 Equity holder: the Company (100%) |
|
26. | SMIC Shenzhen (Cayman) Corporation Principal country of operation: Cayman Islands Place of incorporation: Cayman Islands Authorised capital: US$50,000 Issued share capital: US$0.0004 Equity holder: the Company (100%) |
|
27. | ||
SMIC
(Wuhan) Development Corporation* Principal place of operation: Wuhan, PRC Place of incorporation: Wuhan, PRC Legal entity: Wholly foreign-owned enterprise Total Investment: RMB$20,000,000 Registered capital: RMB$20,000,000 Equity holder: the Company (100%) |
||
* | For identification purposes only |
28. | SMIC Shenzhen (HK) Company Limited Principal place of operation: Hong Kong Place of incorporation: Hong Kong Authorised capital: HK$1,000 Issued share capital: HK$1.00 Equity holder: the Company (100%) |
|
29. | SilTech Semiconductor Corporation Principal country of operation: Cayman Islands Place of incorporation: Cayman Islands Authorised capital: US$10,000 Issued share capital: US$0.1 Equity holder: the Company (100%) |
|
30. | SilTech Semiconductor (Hong Kong) Corporation Limited Principal place of operation: Hong Kong Place of incorporation: Hong Kong Authorised capital: HK$1,000 Issued share capital: HK$1,000 Equity holder: the Company (100% indirectly through SilTech Semiconductor Corporation) |
|
31. | ||
Semiconductor Manufacturing International (Shenzhen) Corporation*
(“SMIC Shenzhen”)
Principal place of operation: Shenzhen, PRC Place of incorporation: Shenzhen, PRC Legal entity: Wholly foreign-owned enterprise Total Investment: US$30,000,000 Registered capital: US$12,000,000 Equity holder: the Company (100%) |
||
32. | SilTech Semiconductor (Shanghai) Corporation Limited Principal place of operation: Shanghai, PRC Place of incorporation: Shanghai, PRC Legal entity: Wholly foreign-owned enterprise Total investment: USD$35,000,000 Registered capital: USD$12,000,000 Equity holder: the Company (100%, indirectly through SilTech Semiconductor (HK) Corporation Limited) |
|
* | For identification purposes only |
Number of | |
Ordinary Shares | |
Outstanding | |
Outstanding Share Capital as at December 31, 2009 | 22,375,886,604 |
Approximate no. of Restricted Share Units (the actual | |
number of shares eventually to be issued may change due | |
Vesting Dates | to departure of eligible participants prior to vesting) |
2009 | |
1-Jan | 21,215,236 |
19-Jan | 12,500 |
21-Jan | 200,000 |
22-Jan | 12,600 |
29-Jan | 75,000 |
1-Feb | 270,000 |
13-Feb | 75,000 |
16-Feb | 75,000 |
1-Mar | 225,000 |
3-Mar | 250,000 |
19-Mar | 13,320 |
23-Mar | 175,000 |
1-Apr | 125,000 |
25-Apr | 50,000 |
29-Apr | 350,000 |
1-May | 75,000 |
15-May | 62,500 |
22-May | 8,750 |
1-Jun | 100,000 |
16-Jun | 125,000 |
21-Jun | 75,000 |
1-Jul | 937,236 |
1-Aug | 640,000 |
1-Sep | 10,367,188 |
13-Sep | 250,000 |
1-Oct | 782,500 |
16-Oct | 222,216 |
27-Oct | 50,000 |
1-Nov | 250,000 |
14-Nov | 50,000 |
1-Dec | 26,930 |
6-Dec | 100,000 |
12-Dec | 75,000 |
Approximate no. of Restricted Share Units (the actual | |
number of shares eventually to be issued may change due | |
Vesting Dates | to departure of eligible participants prior to vesting) |
2010 | |
1-Jan | 21,391,985 |
19-Jan | 12,500 |
21-Jan | 200,000 |
22-Jan | 12,600 |
29-Jan | 75,000 |
1-Feb | 270,000 |
13-Feb | 75,000 |
16-Feb | 75,000 |
1-Mar | 225,000 |
3-Mar | 250,000 |
19-Mar | 13,320 |
23-Mar | 175,000 |
1-Apr | 75,000 |
1-May | 75,000 |
15-May | 62,500 |
22-May | 8,750 |
1-Jun | 100,000 |
16-Jun | 125,000 |
21-Jun | 75,000 |
1-Jul | 640,090 |
1-Sep | 682,000 |
16-Sep | 75,000 |
1-Oct | 782,500 |
16-Oct | 222,216 |
27-Oct | 50,000 |
1-Nov | 250,000 |
14-Nov | 50,000 |
1-Dec | 26,930 |
6-Dec | 100,000 |
12-Dec | 75,000 |
Approximate no. of Restricted Share Units (the actual | |
number of shares eventually to be issued may change due | |
Vesting Dates | to departure of eligible participants prior to vesting) |
2011 | |
1-Jan | 14,682,638 |
2-Jan | 11,750 |
21-Jan | 200,000 |
22-Jan | 12,600 |
29-Jan | 75,000 |
1-Feb | 270,000 |
13-Feb | 75,000 |
16-Feb | 75,000 |
1-Mar | 25,000 |
19-Mar | 13,320 |
1-Apr | 75,000 |
1-May | 75,000 |
13-May | 12,500 |
15-May | 62,500 |
22-May | 8,750 |
1-Jun | 100,000 |
16-Jun | 125,000 |
21-Jun | 75,000 |
1-Jul | 430,000 |
1-Sep | 24,500 |
16-Oct | 150,000 |
27-Oct | 50,000 |
1-Nov | 250,000 |
14-Nov | 50,000 |
12-Dec | 75,000 |
2012 | |
1-Jan | 8,417,888 |
2-Jan | 11,750 |
21-Jan | 200,000 |
29-Jan | 75,000 |
1-Feb | 20,000 |
13-Feb | 75,000 |
16-Feb | 75,000 |
1-Apr | 75,000 |
13-May | 12,500 |
22-May | 8,750 |
27-Oct | 50,000 |
14-Nov | 50,000 |
2013 | |
1-Jan | 82,500 |
2014 | |
1-Jan | 11,750 |
Approximate | |||||
Percentage of | |||||
Aggregate Interests | |||||
Number of | to Total Issued | ||||
Board Member | Nature of Interest | Shares | Share Capital | ||
Jiang Shang Zhou | Personal Interest(1) | 1,000,000 | |||
Total | 1,000,000 | * | |||
Tsuyoshi Kawanishi(7) | Personal Interest(1) | 1,000,000 | |||
Personal Interest(2) | 500,000 | ||||
Personal Interest(3) | 1,500,000 | ||||
Total | 3,000,000 | * | |||
Lip-Bu Tan(7) | Personal Interest(1) | 1,000,000 | |||
Personal Interest(2) | 500,000 | ||||
Total | 1,500,000 | * | |||
Richard R. Chang | Personal Interest(4) | 38,729,500 | |||
(former President, Chief Executive | Personal Interest(5) | 17,600,000 | |||
Officer and Executive Director | Personal Interest(1) | 1,000,000 | |||
who resigned on | Corporate Interest(6) | 20,000,000 | |||
November 9, 2009) | Interest of Spouse | 9,790,000 | |||
Interest of Child under 18 | 11,200,000 | ||||
Total | 98,319,500 | * | |||
Yang Yuan Wang (former Chairman | Personal Interest(1) | 1,000,000 | |||
and Independent Non-executive | Personal Interest(2) | 500,000 | * | ||
Director who resigned on | |||||
June 23, 2009)(7) | |||||
Total | 1,500,000 | ||||
Edward S Yang (former | Personal Interest(1) | 1,000,000 | |||
Independent Non-executive | Personal Interest | 750,000 | |||
Director who resigned on | |||||
November 9, 2009) | |||||
Total | 1,750,000 | * |
1. | On February 17, 2009, each of Richard Ru Gin Chang, Tsuyoshi Kawanishi, Lip-Bu Tan, Yang Yuan Wang, Jiang Shang Zhou and Edward S Yang was granted an option to purchase 1,000,000 Ordinary Shares at a price per Ordinary Share of HK$0.27. 50% percent of these options vested on February 17, 2010 and the remaining 50% will be vested on February 17, 2011. These options will expire on the earlier of February 17, 2019 or 120 days after termination of the Director’s service to the Board, except for the options granted to (i) Yang Yuan Wang (who resigned as an Independent Non-executive Director on June 23, 2009 but continued to act as the Company’s Honorary Chairman and Chief Scientific Advisor) which will expire after termination of his services to the Company in his capacity as the Honorary Chairman and/or Chief Scientific Advisor of the Company; and (ii) Richard Ru Gin Chang (who resigned as President, Chief Executive Officer and Executive Director on November 9, 2009 but continued to act as the Company’s Advisor) which will expire after termination of his services to the Company in his capacity as Advisor of the Company. As of December 31, 2009, these options have not been exercised. | |
2. | Each Director was granted an option to purchase 500,000 Ordinary Shares at a price of US$0.132 per Ordinary Share. These options were fully vested on May 30, 2008 and will expire on the earlier of September 29, 2016 or 120 days after termination of the Director’s service to the Board, except for the options granted to (i) Yang Yuan Wang (who resigned as an Independent Non- Executive Director on June 23, 2009 but continued to act as the Company’s Honorary Chairman and Chief Scientific Advisor) which will expire after termination of his services to the Company in his capacity as the Honorary Chairman and/or Chief Scientific Advisor of the Company; and (ii) Richard Ru Gin Chang (who resigned as President, Chief Executive Officer and Executive Director on November 9, 2009 but continued to act as the Company’s Advisor) which will expire after termination of his services to the Company in his capacity as Advisor of the Company. As of December 31, 2009, these options have not been exercised. Jiang Shang Zhou and Fang Yao (who resigned as Non-executive Director on August 30, 2007) have declined receipt of such option. | |
3. | Tsuyoshi Kawanishi has been granted options to purchase an aggregate of 1,500,000 Ordinary Shares, if fully exercised. As of December 31, 2009, these options have not been exercised. | |
4. | Pursuant to a Charitable Pledge Agreement dated December 1, 2003, Richard Ru Gin Chang and his spouse, Scarlett K. Chang (collectively, the “Donors”) have pledged to transfer 10,000,000 Ordinary Shares as a charitable gift to The Richard and Scarlett Chang Family Foundation, a Delaware nonprofit nonstock corporation organized exclusively for religious, charitable, scientific, literary and education purposes within the meaning of Section 501(c)(3) of the US Internal Revenue Code of 1986, as amended, such transfer to be made in full at or prior to the death of the surviving Donor. In addition, 2,639,550 of such Ordinary Shares are jointly held by Richard Ru Gin Chang and his spouse, Scarlett K. Chang. | |
5. | The Compensation Committee has granted Richard Ru Gin Chang (who resigned as President, Chief Executive Officer and Executive Director on November 9, 2009 but continues to act as the Company’s Advisor) options to purchase an aggregate of 15,600,000 Ordinary Shares, if fully exercised, which will expire after termination of his services to the Company in his capacity as Advisor of the Company. Dr. Chang has also been granted an award of 2,000,000 Restricted Share Units (each representing the right to receive one Ordinary Share). As of December 31, 2009, none of these options has been exercised and 2,000,000 Ordinary Shares were issued pursuant to vesting of the Restricted Share Units. | |
6. | These Ordinary Shares are held by Jade Capital Company, LLC, a Delaware limited liability company (the “LLC”), of which Richard Ru Gin Chang and his spouse, Scarlett K. Chang (collectively, the “Members”), are the sole Members. It is the current intention of the Members that all or a portion of the net income of the LLC be used for philanthropic purposes, including but not limited to contributions to charitable organizations that are tax-exempt under Section 501(c)(3) of the US Internal Revenue Code of 1986, as amended. | |
7. | Each independent Non-executive Director and Non-executive Director was granted an option to purchase 500,000 Ordinary Shares at a price of US$0.22 per Ordinary Share. These options were fully vested on March 19, 2005 and expired on the earlier of November 9, 2009 or 120 days after termination of the Directors’ service to the Board. | |
8. |
On February 23, 2010,
each of Dr. Jiang Shang Zhou, Dr. David N. K. Wang, Mr. Tsuyoshi Kawanishi
and Mr. Lip-Bu Tan were granted an option to purchase 15,674,388,
62,697,553, 3,134,877 and 3,134,877 ordinary shares of the Company
(“Ordinary Shares”), respectively, at a price per Ordinary Share of
HK$0.77. These options are exercisable at the earliest on the expiry of 1
year after 23 February 2010 subject to earlier termination and other terms
and conditions, as provided under the Company’s 2004 Stock Option Plan and
any applicable award documents.
On February 23, 2010,
Dr. David N. K. Wang was granted an award of 26,870,379 Restricted Share
Units (each representing the right to receive one Ordinary Share) pursuant
to the Company’s 2004 Equity Incentive Plan. These Restricted Share Units
shall vest over 4 years as follows: 25% of the Restricted Share Units
shall vest on each anniversary of 23 February 2010, provided that Dr. Wang
has remained an employee of the Company through the applicable vesting
dates.
On February 23, 2010,
Dr. Jiang Shang Zhou, Chairman of the Board, was granted an award of
6,717,594 Restricted Share Units (each representing the right to receive
one Ordinary Share) pursuant to the Company’s 2004 Equity Incentive Plan.
These Restricted Share Units shall vest over 4 years as follows: 25% of
the Restricted Share Units shall vest on each anniversary of 23 February
2010.
|
Number of | |||
Name of Shareholder | Shares Held | Percentage Held | |
Datang Telecom Technology & Industry Holdings Co., Ltd. | 3,699,094,300 | 16.53% | |
(“Datang”) | (long position)(1) | (long position) | |
Shanghai Industrial Investment (Holdings) Company Limited | 420,008,000 | 1.88% | |
(“SIIC”) | (long position)(2) | (long position) | |
1,833,269,340 | 8.19% | ||
(long position)(3) | (long position) | ||
2,253,277,340 | 10.07% | ||
Total: | (long position) | (long position) | |
2,485,407,248 | 11.11% | ||
Taiwan Semiconductor Manufacturing Company Limited (“TSMC”) | (long position)(4) | (long position) |
(1) | All such Shares are held by Datang Holdings (Hongkong) Investment Company Limited which is a wholly-owned subsidiary of Datang Telecom Technology & Industry Holdings Co., Ltd. | |
(2) | All such ordinary shares are held by SIIC Treasury (B.V.I.) Limited which is a wholly-owned subsidiary of SIIC. | |
(3) | All such Shares are held by S.I. Technology Production Holdings Limited (“SITPHL”) which is an indirect wholly-owned subsidiary of SIIC. SITPHL is a wholly-owned subsidiary of Shanghai Industrial Financial (Holdings) Company Limited (“SIFHCL”) which in turn is a wholly-owned subsidiary of Shanghai Industrial Financial Holdings Limited (“SIFHL”) By virtue of the SFO, SIIC and its subsidiaries, SIFHCL and SIFHL are deemed to be interested in the 1,833,269,340 Shares held by SITPHL. As at June 30, 2009, the Company’s Director, Zhou Jie, is an executive director and the executive vice president of SIIC. He is also an executive director and the executive deputy CEO of Shanghai Industrial Holdings Limited. Wang Zheng Gang, alternate to Zhou Jie, is the Chief Representative of the Shanghai Representative Office of SIHL and the chairman of SIIC Management (Shanghai) Limited. It is the Company’s understanding that voting and investment control over the ordinary shares beneficially owned by SIIC are maintained by the board of directors of SIIC. | |
(4) | On November 9, 2009, the Company entered into a share and warrant issuance agreement with TSMC whereupon the Company conditionally agreed to issue to TSMC 1,789,493,218 ordinary shares (the “New Common Shares”) and a warrant (exercisable within three years of issuance) to subscribe for 695,914,030 shares of SMIC, subject to adjustment, at a purchase price of HK$1.30 per share (the “Warrant Shares”), subject to receipt of required government and regulatory approvals. Completion of the share and warrant issuance agreement is conditional upon, amongst other things, the obtaining of governmental approvals and the Listing Committee of the Stock Exchange agreeing to grant approvals for the listing of and permission to deal in the New Common Shares and the Warrant Shares. As at the latest practicable date, the transaction has not been completed and none of the New Common Shares and the Warrant Shares have been issued to TSMC. |
David | Gao | Yang | Jiang | Wang | ||||||||||||||||||||||||||||
N.K. | Chen | Yong | Edward | Zhou | Richard Ru | Tsuyoshi | Yuan | Ta-Lin | Lip-Bu | Henry | Fang | Albert | Shang | Zheng | ||||||||||||||||||
Wang | Shanzhi | Gang | S Yang | Jie | Gin Chang | Kawanishi | Wang | Hsu | Tan | Shaw | Yao | Y. C. Yu | Zhou | Gang | Total | |||||||||||||||||
2009 | ||||||||||||||||||||||||||||||||
Salaries and other benefits | $— | $— | $— | $— | $— | $273,029 | $— | $— | $— | $— | $— | $— | $— | $— | $— | $273,029 | ||||||||||||||||
Stock Option Benefits* | $— | $— | $— | $8,149 | $— | $47,299 | $8,149 | $8,149 | $— | $8,149 | $— | $— | $— | $8,149 | $— | $88,044 | ||||||||||||||||
Total | $— | $— | $— | $8,149 | $— | $320,328 | $8,149 | $8,149 | $— | $8,149 | $— | $— | $— | $8,149 | $— | $361,073 | ||||||||||||||||
2008 | ||||||||||||||||||||||||||||||||
Salaries and other benefits | $— | $— | $— | $— | $— | $218,398 | $— | $— | $— | $— | $— | $— | $— | $— | $— | $218,398 | ||||||||||||||||
Stock Option Benefits* | $— | $— | $— | $— | $— | $144,300 | $4,285 | $4,285 | $4,285 | $4,285 | $4,285 | $— | $12,489 | $— | $— | $178,214 | ||||||||||||||||
Total | $— | $— | $— | $— | $— | $362,698 | $4,285 | $4,285 | $4,285 | $4,285 | $4,285 | $— | $12,489 | $— | $— | $396,612 | ||||||||||||||||
2007 | ||||||||||||||||||||||||||||||||
Salaries and other benefits | $— | $— | $— | $— | $— | $195,395 | $— | $— | $— | $— | $— | $— | $— | $— | $— | $195,395 | ||||||||||||||||
Stock Option Benefits* | $— | $— | $— | $— | $— | $172,203 | $17,189 | $17,189 | $17,189 | $17,189 | $17,189 | $— | $50,094 | $— | $— | $308,242 | ||||||||||||||||
Total | $— | $— | $— | $— | $— | $367,598 | $17,189 | $17,189 | $17,189 | $17,189 | $17,189 | $— | $50,094 | $— | $— | $503,637 |
* | For a description of any options granted and exercised in 2009, please see the summary of grants of options as set forth under “Outstanding Share Options” in this annual report. |
2009 | 2008 | |||
(in US$) | (in US$) | |||
Salaries, housing allowances, other allowances, and benefits in kind | $1,147,923 | $941,001 | ||
Discretionary bonuses | — | — | ||
Stock option benefits* | $182,730 | $232,296 | ||
Amounts paid to induce member to join Board | — | — |
* | For a description of any options exercised in 2009, please see the summary of grants of options as set forth under “Outstanding Share Options” in this section of the annual report. |
Emoluments | Number of Individuals | ||
(in HK$) | 2009 | 2008 | |
$1,000,000–$1,500,000 | 1 | 1 | |
$1,500,001–$2,000,000 | 3 | 3 | |
$2,000,001–$2,500,000 | 1 | 1 |
1. | Indemnification Agreements | |
a. | Original Indemnification Agreements | |
On or around March 18, 2004, upon completion of the Global Offering, the Company entered into identical indemnification agreements with each director whose appointment as director took effect immediately upon the Global Offering (the “Global Offering Directors”), whereby the Company agreed to (inter alia) indemnify its Global Offering Directors in respect of liability arising from their capacity as Directors of the Company (collectively, the “Original Indemnification Agreements”). Pursuant to the Original Indemnification Agreements, the Company was obliged to indemnify each Global Offering Director, to the fullest extent permitted by law, against all costs, charges, expenses, liabilities, losses and obligations incurred in connection with any threatened, pending or completed action, suit, proceeding or alternative dispute resolution mechanism, or any hearing, inquiry or investigation which might lead to any of the foregoing (an “Applicable Claim”) by reason of or arising out of any event or occurrence relating to the fact that he is or was a Director of the Company, or any of its subsidiaries, or is or was serving at the Company’s request at another corporation or enterprise, or by reason of any activity or inactivity while serving in such capacity (an “Indemnifiable Event”). The Company’s obligation to indemnify its Global Offering Directors pursuant to the Original Indemnification Agreements was subject to certain exceptions and limitations set out therein. | ||
b. | New Indemnification Agreements | |
At the annual general meeting of the Company’s shareholders on May 6, 2005 (the “2005 AGM”), the Company’s shareholders, other than the Directors, chief executive officer of the Company and their respective Associates (as defined in the Listing Rules) approved an amendment to the form of the Original Indemnification Agreements (the “New Indemnification Agreement”). The New Indemnification Agreements executed by each of the Directors superseded the Original Indemnification Agreements which the Company had previously entered into with any existing directors and remained in effect until the entering into between the Company and directors of amended service contracts between October 7, 2008 and April 13, 2009 which include indemnity provisions. | ||
The New Indemnification Agreement reflected the then new requirements under Rules 14A.35 of the Listing Rules to set a term of no longer than three years and a maximum aggregate annual value for each connected transaction (as defined under the Listing Rules). The terms of the New Indemnification Agreements were the same as the Original Indemnification Agreements, except that the New Indemnification Agreements were subject to a term of three years and an Annual Cap (as defined and described below). |
The annual cap in relation to the New Indemnification Agreements was not to exceed a maximum aggregate annual value as disclosed in the Company’s previous announcement (the “Previous Limit”). Had the Previous Limit increased, the Company would have been required to make a further announcement and seek independent shareholders’ approval of the new maximum aggregate annual value of the New Indemnification Agreements. | ||
For the year ended December 31, 2009, no payment was made to any Director under the New Indemnification Agreements. | ||
Pursuant to Rule 14A.38 of the Listing Rules, the auditor of the Company performed certain agreed upon procedures in respect of the continuing connected transactions of the Company under the New Indemnification Agreements and reported its factual findings to the board of directors. Pursuant to Rule 14A.37 of the Listing Rules, the Independent Non-Executive Directors have reviewed the report of the auditors. | ||
2. | Strategic Cooperation Agreement | |
On December 24, 2008, upon completion of the Share Purchase Agreement pursuant to which Datang conditionally agreed to subscribe through a Hong Kong incorporated wholly owned subsidiary, and the Company conditionally agreed to allot and issue, shares representing 19.9% of the issued share capital of the Company prior to such issuance and approximately 16.6% following such issuance at a total purchase price of US$171.8 million, the Company and Datang entered into a strategic cooperation agreement (the “Strategic Cooperation Agreement”). | ||
Pursuant to the Strategic Cooperation Agreement, the Company intends to give priority to the production requirements of Datang, while Datang intends to give priority to engage or employ the fabrication services of the Group. In addition, the Company and Datang would share their technological research and development resources, co-operate in the development of international markets and globalization of their businesses, and make joint efforts to apply for PRC national and local projects in connection with scientific research and industrialisation relating to the integrated circuit sector. | ||
The pricing for the transactions contemplated under the Strategic Cooperation Agreement are determined based on market value. The Caps, being the maximum aggregate values of transactions under the Strategic Cooperation Agreement, are US$50,000,000 for the period commencing on June 23, 2009 and ending on December 31, 2009, and US$100,000,000 for the period commencing on January 1, 2010 and ending on December 23, 2010, respectively, were approved by the shareholders of the Company at its annual general meeting held on June 23, 2009. | ||
Pursuant to Rule 14A.38 of the Listing Rules, the auditor of the Company performed certain agreed upon procedures in respect of the continuing connected transactions of the Company under the Strategic Cooperation Agreement and reported its factual findings on these procedures to the Board of Directors. |
Pursuant to Rule 14A.37 of the Listing Rules, the Independent Non-Executive Directors have reviewed the report of the auditors and confirmed that the transactions under the Strategic Cooperation Agreement that took place between Datang and the Company (or any of its subsidiaries) for the year ended December 31, 2009 had been entered into: | |||
(1) | in the ordinary and usual course of business of the Company; | ||
(2) | on normal commercial terms or, if there are not sufficient comparable transactions to judge whether they are on normal commercial terms, on terms no less favourable to the Company than terms available to or from (as appropriate) independent third parties; and | ||
(3) | in accordance with the Strategic Cooperation Agreement on terms that are fair and reasonable and in the interests of the shareholders of the Company as a whole. |
As of December 31, | |||||||
Function | 2006 | 2007 | 2008 | 2009 | |||
Managers | 871 | 916 | 1,015 | 1,064 | |||
Professionals(1) | 3,790 | 4,096 | 4,465 | 4,510 | |||
Technicians | 4804 | 4,806 | 4,837 | 4,484 | |||
Clerical staff | 583 | 287 | 281 | 249 | |||
Total(2) | 10,048 | 10,105 | 10,598 | 10,307 |
(1) | Professionals include engineers, lawyers, accountants and other personnel with specialized qualifications, excluding managers. | |
(2) | Includes 275, 276, 50 and 372 temporary and part-time employees in 2006, 2007, 2008 and 2009 respectively. |
As of December 31, | |||||||
Location of Facility | 2006 | 2007 | 2008 | 2009 | |||
Shanghai | 6,400 | 6,292 | 6,632 | 6,460 | |||
Beijing | 1,827 | 1,877 | 1,674 | 1,552 | |||
Tianjin | 1,073 | 874 | 958 | 997 | |||
Chengdu | 715 | 1,023 | 1,259 | 1,104 | |||
Shenzhen | — | — | 33 | 154 | |||
United States | 16 | 18 | 16 | 17 | |||
Europe | 7 | 8 | 11 | 9 | |||
Japan | 7 | 9 | 8 | 8 | |||
Hong Kong | 3 | 4 | 7 | 6 | |||
Total | 10,048 | 10,105 | 10,598 | 10,307 |
Summary of the terms
of the Stock Option Plan
|
||
(a) | Purpose of the Stock Option Plan | |
The purposes of the Stock Option Plan are to attract, retain and motivate employees and Directors of, and other service providers to the Company, to provide a means of compensating them through the grant of stock options for their contribution to the Company’s growth and profits, and to allow such employees, Directors and service providers to participate in such growth and profitability. | ||
(b) | Who may join | |
The Compensation Committee may, at its discretion, invite any employee, officer or other service provider of (including, but not limited to, any professional or other adviser of, or consultant or contractor to) the Company whether located in China, the United States or elsewhere to take up options to subscribe for ordinary shares at a price calculated in accordance with sub-paragraph (e) below. The Compensation Committee may also grant stock options to a Director who is not an employee of the Company (“Non-Employee Director”). |
(c) | Stock Options | |
Stock options granted under the Stock Option Plan (“Stock Options”) shall entitle a participant (“Participant”) of the Stock Option Plan to purchase a specified number of ordinary shares or ADSs (the “Plan Shares”) during a specified period at a price calculated in accordance with sub-paragraph (e) below. Three types of Stock Options may be granted under the Plan, an Incentive Stock Option, a Non-Qualified Stock Option or a Director Option. An Incentive Stock Option is a stock option that falls within the meaning of Section 422 of the U.S. Internal Revenue Code of 1986 and may only be granted to employees of the Company and its subsidiaries from time to time. A Non-Qualified Stock Option is a stock option that is not an Incentive Stock Option. A Director Option is a Non-Qualified Stock Option granted to a Non-Employee Director. | ||
The Company shall issue an Award Document to each Participant of the Stock Option Plan who is granted a Stock Option. The Award Document shall set out the terms and provisions of the grant of a Stock Option to a Participant including applicable vesting dates or the attainment of specified performance goals (as determined by the Compensation Committee or the Administrator (as defined below), as the case may be) by the Participant. The Company may allow a Participant to exercise his or her Stock Options prior to vesting, provided the Participant agrees to enter into a repurchase agreement in respect of the Stock Option with the Company. The Compensation Committee may also (i) accelerate the vesting of a Stock Option, (ii) set the date on which any Stock Option may first become exercisable, or (iii) extend the period during which a Stock Option remains exercisable, except that no Stock Options may be exercised after the tenth anniversary of the date of grant. | ||
The Stock Option Plan does not provide for any payment upon application or acceptance of an option. | ||
(d) | Administration of the Stock Option Plan | |
The Compensation Committee shall be responsible for the administration of the Stock Option Plan. Its responsibilities include granting Stock Options to eligible individuals, determining the number of Plan Shares subject to each Stock Option, and determining the terms and conditions of each Stock Option. The Compensation Committee is not obligated to grant Stock Options to Participants in uniform terms. | ||
Accordingly, the terms and conditions which may be imposed may vary between Participants. Any determination by the Compensation Committee in relation to the carrying out and administering of the Stock Option Plan shall be final and binding. No member of the Compensation Committee shall be liable for any action or determination made in good faith, and the members of the Compensation Committee shall be entitled to indemnification and reimbursement in the manner provided in the Articles. | ||
The Compensation Committee may delegate some or all of its authority under the Stock Option Plan to an individual or individuals (each an “Administrator”) who may either be one or more of the members of the Committee or one or more of the officers of the Company. An individual’s status as an Administrator shall not affect his or her eligibility to participate in the Stock Option Plan. The Compensation Committee shall not delegate its authority to grant Stock Options to executive officers of the Company. | ||
(e) | Exercise Price | |
The exercise price per Plan Share purchasable under a Stock Option shall be fixed by the Committee at the time of grant or by a method specified by the Compensation Committee at the time of grant, but in no event shall be less than the Fair Market Value of a Plan Share on the date such Stock Option is granted. |
The Fair Market Value of a Share will be the higher of (i) the closing price of the ordinary shares on the HKSE’s daily quotation sheet on the applicable date of grant (which must be a business day), and (ii) the average closing price of the ordinary shares on the HKSE (as stated in the relevant daily quotation sheets of the HKSE) for the five business days immediately preceding the date of grant. | ||
The Fair Market Value of the ADSs shall be the highest of (i) the closing price of the ADSs on the NYSE on the applicable date of grant, and (ii) the average closing price of the ADSs on the NYSE for the five business days immediately preceding the date of grant. | ||
(f) | Limit of the Stock Option Plan | |
At the annual general meeting of the shareholders held on June 23, 2009, the shareholders of the Company approved an increase to the number of ordinary shares reserved for issuance under the Stock Option Plan and the ESPP (the “Global Limit”) from 1,317,000,000 ordinary shares of the Company to 2,434,667,733 ordinary shares of the Company. | ||
The number of ordinary shares which may be issued pursuant to any outstanding Stock Options granted and yet to be exercised under the Stock Option Plan and all outstanding purchase rights granted under the Employee Stock Purchase Plan or other employee stock purchase plan of the Company must not exceed in aggregate 30 percent of the issued and outstanding ordinary shares in issuance from time to time. | ||
(g) | Individual Limit | |
The total number of ordinary shares underlying Stock Options or other options granted by the Company to, and the total number of ordinary shares that may be purchased under one or more purchase rights granted under the Employee Stock Purchase Plan or any other employee stock purchase plan granted by the Company by, a Participant (including both exercised and outstanding Stock Options) in any twelve-month period may not exceed at any time one percent (1%) (or 0.1 percent in the case of an independent Non-executive Director) of the then issued and outstanding ordinary shares unless otherwise allowed under the Listing Rules. | ||
(h) | Exercise of Option | |
A Stock Option shall vest, and be exercised, in accordance with the terms of the Stock Option Plan, the relevant Award Document and any rules and procedures established by the Compensation Committee for this purpose. However, the term of each Stock Option shall not exceed ten years from the date of grant. | ||
(i) | Director Options | |
Each non-employee Director may be granted Stock Options to purchase ordinary shares (or an equivalent of ADSs) on the terms set out in the relevant Award Document. | ||
The Directors shall exercise all authority and responsibility with respect to Stock Options granted to Directors subject to the requirements of the Listing Rules. | ||
All non-employee Directors’ Stock Options shall only vest provided that the Director has remained in service as a Director through such vesting date. The unvested portion of a Stock Option granted to a Director shall be forfeited in full if the Director’s service with the Board ends for any reason prior to the applicable vesting date. |
Following termination of a non-employee Director’s service on the Board, such non-employee Director (or his or her estate, personal representative or beneficiary, as the case may be) shall be entitled to exercise those of his or her Stock Options which have vested as of the date of such termination within 120 days following such termination. | ||||
(j) | Termination or Lapse of Option | |||
A Stock Option shall terminate or lapse automatically on: | ||||
(i) | the expiry of ten years from the date of grant; | |||
(ii) | the termination of a Participant’s employment or service relationship with the Company for a reason set out in sub-paragraph (l) below; | |||
(iii) | save as to any contrary directions of the Compensation Committee, in the event of a complete liquidation or dissolution of the Company, all Stock Options outstanding at the time of the liquidation or dissolution shall terminate without further action by any person; | |||
(iv) | the sale or other divestiture of a subsidiary, division or operating unit of the Company (where the Participant is employed by such subsidiary, division or operating unit); and | |||
(v) | termination of the service relationship with a service provider (where the Participant is a service provider of the Company). | |||
(k) | Rights are personal to Participant | |||
A Stock Option is personal to the Participant and shall be exercisable by such Participant or his Permitted Transferee (as defined below) only. An option shall not be transferred other than by will, by the laws of descent and distribution or pursuant to a domestic relations order. The Compensation Committee may also, at its discretion and subject to such terms and conditions as it shall specify, permit the transfer of a Stock Option for no consideration to a Participant’s family members or to a trust or partnership established for the benefit of such family members (collectively “Permitted Transferees”). Any Stock Option transferred to a Permitted Transferee shall be further transferable only by will or the laws of descent and distribution or, for no consideration, to another Permitted Transferee of the Participant. | ||||
(l) | Termination of employment or service | |||
If a Participant’s employment or service with the Company is terminated for the following reasons: | ||||
(i) | the failure or refusal of the Participant to substantially perform the duties required of him or her as an employee or officer of, or service provider to, the Company; | |||
(ii) | any material violation by the Participant of any law or regulation applicable to any business of the Company, or the Participant’s conviction of, or a plea of nolo contendere to, a felony, or any perpetration by the Participant of a common law fraud against the Company; or | |||
(iii) | any other misconduct by the Participant that is materially injurious to the financial condition, business or reputation of the Company. | |||
Then all Stock Options granted to the Participant, whether or not then vested, shall immediately lapse. |
The Compensation Committee may permit any Incentive Stock Option to convert into a Non-Qualified Stock Option as of a Participant’s termination of employment for purposes of providing such Participant with the benefit of any extended exercise period applicable to Non-Qualified Stock Options when the contract of employment of the holder of Incentive Stock Option terminates. | ||
(m) | Change in control of the Company | |
The Compensation Committee may specify at or after the date of grant of a Stock Option the effect that a Change in Control (as defined in the Stock Option Plan) will have on such Stock Option. The Compensation Committee may also, in contemplation of a Change in Control, accelerate the vesting, exercisability or payment of Stock Options to a date prior to the Change in Control, if the Compensation Committee determines that such action is necessary or advisable to allow the participants to realise fully the value of their share options in connection with such Change in Control. | ||
(n) | Change in the capital structure of the Company | |
In the event of an alteration in the capital structure of the Company (which includes a capitalisation issue, reduction of capital, consolidation, sub-division of Plan Shares, or rights issue to purchase Plan Shares at a price substantially below market value), the Compensation Committee may equitably adjust the number and kind of Plan Shares authorised for issuance in order to preserve the benefits or potential benefits intended to be made available under the Stock Option Plan. In addition, upon the occurrence of any of the foregoing events, the number of outstanding Stock Options and the number and kind of shares subject to any outstanding Stock Option and the purchase price per share under any outstanding Stock Option shall be equitably adjusted so as to preserve the benefits or potential benefits intended to be made available to Participants. | ||
(o) | Period of the Stock Option Plan | |
The Stock Option Plan shall remain in force for a period of ten years commencing on the date of Shareholders’ approval of the Plan. | ||
(p) | Amendments and Termination | |
The Stock Option Plan may be altered, amended in whole or in part, suspended and terminated by the Board at any time provided alterations or amendments of a material nature or any change to the terms of the Stock Options granted must be approved by the shareholders of the Company, unless such alteration or amendment takes effect automatically under the terms of the Stock Option Plan. For the avoidance of doubt, any alteration or amendment pursuant to the exercise of any authority granted under the Stock Option Plan shall be deemed to take effect automatically under the terms of the Share Option Plan. Any alteration or amendment must be in accordance with the requirements of applicable laws, the Listing Rules and permitted by the HKSE. | ||
If the Stock Option Plan is terminated early by the Board, no further Stock Options may be offered but unless otherwise stated in the Plan, Stock Options granted before such termination shall continue to be valid and exercisable in accordance with the Stock Option Plan. | ||
(q) | Voting and dividend rights | |
No voting rights shall be exercisable and no dividends shall be payable in relation to Stock Options that have not been exercised. |
(r) | Cancellation of Stock Options | |
Stock Options granted but not exercised may not be cancelled unless an offer to cancel share options has been made pursuant to Rule 13 of the Hong Kong Code on Takeovers and Mergers and the Hong Kong Securities and Futures commission has consented to such cancellation. | ||
(s) | Ranking of Ordinary Shares | |
The ordinary shares to be allotted upon the exercise of a Stock Option will be subject to the then effective Articles and will rank pari passu with the Plan Shares in issue on the date of such allotment. |
(a) | Purposes of the ESPP | |||
The purposes of the ESPP are to attract, retain and motivate employees of the Company, to provide a means of compensating the employees for their contributions to the growth and profitability by permitting such employees to purchase the ADSs of the Company at a discount and receive favourable U.S. income tax treatment on a subsequent qualifying disposition of such ADSs. | ||||
(b) | Who may join | |||
Subject to any contrary directions given by the Compensation Committee, all full-time and regular part-time employees (the “Employees”) of the Company as at the first business day (the “Offering Date”) of a given period specified by the Committee (the “Offering Period”) shall be eligible to enroll in the ESPP. To be eligible to purchase ADSs, all Employees must maintain his or her employment status, without interruption, with the Company through the last day of the applicable Offering Period (the “Purchase Date”). | ||||
(c) | Offering Period | |||
The ESPP shall be implemented by a series of Offering Periods. An eligible Employee of the Company may elect to participate in the ESPP for any Offering Period by completing the requisite documents. The Compensation Committee shall determine the starting and ending dates of each Offering Period but no Offering Period shall be shorter than 6 months or longer than 27 months. | ||||
(d) | Employees’ Contributions under the ESPP | |||
All amounts that a Participant contributes (“Contributions”) shall be credited to his or her account under the ESPP. Participants must elect to have payroll deductions made on each payday during the Offering Period in a dollar amount specified in the documents submitted by him or by her. The Compensation Committee may permit Participants to make supplemental Contributions into his or her account, on such terms and subject to such limitations as the Compensation Committee may decide. | ||||
Participants may, on one occasion only during an Offering Period, decrease the rate of his or her Contributions to his or her account for the Offering Period, including a decrease to zero. The Participant may restore his or her Contributions to the original level, prior to the earlier of, | ||||
(i) | six months after the effective date of any such decrease; and | |||
(ii) | the end of the relevant Offering Period. |
(e) | Grant of Purchase Right | |||
Each eligible Employee who elects to participate in the ESPP in any given Offering Period shall be granted on the Purchase Date, a right to purchase the Plan Shares (the “Purchase Right”). The Purchase Right of a Participant shall be calculated in accordance with the following formula: | ||||
(i) | dividing (A) the product of US$25,000 and the number of calendar years during all or part of which the Purchase Right shall be outstanding by (B) the closing price of the Plan Shares on the applicable exchange on which Plan Shares are trading (the “Fair Market Value”) on the applicable exchange of the Plan Shares on the Offering Date; and | |||
(ii) | subtracting from the quotient thereof (A) the number of Plan Shares that the Employee has purchased during the calendar year in which the Offering Date occurs under the ESPP or under any other employee stock purchase plan of the Company or any subsidiary of the Company which is intended to qualify under Section 423 of the U.S. International Revenue Code of 1986 plus (B) the number of Plan Shares subject on the Offering Date to any outstanding Purchase Rights granted to the Employee under any related Plan. | |||
If application of the above formula would result in the grant of Purchase Rights covering, in the aggregate, more than the number of Plan Shares that the Compensation Committee has made available for the relevant Offering Period, then the Compensation Committee shall adjust the number of Plan Shares subject to the Purchase Right in order that, following such adjustment, the aggregate number of Plan Shares subject to the purchase Right shall remain within the applicable limit. | ||||
All Purchase Rights outstanding at the tenth anniversary of the Plan shall remain outstanding through, and may be exercised upon the relevant Purchase Date, but no additional Purchase Right shall be granted under the ESPP. | ||||
(f) | Exercise of Purchase Right | |||
Unless a Participant withdraws from the ESPP, his or her Purchase Right shall become exercisable automatically, on the Purchase Date of the relevant Offering Period for the number of Plan Shares obtained by dividing the accumulated Contributions credited to the Participant’s account as of the Purchase Date by the applicable Purchase Price, being an amount not less than 85 percent of the Fair Market Value of the Plan Shares on the Offering Date or on the Purchase Date, whichever is lower (the “Purchase Price”). | ||||
The Compensation Committee may credit any Contributions that have been credited to a Participant’s account under the ESPP with interest. Any interest credited to a Participant’s account shall not be used to purchase Plan Shares and shall instead be paid to the Participant at the end of the relevant Offering Period. | ||||
If any portion of a Participant’s accumulated Contributions is not used to purchase Plan Shares on a given Purchase Date, the remaining amount shall be held in the Participant’s account and used for the purchase of Plan Shares under the next Offering Period, unless the Participant withdraws from the next Offering Period. | ||||
The exercise of the Purchase Right granted under the ESPP is not subject to any performance target. |
(g) | Limit of the ESPP | |||
At the annual general meeting of the shareholders held on June 23, 2009 the shareholders of the Company approved an increase the number of ordinary shares reserved for issuance under the Stock Option Plan and the ESPP (the “Global Limit”) from 1,317,000,000 ordinary shares of the Company to 2,434,667,773 ordinary shares of the Company. | ||||
The number of ordinary shares that may be issued upon exercise of all outstanding Purchase Rights granted under the ESPP or other employee stock purchase plan of the Company or and any outstanding stock options granted under the Stock Option Plan or other stock option plan of the Company must not exceed, in the aggregate, thirty percent of the issued and outstanding ordinary shares in issuance from time to time. | ||||
(h) | Period of the ESPP | |||
The ESPP shall continue for a term of ten years from the date of its approval by the Shareholders unless terminated in accordance with sub-paragraph (i). | ||||
(i) | Amendments and Termination of the ESPP | |||
The Compensation Committee may at any time amend the ESPP in any respect or terminate the ESPP, except that, without the approval of the Company’s shareholders at a meeting duly called, no amendment shall be made in relation to: | ||||
(i) | increasing the number of ADSs approved for the ESPP; or | |||
(ii) | decreasing the Purchase Price per ADSs. | |||
Any alterations or amendments of a material nature or any change to the terms of the Purchase Rights granted must be approved by the shareholders of the Company, unless such alteration or amendment takes effect automatically under the terms of the ESPP. For the avoidance of doubt, any alteration or amendment pursuant to the exercise of any authority granted under the ESPP shall be deemed to take effect automatically under the terms of the ESPP. Any amendment made to the ESPP must be in accordance with applicable law, the requirements of the Listing Rules or permitted by the SEHK. | ||||
If the ESPP is terminated by the Board prior to the tenth anniversary of the date of Board approval, unless the Compensation Committee has also terminated any Offering Period then in progress, Purchase Rights granted before such termination shall continue to be valid and exercisable in accordance with, and subject to, the terms and conditions of the Plan. | ||||
Rule 17.03(9) of the Listing Rules provide that the exercise price of any share option scheme operated by listed issuers may not be lower than effectively the market price of the ordinary shares. As a result of the capital intensive nature of the Company’s business, we have traditionally relied on share options, rather than cash, as an important means of remunerating our employees. This is common in the industry and we wish to continue this practice. Accordingly, we have applied to and obtained from the SEHK a waiver from strict compliance with Rule 17.03(9) of the Listing Rules such that the Company is allowed to continue to grant options over its Plan Shares to its employees under the ESPP at an exercise price which is at a discount (up to 15 percent discount) to the lower of market price at the commencement of the offering period or the market price on the purchase date. | ||||
Up and until December 31, 2009, the Company has not granted any purchase right under the ESPP. |
(a) | Purpose of the Subsidiary Plan | |
The purposes of the Subsidiary Plan are to attract, retain and motivate employees and directors of and other service providers to the Group, to provide a means of compensating them through the grant of stock options for their contributions to the growth and profits of the Group, and to allow such employees, directors and service providers to participate in such growth and profitability. | ||
(b) | Who may join | |
The Compensation Committee of the board of directors of the relevant subsidiary (the “Subsidiary Committee”) may, at its discretion, invite any employee, officer or other service provider of (including, but not limited to, any professional or other adviser of, or consultant or contractor to) the Group whether located in China, the United States or elsewhere to take up options to subscribe for shares (“Subsidiary Shares”) in the relevant subsidiary(ies) which has or have adopted the Subsidiary Plan at a price calculated in accordance with sub-paragraph (e) below. The Subsidiary Committee may also grant stock options to a director who is not an employee of the Company or the relevant subsidiary (“Non-Employee Subsidiary Director”). | ||
(c) | Stock Options | |
Stock Options granted under the Subsidiary Plan (“Stock Options”) shall entitle a participant (“Subsidiary Participant”) of the Subsidiary Plan to purchase a specified number of Subsidiary Shares during a specified period at a price calculated in accordance with sub-paragraph (e) below. Three types of Stock Options may be granted under a Subsidiary Plan, an Incentive Stock Option, a Non-Qualified Stock Option or a Director Option. An Incentive Stock Option is a stock option that falls within the meaning of Section 422 of the U.S. Internal Revenue Code of 1986 (the “Code”) and may only be granted to employees of the Company and its subsidiaries from time to time. A Non Qualified Stock Option is a stock option that is not an Incentive Stock Option. A Director Option is a Non-Qualified Stock Option granted to a Non-Employee Subsidiary Director. | ||
The relevant subsidiary shall issue an Award Document to each Participant of the Subsidiary Plan who is granted a Stock Option. The Award Document shall set out the terms and provisions of the grant of a Stock Option to a Participant including applicable vesting dates or the attainment of specified performance goals (as determined by the Subsidiary Committee or the Administrator (as defined below), as the case may be) by the Subsidiary Participant. The relevant subsidiary may allow a Subsidiary Participant to exercise his or her Stock Options prior to vesting, provided the Subsidiary Participant agrees to enter into a repurchase agreement in respect of the Stock Option with the relevant subsidiary. The Subsidiary Committee may also (i) accelerate the vesting of a Stock Option, (ii) set the date on which any Stock Option may first become exercisable, or (iii) extend the period during which a Stock Option remains exercisable, except that no Stock Options may be exercised after the tenth anniversary of the date of grant. | ||
The Subsidiary Plan does not provide for any payment upon application or acceptance of an option. |
(d) | Administration of the Subsidiary Plan | |||||
The Subsidiary Committee shall be responsible for the administration of the Subsidiary Plan. Its responsibilities include granting Stock Options to eligible individuals, determining the number of Subsidiary Shares subject to each Stock Option, and determining the terms and conditions of each Stock Option. The Subsidiary Committee is not obliged to grant Stock Options to Subsidiary Participants in uniform terms. | ||||||
Accordingly, the terms and conditions which may be imposed may vary between Subsidiary Participants. Any determination by the Subsidiary Committee in relation to the carrying out and administering of the Subsidiary Plan in accordance with its terms shall be final and binding. No member of the Subsidiary Committee shall be liable for any action or determination made in good faith, and the members of the Subsidiary Committee shall be entitled to indemnification and reimbursement in the manner provided in the articles of association, by-laws or other equivalent constitutional document of the relevant subsidiary. | ||||||
The Subsidiary Committee may delegate some or all of its authority under the Subsidiary Plan to an individual or individuals (each an “Administrator”) who may either be one or more of the members of the Subsidiary Committee or one or more of the officers of the Company or relevant subsidiaries. An individual’s status as an Administrator shall not affect his or her eligibility to participate in the Subsidiary Plan. The Subsidiary Committee shall not delegate its authority to grant Stock Options to executive officers of the Company or its subsidiaries. | ||||||
(e) | Exercise Price | |||||
The exercise price per Subsidiary Share purchasable under a Stock Option shall be fixed by the Subsidiary Committee at the time of grant or by a method specified by the Subsidiary Committee at the time of grant, but, subject always to and in accordance with applicable requirements of the Listing Rules or permission of the Stock Exchange: | ||||||
(i) | in the case of an Incentive Stock Option: | |||||
(1) | granted to a Ten Percent Holder, the exercise price shall be no less than 110% of the Fair Market Value per Subsidiary Share on the date of grant; and | |||||
(2) | granted to any other Subsidiary Participant, the exercise price shall be no less than 100% of the Fair Market Value per Subsidiary Share on the date of grant; and | |||||
(ii) | in the case of any Stock Option: | |||||
(1) | granted to a Ten Percent Holder who is a resident of the State of California, the exercise price shall be no less than 110% of the Fair Market Value per Subsidiary Share on the date of grant; and | |||||
(2) | granted to any other Subsidiary Participant who is a resident of the State of California, the exercise price shall be no less than 85% of the Fair Market Value per Subsidiary Share on the date of grant. | |||||
A Ten
Percent Holder is any Participant who owns more than 10% of the total
combined voting power of all classes of outstanding securities of the
relevant subsidiary or any parent or subsidiary (as such terms are defined
in and determined in accordance with the Code) of the relevant
subsidiary.
|
Fair Market Value shall be determined as follows: | ||||
(i) | If the Subsidiary Shares are listed on any established stock exchange or a national market system, including without limitation the NYSE, The Nasdaq Global Market or The Nasdaq Capital Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such Subsidiary Shares (or the closing bid, if no sales were reported) as quoted on such exchange or system on the day of determination, as reported in The Wall Street Journal or such other source as the Administrator deems reliable; | |||
(ii) | If the Subsidiary Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, its Fair Market Value shall be the mean between the high bid and low asked prices for the Subsidiary Shares on the day of determination, as reported in The Wall Street Journal or such other source as the Administrator deems reliable; or | |||
(iii) | In the absence of an established market for the Subsidiary Shares, the Fair Market Value thereof shall be determined in good faith by the Subsidiary Committee in accordance with any applicable law, rule or regulation. | |||
(f) | Limit of the Subsidiary Plan | |||
The number of Subsidiary Shares that may be issued under the Subsidiary Plan and all other schemes of the relevant subsidiary involving the grant by such subsidiary of options over or other similar rights to acquire new shares or other new securities of such subsidiary (“Other Schemes”) shall not exceed ten percent of the issued and outstanding Subsidiary Shares of such subsidiary on the date of approval of the Subsidiary Plan by the board of directors of the relevant subsidiary (the “Subsidiary Board”). | ||||
The number of Subsidiary Shares which may be issued pursuant to any outstanding Stock Options granted and yet to be exercised under the Subsidiary Plan and all Other Schemes of the relevant subsidiary must not exceed in aggregate 30 percent of the issued and outstanding Subsidiary Shares of the relevant subsidiary in issuance from time to time. | ||||
(g) | Individual Limit | |||
The total number of Subsidiary Shares underlying Stock Options or other options granted by the relevant subsidiary to a Subsidiary Participant (including both exercised and outstanding Stock Options) in any twelve-month period may not exceed at any time one percent (1%) (or 0.1 percent in the case of an independent non-executive Director of the Company) of the then issued and outstanding Subsidiary Shares unless otherwise allowed under the Listing Rules. | ||||
(h) | Exercise of Option | |||
A Stock Option shall vest, and be exercised, in accordance with the terms of the Subsidiary Plan, the relevant Award Document and any rules and procedures established by the Subsidiary Committee for this purpose. However, the term of each Stock Option shall not exceed ten years from the date of grant, provided that any Incentive Stock Option granted to a Ten Percent Holder shall not by its terms be exercisable after the expiration of five (5) years from the date of grant. | ||||
(i) | Director Options | |||
Each Non-Employee Subsidiary Director may be granted Stock Options to purchase Subsidiary Shares on the terms set out in the relevant Award Document. |
The
directors shall exercise all authority and responsibility with respect to
Stock Options granted to directors subject to the requirements of the
Listing Rules.
All
Non-Employee Subsidiary Directors’ Stock Options shall only vest provided
that the director has remained in service as a director through such
vesting date. The unvested portion of a Stock Option granted to a director
shall be forfeited in full if the director ’s service with the Company or
the relevant subsidiary ends for any reason prior to the applicable
vesting date.
Following
termination of a Non-Employee Subsidiary Director ’s service on the Board,
such Non-Employee Subsidiary Director (or his or her estate, personal
representative or beneficiary, as the case may be) shall be entitled to
exercise those of his or her Stock Options which have vested as of the
date of such termination within 120 days following such
termination.
|
||||
(j) | Termination or lapse of Option | |||
A Stock Option shall terminate or lapse automatically on: | ||||
(i) | the expiry of ten years from the date of grant; | |||
(ii) | the termination of a Subsidiary Participant’s employment or service with the relevant subsidiary for a reason set out in sub-paragraph (l) below; | |||
(iii) | save as to any contrary directions of the Subsidiary Committee with the prior approval of the Board of Directors of the Company, in the event of a complete liquidation or dissolution of the relevant subsidiary, all Stock Options outstanding at the time of the liquidation or dissolution shall terminate without further action by any person; | |||
(iv) | the sale or other divestiture of a subsidiary, division or operating unit of the Company (where the Subsidiary Participant is employed by such subsidiary, division or operating unit); and | |||
(v) | termination of the service relationship with a service provider (where the Subsidiary Participant is a service provider of the Company or its subsidiaries). | |||
(k) | Rights are personal to Subsidiary Participant | |||
A Stock Option is personal to the Subsidiary Participant and shall be exercisable by such Subsidiary Participant or his Permitted Transferee (as defined below) only. An option shall not be transferred other than by will, by the laws of descent and distribution or pursuant to a domestic relations order. The Subsidiary Committee may also, at its discretion and subject to such terms and conditions as it shall specify, permit the transfer of a Stock Option for no consideration to a Subsidiary Participant’s family members or to a trust or partnership established for the benefit of such family members (collectively “Permitted Transferees”). Any Stock Option transferred to a Permitted Transferee shall be further transferable only by will or the laws of descent and distribution or, for no consideration, to another Permitted Transferee of the Subsidiary Participant. | ||||
(l) | Termination of employment or service | |||
If a Subsidiary Participant’s employment or service with the relevant member(s) of the Group is terminated for the following reasons: | ||||
(i) | the failure or refusal of the Subsidiary Participant to substantially perform the duties required of him or her as an employee or officer of, or service provider to, the relevant member(s) of the Group; |
(ii) | any material violation by the Subsidiary Participant of any law or regulation applicable to any business of any relevant member(s) of the Group, or the Subsidiary Participant’s conviction of, or a plea of nolo contendere to, a felony, or any perpetration by the Subsidiary Participant of a common law fraud against any relevant member(s) of the Group; or | |||
(iii) | any other misconduct by the Subsidiary Participant that is materially injurious to the financial condition, business or reputation of the Group, then all Stock Options granted to the Subsidiary Participant, whether or not then vested, shall immediately lapse. | |||
The Subsidiary Committee may permit any Incentive Stock Option to convert into a Non-Qualified Stock Option as of a Subsidiary Participant’s termination of employment for purposes of providing such Subsidiary Participant with the benefit of any extended exercise period applicable to Non-Qualified Stock Options when the contract of employment of the holder of Incentive Stock Option terminates. | ||||
(m) | Change in control of the Company | |||
The Subsidiary Committee must seek the prior approval of the Board of Directors of the Company and may, subject to such prior approval by the Board of Directors of the Company, specify at or after the date of grant of a Stock Option the effect that a Change in Control (as defined in the Subsidiary Plan) will have on such Stock Option. The Subsidiary Committee may also, subject to such prior approval by the Board of Directors of the Company, in contemplation of a Change in Control, accelerate the vesting, exercisability or payment of Stock Options to a date prior to the Change in Control, if the Subsidiary Committee determines that such action is necessary or advisable to allow the participants to realise fully the value of their share options in connection with such Change in Control. | ||||
(n) | Change in the capital structure of the Company | |||
In the event of an alteration in the capital structure of the relevant subsidiary (which includes a capitalisation issue, reduction of capital, consolidation, sub-division of Subsidiary Shares, or rights issue to purchase Subsidiary Shares at a price substantially below market value), the Subsidiary Committee may equitably adjust the number and kind of Subsidiary Shares authorised for issuance in order to preserve, the benefits or potential benefits intended to be made available under the Subsidiary Plan. In addition, upon the occurrence of any of the foregoing events, the number of outstanding Stock Options and the number and kind of shares subject to any outstanding Stock Option and the purchase price per share under any outstanding Stock Option shall be equitably adjusted so as to preserve the benefits or potential benefits intended to be made available to Subsidiary Participants. | ||||
(o) | Period of the Subsidiary Plan | |||
The form of the Subsidiary Plan shall be approved by the shareholders of the Company and of the relevant subsidiary respectively, and shall become effective upon its approval by the Subsidiary Board in accordance with the terms thereof. Each Subsidiary Plan shall remain in force for a period of ten years commencing on the date of Subsidiary Board approval of the relevant Subsidiary Plan. | ||||
(p) | Amendments and Termination | |||
The Subsidiary Plan may be changed, altered, amended in whole or in part, suspended and terminated by the Subsidiary Board, subject to such prior approval by the Board of Directors of the Company, at any time provided alterations or amendments of a material nature or any change to the terms of the Stock Options granted, or any change to the authority of the Subsidiary Board or the Subsidiary Committee in relation to any alteration to the terms of the Subsidiary Plan, must be approved by the shareholders of the Company, unless such change, alteration or amendment takes effect automatically under the terms of the Subsidiary Plan. For the avoidance of doubt, any change, alteration or amendment pursuant to the exercise of any authority granted under a Subsidiary Plan shall be deemed to take effect automatically under the terms of the relevant Subsidiary Plan. Any change, alteration or amendment must be in accordance with the requirements of the Listing Rules or permitted by the Hong Kong Stock Exchange. |
The
Subsidiary Board may, subject to prior approval by the Board of Directors
of the Company, at any time and from time to time make such changes,
alterations or amendments to the Subsidiary Plan as may be necessary or
desirable, including (without limitation) changes, alterations or
amendments:
|
||||
(i) | relating to local legal, regulatory and/or taxation requirements and/or implications applicable to the relevant subsidiary and/or Eligible Participants; and/or | |||
(ii) | for the purposes of clarification, improvement or facilitation of the interpretation, and/or application of the terms of the Subsidiary Plan and/or for the purposes of improving or facilitating the administration of the Subsidiary Plan, and other changes, alterations or amendments of a similar nature. | |||
If the Subsidiary Plan is terminated early by the Subsidiary Board, subject to prior approval by the Board of Directors of the Company, no further Stock Options may be offered but unless otherwise stated in the Subsidiary Plan. Stock Options granted before such termination shall continue to be valid and exercisable in accordance with the Subsidiary Plan. | ||||
(q) | Voting and dividend rights | |||
No voting rights shall be exercisable and no dividends shall be payable in relation to Stock Options that have not been exercised. | ||||
(r) | Cancellation of Stock Options | |||
If the relevant subsidiary is or becomes a public company (within the meaning of the Hong Kong Code on Takeovers and Mergers), then in the case of a Change in Control of the relevant subsidiary, Stock Options granted but not exercised may not be cancelled unless an offer or proposal in respect of the Stock Options has, where applicable, been made pursuant to Rule 13 of The Hong Kong Code on Takeovers and Mergers and the Hong Kong Securities and Futures Commission has consented to such cancellation. | ||||
(s) | Ranking of Subsidiary Shares | |||
The Subsidiary Shares to be allotted upon the exercise of a Stock Option will be subject to the then effective articles of association (or equivalent constitutional document) of the relevant subsidiary and will rank pari passu with the Subsidiary Shares in issue on the date of such allotment. | ||||
The Subsidiary Plans will be administered by the relevant Subsidiary Committees and no other trustee is expected to be appointed in respect of any Subsidiary Plan. | ||||
As of December 31, 2009, none of the subsidiaries of the Company has adopted the Subsidiary Plan. |
2001 STOCK PLAN | ||||||||||||||||||||||||
Weighted | Weighted | |||||||||||||||||||||||
Average Closing | Average Closing | |||||||||||||||||||||||
Options Lapsed | Price of Shares | Price of Shares | ||||||||||||||||||||||
Options | Due to | Options | Options | Options | immediately | immediately | ||||||||||||||||||
No. of | Outstanding | Options | Repurchase of | Exercised | Cancelled | Outstanding | before Dates on | before Dates on | ||||||||||||||||
Name/Eligible | Period during which | Options | Exercise Price | as of | Lapsed | Ordinary Shares | During | During | as of | which Options | which Options | |||||||||||||
Employees | Date Granted | Rights Exercisable | Granted | Per Share | 12/31/08 | During Period | During Period* | Period | Period | 12/31/09 | were Exercised | were Granted | ||||||||||||
(USD) | (USD) | (USD) | ||||||||||||||||||||||
Employees | 3/28/2001 | 3/28/2001–3/27/2011 | 89,385,000 | $0.01 | 4,666,500 | — | — | 248,000 | — | 4,418,500 | $0.07 | $0.03 | ||||||||||||
Employees | 4/2/2001 | 4/02/2001–4/01/2011 | 2,216,000 | $0.01 | 281,000 | — | — | 40,000 | — | 241,000 | $— | $0.03 | ||||||||||||
Employees | 4/16/2001 | 4/16/2001–4/15/2011 | 575,000 | $0.01 | 35,000 | — | — | — | — | 35,000 | $— | $0.03 | ||||||||||||
Employees | 4/28/2001 | 4/28/2001–4/27/2011 | 60,000 | $0.01 | 42,000 | — | — | — | — | 42,000 | $— | $0.03 | ||||||||||||
Employees | 5/14/2001 | 5/14/2001–5/13/2011 | 1,597,000 | $0.01 | 25,000 | — | — | 15,000 | — | 10,000 | $— | $0.03 | ||||||||||||
Employees | 5/15/2001 | 5/15/2001–5/14/2011 | 95,000 | $0.01 | 35,000 | — | — | — | — | 35,000 | $— | $0.03 | ||||||||||||
Employees | 6/1/2001 | 6/01/2001–5/31/2011 | 80,000 | $0.01 | 40,000 | — | — | 40,000 | — | — | $— | $0.03 | ||||||||||||
Employees | 7/1/2001 | 7/1/2001–6/30/2011 | 745,000 | $0.01 | 49,000 | — | — | — | — | 49,000 | $— | $0.03 | ||||||||||||
Employees | 7/15/2001 | 7/15/2001–7/14/2011 | 1,045,000 | $0.01 | 314,000 | — | — | 34,000 | — | 280,000 | $— | $0.03 | ||||||||||||
Employees | 7/16/2001 | 7/16/2001–7/15/2011 | 2,220,000 | $0.01 | 88,000 | — | — | 25,000 | — | 63,000 | $— | $0.03 | ||||||||||||
Employees | 7/27/2001 | 7/27/2001–7/26/2011 | 50,000 | $0.01 | 50,000 | — | — | — | — | 50,000 | $— | $0.03 | ||||||||||||
Employees | 7/30/2001 | 7/30/2001–7/29/2011 | 140,000 | $0.01 | 100,000 | — | — | — | — | 100,000 | $— | $0.03 | ||||||||||||
Employees | 8/1/2001 | 8/01/2001–7/31/2011 | 195,000 | $0.01 | 54,000 | — | — | 14,000 | — | 40,000 | $— | $0.03 | ||||||||||||
Employees | 8/7/2001 | 8/07/2001–8/06/2011 | 20,000 | $0.01 | 20,000 | — | — | — | — | 20,000 | $— | $0.03 | ||||||||||||
Employees | 8/15/2001 | 8/15/2001–8/14/2011 | 100,000 | $0.01 | 100,000 | — | — | — | — | 100,000 | $— | $0.03 | ||||||||||||
Employees | 8/20/2001 | 8/20/2001–8/19/2011 | 20,000 | $0.01 | 20,000 | — | — | — | — | 20,000 | $— | $0.03 | ||||||||||||
Employees | 9/24/2001 | 9/24/2001–9/23/2011 | 98,708,500 | $0.01 | 14,672,700 | 10,000 | — | 1,518,000 | — | 13,144,700 | $0.05 | $0.03 | ||||||||||||
Employees | 9/28/2001 | 9/28/2001–9/27/2011 | 50,000 | $0.01 | 50,000 | — | — | — | — | 50,000 | $— | $0.03 | ||||||||||||
Employees | 1/24/2002 | 1/24/2002–1/23/2012 | 47,653,000 | $0.01 | 10,314,500 | 10,000 | — | 120,000 | — | 10,184,500 | $0.04 | $0.03 | ||||||||||||
Employees | 1/24/2002 | 1/24/2002–1/23/2012 | 7,684,500 | $0.02 | 1,042,300 | 5,500 | — | 132,500 | — | 904,300 | $0.06 | $0.03 | ||||||||||||
Employees | 4/10/2002 | 4/10/2002–4/09/2012 | 1,315,000 | $0.01 | 10,000 | — | — | — | — | 10,000 | $— | $0.05 | ||||||||||||
Employees | 4/10/2002 | 4/10/2002–4/09/2012 | 48,699,000 | $0.02 | 9,950,900 | — | — | 662,000 | — | 9,288,900 | $0.06 | $0.05 | ||||||||||||
Employees | 4/11/2002 | 4/11/2002–4/10/2012 | 4,100,000 | $0.01 | 2,100,000 | — | — | — | — | 2,100,000 | $— | $0.05 | ||||||||||||
Employees | 6/28/2002 | 6/28/2002–6/27/2012 | 39,740,000 | $0.02 | 7,338,000 | — | — | 220,000 | — | 7,118,000 | $0.07 | $0.06 | ||||||||||||
Employees | 6/28/2002 | 6/28/2002–6/27/2012 | 18,944,000 | $0.05 | 7,694,000 | 640,000 | — | 357,000 | — | 6,697,000 | $0.06 | $0.06 | ||||||||||||
Kawanishi, Tsuyoshi | 7/11/2002 | 7/11/2002–7/10/2012 | 500,000 | $0.05 | 500,000 | — | — | — | — | 500,000 | $— | $0.07 | ||||||||||||
Employees | 7/11/2002 | 7/11/2002–7/10/2012 | 2,780,000 | $0.05 | 80,000 | — | — | — | — | 80,000 | $— | $0.07 | ||||||||||||
Service Providers | 9/26/2002 | 9/26/2002–9/25/2012 | 50,000 | $0.05 | 50,000 | — | — | — | — | 50,000 | $— | $0.03 | ||||||||||||
Employees | 9/26/2002 | 9/26/2005–9/25/2012 | 5,770,000 | $0.02 | 1,505,000 | — | — | — | — | 1,505,000 | $0.07 | $0.08 | ||||||||||||
Employees | 9/26/2002 | 9/26/2005–9/25/2012 | 65,948,300 | $0.05 | 15,980,410 | 293,200 | — | 142,500 | — | 15,544,710 | $0.08 | $0.08 | ||||||||||||
Employees | 1/9/2003 | 1/09/2003–1/08/2013 | 53,831,000 | $0.05 | 16,100,400 | 328,000 | — | 16,000 | — | 15,756,400 | $0.08 | $0.10 | ||||||||||||
Employees | 4/1/2003 | 4/01/2003–3/31/2013 | 18,804,900 | $0.05 | 7,210,418 | 401,000 | — | 122,800 | — | 6,686,618 | $0.08 | $0.14 | ||||||||||||
Employees | 4/15/2003 | 4/15/2003–4/14/2013 | 550,000 | $0.05 | 550,000 | — | — | — | — | 550,000 | $— | $0.14 | ||||||||||||
Senior Management | 4/24/2003 | 4/24/2003–4/23/2013 | 1,850,000 | $0.05 | 1,450,000 | — | — | — | — | 1,450,000 | $— | $0.14 | ||||||||||||
Employees | 4/24/2003 | 4/24/2003–4/23/2013 | 58,488,000 | $0.05 | 19,900,400 | 980,000 | — | 1,254,000 | — | 17,666,400 | $0.08 | $0.14 | ||||||||||||
Employees | 7/15/2003 | 7/15/2003–7/14/2013 | 59,699,900 | $0.05 | 18,182,660 | 1,491,900 | — | 1,078,000 | — | 15,612,760 | $0.08 | $0.17 | ||||||||||||
Employees | 10/10/2003 | 10/10/2003–10/09/2013 | 49,535,400 | $0.10 | 17,941,900 | 476,800 | — | — | — | 17,465,100 | $— | $0.29 | ||||||||||||
Employees | 1/5/2004 | 1/05/2004–1/04/2014 | 130,901,110 | $0.10 | 61,970,980 | 5,510,648 | — | — | — | 56,460,332 | $0.10 | $0.33 | ||||||||||||
Kawanishi, Tsuyoshi | 1/15/2004 | 1/15/2004–1/14/2014 | 1,000,000 | $0.10 | 1,000,000 | — | — | — | — | 1,000,000 | $— | $0.33 | ||||||||||||
Service Providers | 1/15/2004 | 1/15/2004–3/01/2005 | 4,100,000 | $0.10 | 100,000 | — | — | — | — | 100,000 | $— | $0.14 | ||||||||||||
Senior Management | 1/15/2004 | 1/15/2004–1/14/2014 | 2,700,000 | $0.10 | 2,155,000 | — | — | — | — | 2,155,000 | $— | $0.14 | ||||||||||||
Others | 1/15/2004 | 1/15/2004–1/14/2014 | 4,600,000 | $0.10 | 2,500,000 | — | — | — | — | 2,500,000 | $— | $0.35 | ||||||||||||
Employees | 1/15/2004 | 1/15/2004–1/14/2014 | 20,885,000 | $0.10 | 7,354,000 | 225,000 | — | — | — | 7,129,000 | $— | $0.33 | ||||||||||||
Senior Management | 2/16/2004 | 2/16/2004–2/15/2014 | 900,000 | $0.25 | 900,000 | — | — | — | — | 900,000 | $— | $0.33 | ||||||||||||
Others | 2/16/2004 | 2/16/2004–2/15/2014 | 12,300,000 | $0.25 | 6,130,000 | — | — | — | — | 6,130,000 | $— | $0.35 | ||||||||||||
Employees | 2/16/2004 | 2/16/2004–2/15/2014 | 14,948,600 | $0.10 | 3,911,900 | 142,400 | — | — | — | 3,769,500 | $— | $0.33 | ||||||||||||
Employees | 2/16/2004 | 2/16/2004–2/15/2014 | 76,454,880 | $0.25 | 40,858,260 | 2,407,680 | — | — | — | 38,450,580 | $— | $0.33 | ||||||||||||
952,034,090 | 285,423,228 | 12,922,128 | — | 6,038,800 | — | 266,462,300 |
2001 PREFERENCE SHARE PLAN | ||||||||||||||||||||||||
Weighted | Weighted | |||||||||||||||||||||||
Average Closing | Average Closing | |||||||||||||||||||||||
Options Lapsed | Price of Shares | Price of Shares | ||||||||||||||||||||||
Options | Due to | Options | Options | Options | immediately | immediately | ||||||||||||||||||
No. of | Outstanding | Options | Repurchase of | Exercised | Cancelled | Outstanding | before Dates on | before Dates on | ||||||||||||||||
Name/Eligible | Period during which | Options | Exercise Price | as of | Lapsed | Ordinary Shares | During | During | as of | which Options | which Options | |||||||||||||
Employees | Date Granted | Rights Exercisable | Granted | Per Share | 12/31/08 | During Period | During Period* | Period | Period | 12/31/09 | were Exercised | were Granted | ||||||||||||
(USD) | (USD) | (USD) | ||||||||||||||||||||||
Employees | 9/24/2001 | 9/24/2001–9/23/2011 | 246,698,700 | $0.11 | 21,450,200 | 3,549,000 | — | — | — | 17,901,200 | $— | $0.11 | ||||||||||||
Employees | 9/28/2001 | 9/28/2001–9/27/2011 | 50,000 | $0.11 | 50,000 | — | — | — | — | 50,000 | $— | $0.11 | ||||||||||||
Employees | 11/3/2001 | 11/03/2001–11/02/2011 | 780,000 | $0.35 | 505,000 | 20,000 | — | — | — | 485,000 | $— | $0.11 | ||||||||||||
Employees | 1/24/2002 | 1/24/2002–1/23/2012 | 58,357,500 | $0.11 | 5,494,500 | 83,200 | — | — | — | 5,411,300 | $— | $0.12 | ||||||||||||
Employees | 4/10/2002 | 4/10/2002–4/09/2012 | 52,734,000 | $0.11 | 3,069,900 | 711,000 | — | — | — | 2,358,900 | $— | $0.13 | ||||||||||||
Employees | 6/28/2002 | 6/28/2002–6/27/2012 | 63,332,000 | $0.11 | 7,742,500 | 519,500 | — | — | — | 7,223,000 | $— | $0.14 | ||||||||||||
Service Providers | 7/11/2002 | 7/11/2002–7/10/2012 | 462,000 | $0.11 | 202,000 | — | — | — | — | 202,000 | $— | $0.14 | ||||||||||||
Employees | 7/11/2002 | 7/11/2002–7/10/2012 | 4,530,000 | $0.11 | 805,000 | — | — | — | — | 805,000 | $— | $0.14 | ||||||||||||
Service Providers | 9/26/2002 | 9/26/2002–9/25/2012 | 50,000 | $0.11 | 50,000 | — | — | — | — | 50,000 | $— | $0.15 | ||||||||||||
Employees | 9/26/2002 | 9/26/2002–9/25/2012 | 73,804,800 | $0.11 | 11,738,500 | 382,450 | — | — | — | 11,356,050 | $— | $0.15 | ||||||||||||
Employees | 1/9/2003 | 1/09/2003–1/08/2013 | 12,686,000 | $0.11 | 1,237,000 | — | — | — | — | 1,237,000 | $— | $0.17 | ||||||||||||
513,485,000 | 52,344,600 | 5,265,150 | — | — | — | 47,079,450 |
2004 STOCK OPTION PLAN | ||||||||||||||||||||||||||
Weighted | Weighted | |||||||||||||||||||||||||
Average Closing | Average Closing | |||||||||||||||||||||||||
Additional | Options Lapsed | Price of Shares | Price of Shares | |||||||||||||||||||||||
Options | Options | Options | Due to | Options | Options | immediately | immediately | |||||||||||||||||||
No. of | Exercise | Outstanding | Granted | Lapsed | Repurchase of | Exercised | Cancelled | Options | before Dates on | before Dates on | ||||||||||||||||
Name/Eligible | Period during which | Options | Price Per | as of | During | During | Ordinary Shares | During | During | Outstanding | which Options | which Options | ||||||||||||||
Employees | Date Granted | Rights Exercisable | Granted | Share | 12/31/08 | Period | Period | During Period* | Period | Period | as of 12/31/09 | were Exercised | were Granted | |||||||||||||
(USD) | (USD) | (USD) | ||||||||||||||||||||||||
Senior Management | 3/18/2004 | 3/18/2004–3/17/2014 | 190,000 | $0.35 | 190,000 | — | — | — | — | — | 190,000 | $— | $0.35 | |||||||||||||
Others | 3/18/2004 | 3/18/2004–3/17/2014 | 20,000 | $0.35 | 20,000 | — | — | — | — | — | 20,000 | $— | $0.35 | |||||||||||||
Employees | 3/18/2004 | 3/18/2004–3/17/2014 | 49,869,700 | $0.35 | 26,610,950 | — | 1,782,100 | — | — | — | 24,828,850 | $— | $0.35 | |||||||||||||
Richard Chang | 4/7/2004 | 4/07/2004–4/06/2014 | 100,000 | $0.31 | 100,000 | — | — | — | — | — | 100,000 | $— | $0.31 | |||||||||||||
Employees | 4/25/2004 | 4/25/2004–4/24/2014 | 22,591,800 | $0.28 | 10,933,200 | — | 514,000 | — | — | — | 10,419,200 | $— | $0.28 | |||||||||||||
Others | 7/27/2004 | 7/27/2004–7/26/2014 | 200,000 | $0.20 | 100,000 | — | — | — | — | — | 100,000 | $— | $0.20 | |||||||||||||
Employees | 7/27/2004 | 7/27/2004–7/26/2014 | 35,983,000 | $0.20 | 17,156,000 | — | 1,045,000 | — | — | — | 16,111,000 | $— | $0.20 | |||||||||||||
Kawanishi, Tsuyoshi | 11/10/2004 | 11/10/2004–11/09/2009 | 500,000 | $0.22 | 500,000 | — | — | — | — | — | 500,000 | $— | $0.22 | |||||||||||||
Employees | 11/10/2004 | 11/10/2004–11/09/2014 | 52,036,140 | $0.22 | 22,521,200 | — | 3,290,450 | — | — | — | 19,230,750 | $— | $0.22 | |||||||||||||
Ta-Lin Hsu | 11/10/2004 | 11/10/2004–11/09/2009 | 500,000 | $0.22 | 500,000 | — | 500,000 | — | — | — | — | $— | $0.22 | |||||||||||||
Henry Shaw | 11/10/2004 | 11/10/2004–11/09/2009 | 500,000 | $0.22 | 500,000 | — | 500,000 | — | — | — | — | $— | $0.22 | |||||||||||||
Lip-Bu Tan | 11/10/2004 | 11/10/2004–11/09/2009 | 500,000 | $0.22 | 500,000 | — | — | — | — | — | 500,000 | $— | $0.22 | |||||||||||||
Wang Yang Yuan | 11/10/2004 | 11/10/2004–11/09/2009 | 500,000 | $0.22 | 500,000 | — | — | — | — | — | 500,000 | $— | $0.22 | |||||||||||||
Cai Lai Xing | 11/10/2004 | 11/10/2004–11/09/2009 | 500,000 | $0.22 | 500,000 | — | — | — | — | — | 500,000 | $— | $0.22 | |||||||||||||
Senior Management | 5/11/2005 | 5/11/2005–5/10/2015 | 900,000 | $0.20 | 900,000 | — | — | — | — | — | 900,000 | $— | $0.20 | |||||||||||||
Others | 5/11/2005 | 5/11/2005–5/10/2015 | 100,000 | $0.20 | 100,000 | — | — | — | — | — | 100,000 | $— | $0.20 | |||||||||||||
Employees | 5/11/2005 | 5/11/2005–5/10/2015 | 94,581,300 | $0.20 | 54,625,641 | — | 4,035,904 | — | — | — | 50,589,737 | $— | $0.20 | |||||||||||||
Richard Chang | 5/11/2005 | 5/11/2005–5/10/2015 | 15,000,000 | $0.20 | 15,000,000 | — | — | — | — | — | 15,000,000 | $— | $0.22 | |||||||||||||
Employees | 8/11/2005 | 8/11/2005–8/10/2015 | 32,279,500 | $0.22 | 14,948,100 | — | 666,600 | — | — | — | 14,281,500 | $— | $0.22 | |||||||||||||
Senior Management | 11/11/2005 | 11/11/2005–11/10/2015 | 11,640,000 | $0.15 | 11,640,000 | — | 850,000 | — | — | — | 10,790,000 | $— | $0.15 | |||||||||||||
Others | 11/11/2005 | 11/11/2005–11/10/2015 | 3,580,000 | $0.15 | 3,580,000 | — | — | — | — | — | 3,580,000 | $— | $0.15 | |||||||||||||
Employees | 11/11/2005 | 11/11/2005–11/10/2015 | 149,642,000 | $0.15 | 99,565,400 | — | 4,466,900 | — | — | — | 95,098,500 | $— | $0.15 | |||||||||||||
Employees | 2/20/2006 | 2/20/2006–2/19/2016 | 62,756,470 | $0.15 | 37,109,935 | — | 1,835,409 | — | — | — | 35,274,526 | $— | $0.15 | |||||||||||||
Employees | 5/12/2006 | 5/12/2006–5/11/2016 | 22,216,090 | $0.15 | 14,918,800 | — | 518,400 | — | — | — | 14,400,400 | $— | $0.15 | |||||||||||||
Kawanishi, Tsuyoshi | 9/29/2006 | 9/29/2006–9/28/2011 | 500,000 | $0.13 | 500,000 | — | — | — | — | — | 500,000 | $— | $0.13 | |||||||||||||
Employees | 9/29/2006 | 9/29/2006–9/28/2016 | 40,394,000 | $0.13 | 28,339,200 | — | 2,412,000 | — | — | — | 25,927,200 | $— | $0.13 | |||||||||||||
Richard Chang | 9/29/2006 | 9/29/2006–9/28/2016 | 500,000 | $0.13 | 500,000 | — | — | — | — | — | 500,000 | $— | $0.13 | |||||||||||||
Ta-Lin Hsu | 9/29/2006 | 9/29/2006–9/28/2011 | 500,000 | $0.13 | 500,000 | — | 500,000 | — | — | — | — | $— | $0.13 | |||||||||||||
Henry Shaw | 9/29/2006 | 9/29/2006–9/28/2011 | 500,000 | $0.13 | 500,000 | — | 500,000 | — | — | — | — | $— | $0.13 | |||||||||||||
Lip-Bu Tan | 9/29/2006 | 9/29/2006–9/28/2011 | 500,000 | $0.13 | 500,000 | — | — | — | — | — | 500,000 | $— | $0.13 | |||||||||||||
Wang Yang Yuan | 9/29/2006 | 9/29/2006–9/28/2011 | 500,000 | $0.13 | 500,000 | — | — | — | — | — | 500,000 | $— | $0.13 | |||||||||||||
Others | 11/10/2006 | 11/10/2006–11/09/2016 | 2,450,000 | $0.13 | 2,150,000 | — | — | — | — | — | 2,150,000 | $— | $0.13 | |||||||||||||
Employees | 11/10/2006 | 11/10/2006–11/09/2016 | 33,271,000 | $0.11 | 21,019,800 | — | 2,538,800 | — | — | — | 18,481,000 | $— | $0.11 | |||||||||||||
Employees | 5/16/2007 | 5/16/2007–5/15/2017 | 122,828,000 | $0.15 | 94,398,050 | — | 7,254,550 | — | — | — | 87,143,500 | $— | $0.15 | |||||||||||||
Senior Management | 5/16/2007 | 5/16/2007–5/15/2017 | 2,000,000 | $0.15 | 2,000,000 | — | 350,000 | — | — | — | 1,650,000 | $— | $0.15 | |||||||||||||
Others | 5/16/2007 | 5/16/2007–5/15/2017 | 5,421,000 | $0.15 | 5,001,000 | — | — | — | — | — | 5,001,000 | $— | $0.15 | |||||||||||||
Employees | 12/28/2007 | 12/28/2007–12/27/2017 | 89,839,000 | $0.10 | 68,473,000 | — | 1,626,600 | — | — | — | 66,846,400 | $— | $0.10 | |||||||||||||
Others | 12/28/2007 | 12/28/2007–12/27/2017 | 3,800,000 | $0.10 | 3,800,000 | — | — | — | — | — | 3,800,000 | $— | $0.10 | |||||||||||||
Employees | 2/12/2008 | 2/12/2008–2/11/2018 | 126,941,000 | $0.08 | 110,576,800 | — | 5,035,300 | — | — | — | 105,541,500 | $— | $0.08 | |||||||||||||
Senior Management | 2/12/2008 | 2/12/2008–2/11/2018 | 2,300,000 | $0.08 | 2,300,000 | — | 600,000 | — | — | — | 1,700,000 | $— | $0.08 | |||||||||||||
Others | 2/12/2008 | 2/12/2008–2/11/2018 | 600,000 | $0.08 | 600,000 | — | — | — | — | — | 600,000 | $— | $0.08 | |||||||||||||
Employees | 11/18/2008 | 11/18/2008–11/17/2018 | 117,224,090 | $0.02 | 109,936,090 | — | 15,495,000 | — | 415,000 | — | 94,026,090 | $— | $0.02 | |||||||||||||
Others | 11/18/2008 | 11/18/2008–11/17/2018 | 1,375,000 | $0.02 | 1,375,000 | — | — | — | — | — | 1,375,000 | $— | $0.02 | |||||||||||||
Senior Management | 11/18/2008 | 11/18/2008–11/17/2018 | 400,000 | $0.02 | 400,000 | — | — | — | — | — | 400,000 | $— | $0.02 | |||||||||||||
Employees | 2/17/2009 | 2/17/2009–2/16/2019 | 131,943,000 | $0.03 | — | 131,943,000 | 7,250,000 | — | — | — | 124,693,000 | $— | $0.03 | |||||||||||||
Lip-Bu Tan | 2/17/2009 | 2/17/2009–2/16/2014 | 1,000,000 | $0.03 | — | 1,000,000 | — | — | — | — | 1,000,000 | $— | $0.03 | |||||||||||||
Wang Yang Yuan | 2/17/2009 | 2/17/2009–2/16/2014 | 1,000,000 | $0.03 | — | 1,000,000 | — | — | — | — | 1,000,000 | $— | $0.03 | |||||||||||||
Jiang Shang Zhou | 2/17/2009 | 2/17/2009–2/16/2014 | 1,000,000 | $0.03 | — | 1,000,000 | — | — | — | — | 1,000,000 | $— | $0.03 | |||||||||||||
Edward S Yang | 2/17/2009 | 2/17/2009–2/16/2014 | 1,000,000 | $0.03 | — | 1,000,000 | — | — | — | — | 1,000,000 | $— | $0.03 | |||||||||||||
Kawanishi, Tsuyoshi | 2/17/2009 | 2/17/2009–2/16/2019 | 1,000,000 | $0.03 | — | 1,000,000 | — | — | — | — | 1,000,000 | $— | $0.03 | |||||||||||||
Others | 2/17/2009 | 2/17/2009–2/16/2019 | 400,000 | $0.03 | — | 400,000 | — | — | — | — | 400,000 | $— | $0.03 | |||||||||||||
Richard Chang | 2/17/2009 | 2/17/2009–2/16/2019 | 1,000,000 | $0.03 | — | 1,000,000 | — | — | — | — | 1,000,000 | $— | $0.03 | |||||||||||||
Senior Management | 2/17/2009 | 2/17/2009–2/16/2019 | 1,150,000 | $0.03 | — | 1,150,000 | 400,000 | — | — | — | 750,000 | $— | $0.03 | |||||||||||||
Others | 2/17/2009 | 2/17/2009–2/16/2019 | 977,500 | $0.03 | — | 977,500 | — | — | — | — | 977,500 | $— | $0.03 | |||||||||||||
Richard Chang | 2/17/2009 | 2/17/2009–2/16/2019 | 5,925,000 | $0.03 | — | 5,925,000 | — | — | — | — | 5,925,000 | $— | $0.03 | |||||||||||||
Senior Management | 2/17/2009 | 2/17/2009–2/16/2019 | 3,437,200 | $0.03 | — | 3,437,200 | 1,062,000 | — | — | — | 2,375,200 | $— | $0.03 | |||||||||||||
Employees | 2/17/2009 | 2/17/2009–2/16/2019 | 213,049,193 | $0.03 | — | 213,049,193 | 8,953,966 | — | — | — | 204,095,227 | $— | $0.03 | |||||||||||||
Employees | 5/11/2009 | 5/11/2009–5/10/2019 | 24,102,002 | $0.04 | — | 24,102,002 | 2,373,002 | — | — | — | 21,729,000 | $— | $0.04 | |||||||||||||
1,495,512,985 | 786,388,166 | 386,983,895 | 76,355,981 | — | 415,000 | — | 1,096,601,080 |
2004 EQUITY INCENTIVE PLAN | ||||||||||||||||||||||||||
Weighted Average | Weighted Average | |||||||||||||||||||||||||
Closing Price of | Closing Price of | |||||||||||||||||||||||||
Additional | Options Lapsed | Shares immediately | Shares immediately | |||||||||||||||||||||||
Options | Options | Options | Due to | Options | Options | Options | before Dates on | before Dates on | ||||||||||||||||||
No. of | Exercise | Outstanding | Granted | Lapsed | Repurchase of | Exercised | Cancelled | Outstanding | which Restricted | which Restricted | ||||||||||||||||
Name/Eligible | Period during which | Options | Price Per | as of | During | During | Ordinary Shares | During | During | as of | Share Units were | Share Units were | ||||||||||||||
Employees | Date Granted | Rights Exercisable | Granted | Share | 12/31/08 | Period | Period | During Period* | Period | Period | 12/31/09 | Vested | Granted | |||||||||||||
(USD) | (USD) | (USD) | ||||||||||||||||||||||||
Employees | 7/1/2004 | 7/01/2005–6/30/2015 | 96,856,590 | $0.00 | 120,001 | — | 67,500 | — | 15,001 | — | 37,500 | $0.13 | $0.22 | |||||||||||||
Senior Management | 7/27/2004 | 7/27/2005–7/26/2015 | 1,130,000 | $0.00 | — | — | — | — | — | — | — | $— | $0.20 | |||||||||||||
Employees | 7/27/2004 | 7/27/2005–7/26/2015 | 18,747,520 | $0.00 | 150,000 | — | — | — | 100,000 | — | 50,000 | $0.07 | $0.20 | |||||||||||||
Employees | 5/11/2005 | 5/11/2006–5/10/2016 | 4,630,000 | $0.00 | 322,500 | — | — | — | 287,500 | — | 35,000 | $0.11 | $0.20 | |||||||||||||
Senior Management | 8/11/2005 | 8/11/2005–8/10/2015 | 916,830 | $0.00 | 278,056 | — | — | — | 86,423 | — | 191,633 | $0.11 | $0.22 | |||||||||||||
Others | 8/11/2005 | 8/11/2005–8/10/2015 | 156,888 | $0.00 | 9,394 | — | — | — | — | — | 9,394 | $— | $0.22 | |||||||||||||
Employees | 8/11/2005 | 8/11/2005–8/10/2015 | 69,430,022 | $0.00 | 11,097,569 | — | 343,067 | — | 10,391,061 | — | 363,441 | $0.09 | $0.22 | |||||||||||||
Senior Management | 11/11/2005 | 11/11/2005–11/10/2015 | 2,910,000 | $0.00 | 1,455,000 | — | 212,500 | — | 515,000 | — | 727,500 | $0.11 | $0.15 | |||||||||||||
Others | 11/11/2005 | 11/11/2005–11/10/2015 | 2,100,000 | $0.00 | 550,000 | — | — | — | 525,000 | — | 25,000 | $0.11 | $0.15 | |||||||||||||
Employees | 11/11/2005 | 11/11/2005–11/10/2015 | 40,275,000 | $0.00 | 13,972,500 | — | 192,500 | — | 7,218,750 | — | 6,561,250 | $0.11 | $0.15 | |||||||||||||
Employees | 2/20/2006 | 2/20/2006–2/19/2016 | 3,110,000 | $0.00 | 450,000 | — | — | — | 225,000 | — | 225,000 | $0.11 | $0.15 | |||||||||||||
Employees | 5/12/2006 | 5/12/2006–5/11/2016 | 2,700,000 | $0.00 | 1,725,000 | — | — | — | 1,100,000 | — | 625,000 | $0.07 | $0.15 | |||||||||||||
Employees | 9/29/2006 | 9/29/2006–9/28/2016 | 720,000 | $0.00 | 210,000 | — | — | — | 105,000 | — | 105,000 | $— | $0.13 | |||||||||||||
Others | 11/10/2006 | 11/10/2006–11/09/2016 | 1,688,864 | $0.00 | 844,432 | — | — | — | 422,216 | — | 422,216 | $0.13 | $0.11 | |||||||||||||
Employees | 11/10/2006 | 11/10/2006–11/09/2016 | 7,340,000 | $0.00 | 2,165,000 | — | 40,000 | — | 1,062,500 | — | 1,062,500 | $0.13 | $0.11 | |||||||||||||
Employees | 5/16/2007 | 5/16/2007–5/15/2017 | 33,649,720 | $0.00 | 19,624,360 | — | 731,250 | — | 6,760,430 | — | 12,132,680 | $0.11 | $0.14 | |||||||||||||
Others | 5/16/2007 | 5/16/2007–5/15/2017 | 1,000,000 | $0.00 | 750,000 | — | — | — | 250,000 | — | 500,000 | $0.10 | $0.14 | |||||||||||||
Employees | 12/28/2007 | 12/28/2007–12/27/2017 | 4,910,000 | $0.00 | 3,607,500 | — | — | — | 652,500 | — | 2,955,000 | $— | $0.10 | |||||||||||||
Others | 12/28/2007 | 12/28/2007–12/27/2017 | 960,000 | $0.00 | 720,000 | — | — | — | 240,000 | — | 480,000 | $— | $0.10 | |||||||||||||
Employees | 2/12/2008 | 2/12/2008–2/11/2018 | 38,597,100 | $0.00 | 34,259,450 | — | 1,082,738 | — | 8,671,549 | — | 24,505,163 | $— | $0.08 | |||||||||||||
Others | 2/12/2008 | 2/12/2008–2/11/2018 | 270,000 | $0.00 | 270,000 | — | — | — | 67,500 | — | 202,500 | $— | $0.08 | |||||||||||||
Senior Management | 2/12/2008 | 2/12/2008–2/11/2018 | 960,000 | $0.00 | 960,000 | — | 225,000 | — | 185,000 | — | 550,000 | $— | $0.08 | |||||||||||||
Employees | 11/18/2008 | 11/18/2008–11/17/2018 | 2,080,000 | $0.00 | 2,080,000 | — | — | — | 520,000 | — | 1,560,000 | $— | $0.02 | |||||||||||||
Employees | 5/11/2009 | 5/11/2009–5/10/2019 | 787,797 | $0.00 | — | 787,797 | 387,797 | — | 100,000 | — | 300,000 | $— | $0.04 | |||||||||||||
335,926,331 | 95,620,762 | 787,797 | 3,282,352 | — | 39,500,430 | — | 53,625,777 |
Name of Director | Category of Director | Class of Director | ||
Jiang Shang Zhou | Chairman, Independent Non-executive Director | Class II | ||
David N.K. Wang | President, Chief Executive Officer, Executive Director | Class I | ||
Gao Yonggang | Non-executive Director | Class I | ||
Chen Shanzhi | Non-executive Director | Class II | ||
Lip-Bu Tan | Independent Non-executive Director | Class II | ||
Tsuyoshi Kawanishi | Independent Non-executive Director | Class III | ||
Zhou Jie | Non-executive Director | Class III | ||
Wang Zheng Gang | Alternate Director to Zhou Jie | Class III |
Number of | |||||
meetings Attended | Attendance Rate | ||||
Henry Shaw(1) | — | — | |||
Wang Yang Yuan(2) | 3/3 | 100 | % | ||
Richard Ru Gin Chang(3) | 10/10 | 100 | % | ||
Jiang Shang Zhou | 14/14 | 100 | % | ||
Tsuyoshi Kawanishi(4) | 14/14 | 100 | % | ||
Lip-Bu Tan(5) | 13/14 | 93 | % | ||
Zhou Jie(6) | 14/14 | 100 | % | ||
Edward S Yang(7) | 9/11 | 82 | % | ||
Chen Shanzhi(8) | 11/11 | 100 | % | ||
Gao Yonggnang(9) | 11/11 | 100 | % | ||
David N. K. Wang(10) | 3/3 | 100 | % |
(1) | Mr. Henry Shaw resigned as Independent Non-executive Director on January 13, 2009. | |
(2) | Professor Wang Yang Yuan resigned as Chairman and Independent Non-executive Director on June 23, 2009. | |
(3) | Dr. Richard Ru Gin Chang resigned as Executive Director on November 9, 2009. | |
(4) | 6 of these meetings were attended by proxy. | |
(5) | 1 of these meetings was attended by proxy. | |
(6) | 4 of these meetings were attended by Mr. Wang Zheng Gang, Alternate Director to Mr. Zhou Jie. | |
(7) | Professor Edward S Yang resigned as Independent Non-executive Director on November 9, 2009; 1 of these meetings was attended by proxy. | |
(8) | Dr. Chen Shanzhi was appointed as Non-executive Director on June 23, 2009; 2 of these meetings were attended by proxy. | |
(9) | Mr. Gao Yonggang was appointed as Non-executive Director on June 23, 2009; 1 of these meetings was attended by proxy. | |
(10) | Dr. David N. K. Wang was appointed as Executive Director on November 9, 2009. |
Number of | |||||
meetings Attended | Attendance Rate | ||||
Edward S Yang(1) | 1/1 | 100 | % | ||
Lip-Bu Tan | 5/5 | 100 | % | ||
Zhou Jie(2) | 5/5 | 100 | % | ||
Tsuyoshi Kawanishi(3) | 5/6 | 83 | % |
(1) | Professor Yang resigned as Independent Non-executive Director on November 9, 2009. | |
(2) | 2 of these meetings were attended by Mr. Wang Zheng Gang, alternate director to Mr. Zhou. | |
(3) | 2 of these meetings were attended by proxy. |
Number of | |||||
meetings Attended | Attendance Rate | ||||
Wang Yang Yuan(1) | 2/2 | 100 | % | ||
Lip-Bu Tan | 5/5 | 100 | % | ||
Jiang Shang Zhou(2) | 5/5 | 100 | % | ||
Gao Yonggang | 3/3 | 100 | % |
(1) | Professor Wang Yang Yuan resigned as Independent Non-executive Director on June 23, 2009; 1 of these meetings was attended by proxy. | |
(2) | 1 of these meetings was attended by proxy. |
2009 | |
Audit Fees | 1,291,969 |
Audit-Related Fees | — |
Tax Fees | — |
All Other Fees | — |
Total | 1,291,969 |
Year ended December 31, | |||||||||||
NOTES | 2009 | 2008 | 2007 | ||||||||
Sales | 23 | $1,070,387,103 | $1,353,711,299 | $1,549,765,288 | |||||||
Cost of sales | 1,184,589,553 | 1,412,851,079 | 1,397,037,881 | ||||||||
Gross (loss) profit | (114,202,450 | ) | (59,139,780 | ) | 152,727,407 | ||||||
Operating expenses (income): | |||||||||||
Research and development | 160,753,629 | 102,239,779 | 97,034,208 | ||||||||
General and administrative | 21 | 215,565,907 | 58,841,103 | 74,489,877 | |||||||
Selling and marketing | 26,565,692 | 20,661,254 | 18,715,961 | ||||||||
Amortization of acquired intangible assets | 35,064,589 | 32,191,440 | 27,070,617 | ||||||||
Impairment loss of long-lived assets | 10 | 138,294,783 | 106,740,667 | — | |||||||
Loss (gain) from sale of equipment and | |||||||||||
other fixed assets | 9 | 3,832,310 | (2,877,175 | ) | (28,651,446 | ) | |||||
Litigation settlement | 26 | 269,637,431 | — | — | |||||||
Total operating expenses, net | 849,714,341 | 317,797,068 | 188,659,217 | ||||||||
Loss from operations | 29 | (963,916,791 | ) | (376,936,848 | ) | (35,931,810 | ) | ||||
Other income (expense): | |||||||||||
Interest income | 2,591,284 | 11,542,339 | 12,348,630 | ||||||||
Interest expense | (24,699,336 | ) | (50,766,958 | ) | (37,936,126 | ) | |||||
Change in the fair value of commitment | |||||||||||
to issue shares and warrants | 26 | (30,100,793 | ) | — | — | ||||||
Foreign currency exchange gain | 4,179,986 | 3,229,710 | 11,249,889 | ||||||||
Others, net | 4,626,008 | 7,428,721 | 2,237,902 | ||||||||
Total other expense, net | (43,402,851 | ) | (28,566,188 | ) | (12,099,705 | ) | |||||
Loss before income tax | (1,007,319,642 | ) | (405,503,036 | ) | (48,031,515 | ) | |||||
Income tax benefit (expense) | 17 | 46,624,242 | (26,432,993 | ) | 29,719,775 | ||||||
Loss from equity investment | 12 | (1,782,142 | ) | (444,211 | ) | (4,012,665 | ) | ||||
Net loss | (962,477,542 | ) | (432,380,240 | ) | (22,324,405 | ) | |||||
Accretion of interest to noncontrolling | |||||||||||
interest | (1,059,663 | ) | (7,850,880 | ) | 2,856,258 | ||||||
Loss attributable to Semiconductor | |||||||||||
Manufacturing International | |||||||||||
Corporation | (963,537,205 | ) | (440,231,120 | ) | (19,468,147 | ) | |||||
Loss per share, basic and diluted | |||||||||||
Net loss per share attributed to | |||||||||||
Semiconductor Manufacturing | |||||||||||
International Corporation | 20 | $(0.04 | ) | $(0.02 | ) | $(0.00 | ) | ||||
Shares used in calculating basic and | |||||||||||
diluted loss per share | 20 | 22,359,237,084 | 18,682,544,866 | 18,501,940,489 |
December 31, | ||||||||
NOTES | 2009 | 2008 | 2007 | |||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $443,462,514 | $450,229,569 | $469,284,013 | |||||
Restricted cash | 20,360,185 | 6,254,813 | — | |||||
Short-term investments | 4 | — | 19,928,289 | 7,637,870 | ||||
Accounts receivable, net of allowances | ||||||||
of $96,144,543, $5,680,658 and | ||||||||
$4,492,090 at December 31, 2009, | ||||||||
2008 and 2007, respectively | 6, 21 | 204,290,545 | 199,371,694 | 298,387,652 | ||||
Inventories | 7 | 193,705,195 | 171,636,868 | 248,309,765 | ||||
Prepaid expense and other current | ||||||||
assets | 28,881,866 | 56,299,086 | 31,237,755 | |||||
Receivable for sale of equipment and | ||||||||
other fixed assets | — | 23,137,764 | 17,321,000 | |||||
Assets held for sale | 8 | 8,184,462 | — | 3,123,567 | ||||
Current portion of deferred tax assets | 17 | 8,173,216 | — | — | ||||
Total current assets | 907,057,983 | 926,858,083 | 1,075,301,622 | |||||
Prepaid land use rights | 78,111,788 | 74,293,284 | 57,551,991 | |||||
Plant and equipment, net | 9 | 2,251,614,217 | 2,963,385,840 | 3,202,957,665 | ||||
Acquired intangible assets, net | 11 | 182,694,105 | 200,059,106 | 232,195,132 | ||||
Deferred cost, net | 26 | — | 47,091,516 | 70,637,275 | ||||
Equity investment | 12 | 9,848,148 | 11,352,186 | 9,896,398 | ||||
Other long-term prepayments | 391,741 | 1,895,337 | 2,988,404 | |||||
Deferred tax assets | 17 | 94,358,635 | 45,686,470 | 56,915,172 | ||||
TOTAL ASSETS | 3,524,076,617 | $4,270,621,822 | $4,708,443,659 | |||||
LIABILITIES AND STOCKHOLDERS’ | ||||||||
EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | 13 | $228,882,804 | $185,918,539 | $301,992,739 | ||||
Short-term borrowings | 15 | 286,864,063 | 201,257,773 | 107,000,000 | ||||
Current portion of long-term debt | 15 | 205,784,080 | 360,628,789 | 340,692,788 | ||||
Accrued expenses and other current | ||||||||
liabilities | 111,086,990 | 122,173,803 | 150,109,963 | |||||
Current portion of promissory notes | 14 | 78,608,288 | 29,242,001 | 29,242,000 | ||||
Commitment to issue shares and | ||||||||
warrants relating to litigation | ||||||||
settlement | 26 | 120,237,773 | — | — | ||||
Income tax payable | 58,573 | 552,006 | 1,152,630 | |||||
Total current liabilities | 1,031,522,571 | 899,772,911 | 930,190,120 |
December 31, | |||||||||||
NOTES | 2009 | 2008 | 2007 | ||||||||
Long-term liabilities: | |||||||||||
Non-current portion of
promissory
|
|||||||||||
notes | 14 | 83,324,641 | 23,589,958 | 51,057,163 | |||||||
Long-term
debt
|
15 | 550,653,099 | 536,518,281 | 616,294,743 | |||||||
Long-term payables relating to license | |||||||||||
agreements | 16 | 4,779,562 | 18,169,006 | 62,833,433 | |||||||
Other long term
liabilities
|
25 | 21,679,690 | — | — | |||||||
Deferred tax liabilities | 17 | 1,035,164 | 411,877 | 604,770 | |||||||
Total long-term liabilities | 661,472,156 | 578,689,122 | 730,790,109 | ||||||||
Total liabilities | 1,692,994,727 | 1,478,462,033 | 1,660,980,229 | ||||||||
Noncontrolling interest | 18 | 34,841,507 | 42,795,288 | 34,944,408 | |||||||
Commitments | 22 | ||||||||||
Equity: | |||||||||||
Ordinary shares, $0.0004 par value, | |||||||||||
50,000,000,000 shares authorized, | |||||||||||
22,375,886,604, 22,327,784,827 | |||||||||||
and 18,558,919,712 shares issued | |||||||||||
and outstanding at December 31, | |||||||||||
2009, 2008 and 2007, respectively | 8,950,355 | 8,931,114 | 7,423,568 | ||||||||
Additional paid-in
capital
|
3,499,723,153 | 3,489,382,267 | 3,313,375,972 | ||||||||
Accumulated other comprehensive loss | (386,163 | ) | (439,123 | ) | (1,881 | ) | |||||
Accumulated
deficit
|
(1,712,046,962 | ) | (748,509,757 | ) | (308,278,637 | ) | |||||
Total stockholders’ equity | 1,796,240,383 | 2,749,364,501 | 3,012,519,022 | ||||||||
TOTAL LIABILITIES, NONCONTROLLING | |||||||||||
INTEREST AND
STOCKHOLDERS’
|
|||||||||||
EQUITY
|
$3,524,076,617 | $4,270,621,822 | $4,708,443,659 | ||||||||
Net current assets | $(124,464,588 | ) | $27,085,172 | $145,111,502 | |||||||
Total assets less current liabilities | $2,492,554,046 | $3,370,848,911 | $3,778,253,539 |
Accumulated | |||||||||||||||||||||
other | Total | Total | |||||||||||||||||||
Ordinary | Additional paid-in | comprehensive | Accumulated | stockholders’ | comprehensive | ||||||||||||||||
Share | Amount | capital | loss | deficit | equity | loss | |||||||||||||||
Balance at January 1, 2007 | 18,432,756,463 | $7,373,103 | $3,288,765,465 | $91,840 | $(288,810,490 | ) | $3,007,419,918 | $(44,156,216 | ) | ||||||||||||
Exercise of stock options | 126,455,749 | 50,582 | 3,988,549 | — | — | 4,039,131 | — | ||||||||||||||
Repurchase of restricted ordinary shares | (292,500 | ) | (117 | ) | (21,383 | ) | — | — | (21,500 | ) | — | ||||||||||
Share-based compensation | — | — | 20,643,341 | — | — | 20,643,341 | — | ||||||||||||||
Net loss | — | — | — | — | (19,468,147 | ) | (19,468,147 | ) | (19,468,147 | ) | |||||||||||
Foreign currency translation adjustments | — | — | — | (93,721 | ) | — | (93,721 | ) | (93,721 | ) | |||||||||||
Balance at December 31, 2007 | 18,558,919,712 | $7,423,568 | $3,313,375,972 | $(1,881 | ) | $(308,278,637 | ) | $3,012,519,022 | $(19,561,868 | ) | |||||||||||
Exercise of stock options | 69,770,815 | 27,908 | 768,361 | — | — | 796,269 | — | ||||||||||||||
Issuance of ordinary shares to a stockholder | 3,699,094,300 | 1,479,638 | 163,620,362 | — | — | 165,100,000 | — | ||||||||||||||
Share-based compensation | — | — | 11,617,572 | — | — | 11,617,572 | — | ||||||||||||||
Net loss | — | — | — | — | (440,231,120 | ) | (440,231,120 | ) | (440,231,120 | ) | |||||||||||
Foreign currency translation adjustments | — | — | — | (437,242 | ) | — | (437,242 | ) | (437,242 | ) | |||||||||||
Balance at December 31, 2008 | 22,327,784,827 | $8,931,114 | $3,489,382,267 | $(439,123 | ) | $(748,509,757 | ) | $2,749,364,501 | $(440,668,362 | ) | |||||||||||
Exercise of stock options | 48,101,777 | 19,241 | 195,785 | — | — | 215,026 | — | ||||||||||||||
Share-based compensation | — | — | 10,145,101 | — | — | 10,145,101 | — | ||||||||||||||
Net loss | — | — | — | — | (963,537,205 | ) | (963,537,205 | ) | (963,537,205 | ) | |||||||||||
Foreign currency translation adjustments | — | — | — | 52,960 | — | 52,960 | 52,960 | ||||||||||||||
Balance at December 31, 2009 | 22,375,886,604 | $8,950,355 | $3,499,723,153 | $(386,163 | ) | $(1,712,046,962 | ) | $1,796,240,383 | $(963,484,245 | ) |
Year ended December 31, | |||||||||
2009 | 2008 | 2007 | |||||||
Operating activities: | |||||||||
Net loss | $(962,477,542 | ) | $(432,380,240 | ) | $(22,324,405 | ) | |||
Adjustments to reconcile net loss to | |||||||||
net cash provided by operating activities: | |||||||||
Deferred taxes | (56,222,094 | ) | 11,035,809 | (31,234,415 | ) | ||||
Loss (income) from sale of fixed assets | 3,832,310 | (2,877,175 | ) | (28,651,446 | ) | ||||
Depreciation and amortization | 748,185,169 | 761,808,822 | 706,277,464 | ||||||
Non-cash interest expense on promissory notes | |||||||||
and long-term payable relating to license | |||||||||
agreements | 3,844,324 | 6,915,567 | 4,762,343 | ||||||
Amortization of acquired intangible assets | 35,064,589 | 32,191,440 | 27,070,616 | ||||||
Share-based compensation | 10,145,101 | 11,617,572 | 20,643,341 | ||||||
Loss from equity investment | 1,782,142 | 444,211 | 4,012,665 | ||||||
Impairment loss of long-lived assets | 138,294,783 | 106,740,667 | — | ||||||
Litigation settlement (noncash portion) | 239,637,431 | — | — | ||||||
Change in the fair value of commitment to issue | |||||||||
shares and warrants | 30,100,793 | — | — | ||||||
Allowance for doubtful accounts | 111,584,756 | 1,188,568 | 443,245 | ||||||
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | (95,382,736 | ) | 97,827,390 | (46,645,922 | ) | ||||
Inventories | (22,068,328 | ) | 76,672,897 | 26,869,187 | |||||
Prepaid expense and other current assets | 28,920,815 | (23,968,264 | ) | (9,339,779 | ) | ||||
Accounts payable | 35,788,601 | (76,827,049 | ) | 19,852,824 | |||||
Accrued expenses and other current liabilities | 11,349,772 | (7,487 | ) | 2,982,369 | |||||
Income tax payable | (493,433 | ) | (600,624 | ) | 1,080,213 | ||||
Other long term liabilities | 21,679,690 | — | (3,333,333 | ) | |||||
Net cash provided by operating activities | 283,566,143 | 569,782,104 | 672,464,967 | ||||||
Investing activities: | |||||||||
Purchase of plant and equipment | (217,269,234 | ) | (669,054,599 | ) | (717,170,957 | ) | |||
Proceeds from government subsidy to purchase plant | |||||||||
and equipment | 54,125,325 | 4,181,922 | — | ||||||
Proceeds received from sale of assets held for sale | 1,482,716 | 563,008 | 16,476,045 | ||||||
Proceeds from disposal of plant and equipment | 3,715,641 | 2,319,597 | 98,128,041 | ||||||
Purchase of acquired intangible assets | (59,096,987 | ) | (79,277,586 | ) | (90,090,114 | ) | |||
Purchase of short-term investments | (49,974,860 | ) | (291,007,766 | ) | (135,241,799 | ) | |||
Sale of short-term investments | 69,903,150 | 278,717,347 | 185,554,532 | ||||||
Change in restricted cash | (14,105,371 | ) | (6,254,813 | ) | — | ||||
Purchase of equity investment | (278,103 | ) | (1,900,000 | ) | — | ||||
Net cash used in investing activities | (211,497,723 | ) | (761,712,890 | ) | (642,344,252 | ) |
Year ended December 31, | |||||||||
2009 | 2008 | 2007 | |||||||
Financing activities: | |||||||||
Proceeds from short-term borrowings | 726,897,421 | 422,575,386 | 201,658,000 | ||||||
Repayment of short-term borrowings | (641,291,131 | ) | (328,317,613 | ) | (165,658,000 | ) | |||
Repayment of promissory note | (15,000,000 | ) | (30,000,000 | ) | (30,000,000 | ) | |||
Proceeds from long-term debt | 100,945,569 | 285,929,954 | 262,247,672 | ||||||
Repayment of long-term debt | (241,655,460 | ) | (345,770,415 | ) | (195,628,015 | ) | |||
Proceeds from exercise of employee stock options | 215,026 | 796,269 | 4,039,131 | ||||||
Proceeds from issuance of ordinary shares | — | 168,100,000 | — | ||||||
Repurchase of restricted ordinary shares | — | — | (21,500 | ) | |||||
Redemption of noncontrolling interest | (9,013,444 | ) | — | (1,000,000 | ) | ||||
Net cash (used in) provided by financing activities | (78,902,019 | ) | 173,313,581 | 75,637,288 | |||||
Effect of exchange rate changes | 66,544 | (437,239 | ) | (93,721 | ) | ||||
NET (DECREASE) INCREASE IN CASH AND CASH | |||||||||
EQUIVALENTS | (6,767,055 | ) | (19,054,444 | ) | 105,664,282 | ||||
CASH AND CASH EQUIVALENTS, beginning of year | 450,229,569 | 469,284,013 | 363,619,731 | ||||||
CASH AND CASH EQUIVALENTS, end of year | $443,462,514 | $450,229,569 | $469,284,013 | ||||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW | |||||||||
INFORMATION: | |||||||||
Income taxes paid | $9,636,901 | $15,997,808 | $435,109 | ||||||
Interest paid | $37,934,992 | $54,423,059 | $45,322,891 | ||||||
SUPPLEMENTAL DISCLOSURES OF INVESTING OR | |||||||||
FINANCING ACTIVITIES | |||||||||
Accounts payable for plant and equipment | $(105,618,026 | ) | $(99,592,362 | ) | $(138,839,513 | ) |
Place and date of | Attributable | |||||
incorporation/ | equity interest | |||||
Name of company | establishment | held | Principal activity | |||
Better Way Enterprises Limited | Samoa | 100% | Provision of marketing related | |||
(“Better Way”) | April 5, 2000 | activities | ||||
Semiconductor Manufacturing | People’s Republic of | 100% | Manufacturing and trading of | |||
International
(Shanghai)
|
China (the
“PRC”)
|
semiconductor products | ||||
Corporation (“SMIS”)*# | December 21, 2000 | |||||
SMIC, Americas | United States of America | 100% | Provision of marketing related | |||
June 22, 2001 | activities | |||||
Semiconductor Manufacturing | PRC | 100% | Manufacturing and trading of | |||
International (Beijing) Corporation | July 25, 2002 | semiconductor products | ||||
(“SMIB”)*# | ||||||
SMIC Japan Corporation# | Japan | 100% | Provision of marketing related | |||
October 8, 2002 | activities | |||||
SMIC Europe S.R.L | Italy | 100% | Provision of marketing related | |||
July 3, 2003 | activities | |||||
SMIC Commercial (Shanghai) Limited | PRC | 100% | Operation of a convenience | |||
Company (formerly SMIC | September 30, 2003 | store | ||||
Consulting Corporation)* | ||||||
Semiconductor Manufacturing | PRC | 100% | Manufacturing and trading of | |||
International (Tianjin) Corporation | November 3, 2003 | semiconductor products | ||||
(“SMIT”)*# | ||||||
Semiconductor Manufacturing | Cayman Islands | 66.3% | Investment holding | |||
International (AT) Corporation | July 26, 2004 | |||||
(“AT”)# | ||||||
Semiconductor Manufacturing | PRC | 66.3% | Manufacturing and trading of | |||
International (Chengdu) | August 16, 2004 | semiconductor products | ||||
Corporation (“SMICD”)* | ||||||
SMIC Energy Technology (Shanghai) | PRC | 100% | Manufacturing and trading of | |||
Corporation (“Energy Science”)*# | September 9, 2005 | solar cell related | ||||
semiconductor products | ||||||
SMIC Development (Chengdu) | PRC | 100% | Construction, operation, and | |||
Corporation*# | December 29, 2005 | management of SMICD’s | ||||
living quarter, schools, and | ||||||
supermarket |
Place and date of | Attributable | |||||
incorporation/ | equity interest | |||||
Name of company | establishment | held | Principal activity | |||
Magnificent Tower Limited | British Virgin Islands | 100% | Investment holding | |||
January 5, 2006 | ||||||
Semiconductor Manufacturing | British Virgin Islands | 100% | Investment holding | |||
International (BVI) Corporation | April 26, 2007 | |||||
(“SMIC (BVI)”) | ||||||
Admiral Investment Holdings Limited | British Virgin Islands | 100% | Investment holding | |||
October 10, 2007 | ||||||
SMIC Shenzhen (HK) Company | Hong Kong | 100% | Investment holding | |||
Limited | January 29, 2008 | |||||
Semiconductor Manufacturing | PRC | 100% | Manufacturing and trading of | |||
International (Shenzhen) | March 20, 2008 | semiconductor products | ||||
Corporation* | ||||||
SilTech Semiconductor (Shanghai) | PRC | 100% | Manufacturing and trading of | |||
Corporation Limited* | March 3, 2009 | semiconductor products |
* | Companies registered as wholly foreign-owned enterprises in the People’s Republic of China (“PRC”) excluding for the purpose of this annual report, Hong Kong, Macau and Taiwan. | |
# | Abbreviation for identification purposes |
(a) | Basis of presentation | |
The consolidated financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). | ||
(b) | Principles of consolidation | |
The consolidated financial statements include the accounts of Semiconductor Manufacturing International Corporation and its majority owned subsidiaries. All inter-company transactions and balances have been eliminated upon consolidation. |
(c) | Use of estimates | |
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenue and expenses in the financial statements and accompanying notes. Significant accounting estimates reflected in the Company’s financial statements include contingent liabilities, valuation allowance for deferred tax assets, allowance for doubtful accounts, inventory valuation, non-marketable equity investment valuation, useful lives of plant and equipment and acquired intangible assets, impairment of long-lived assets, accrued expenses, contingencies and assumptions related to the valuation of share-based compensation and related forfeiture rates. | ||
(d) | Cash and cash equivalents | |
Cash and cash equivalents consist of cash on hand and highly liquid investments which are unrestricted as to withdrawal or use, and which have maturities of three months or less when purchased. | ||
(e) | Restricted Cash | |
Restricted cash consists of bank deposits pledged against short-term credit facilities and unused government grants for fab construction. | ||
(f) | Investments | |
Short-term investments consisting primarily of debt instruments and mutual funds are classified either as held-to-maturity, available-for-sale or trading securities. | ||
Held-to-maturity securities have been recorded at amortized cost. | ||
Available-for-sale securities have been recorded at fair market value. Unrealized gains and losses are recorded as accumulated other comprehensive income or loss. The unrealized gains and losses are reclassified to earnings once the available-for-sale investments are settled. Unrealized losses, which are deemed other than temporary, are recorded in the statement of operations as other expenses. | ||
Trading securities are recorded at fair value with unrealized gains and losses classified in earnings. | ||
Equity investments are recorded in long-term assets and accounted for under the equity method when the Company has the ability to exercise significant influence, but not control, over the investee or under the cost method when the investment does not qualify for the equity method. Equity method investments only include non-marketable investments. | ||
Held-to-maturity securities, available-for-sale securities and non-marketable equity investments are evaluated for impairment annually, or more frequently if the Company identifies indicator of impairment. Investments are considered to be impaired when a decline in fair value is judged to be other than temporary, when events or circumstances are identified that would significantly harm the fair value of the investment and the fair value is significantly below cost basis and/or the significant decline has lasted for an extended period of time. If the investment is other than temporarily impaired, the investment would be written down to its fair value. |
(g) | Concentration of credit risk | |
Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments, accounts receivable and receivable for sale of manufacturing equipment. The Company places its cash and cash equivalents with reputable financial institutions. | ||
The Company conducts credit evaluations of customers and generally does not require collateral or other security from its customers. The Company establishes an allowance for doubtful accounts based upon estimates, factors surrounding the credit risk of specific customers and other information. | ||
(h) | Inventories | |
Inventories are stated at the lower of cost (weighted average) or market. Cost comprises direct materials, direct labor costs and those overheads that were incurred in bringing the inventories to their present location and condition. | ||
(i) | Prepaid land use rights | |
Prepaid land use rights, which all located in the PRC, are recorded at cost and are charged to income ratably over the term of the agreements which range from 50 to 70 years. | ||
(j) | Plant and equipment, net | |
Plant and equipment are carried at cost less accumulated depreciation and are depreciated on a straight-line basis over the following estimated useful lives: |
Buildings | 25 years |
Facility, machinery and equipment | 10 years |
Manufacturing machinery and equipment | 5–7 years |
Furniture and office equipment | 3–5 years |
Transportation equipment | 5 years |
The Company constructs certain of its plant and equipment. In addition to costs under the construction contracts, external costs directly related to the construction of such facilities, including duties and tariffs, equipment installation and shipping costs, are capitalized. Interest incurred during the active construction period is capitalized, net of government subsidies received. (see Note 2(n) — “Capitalization of interest”). Depreciation is recorded at the time assets are ready for their intended use. | ||
(k) | Acquired intangible assets | |
Acquired intangible assets, which consist primarily of technology, licenses and patents, are carried at cost less accumulated amortization. Amortization is computed using the straight-line method over the expected useful lives of the assets of 3 to 10 years. |
(l) | Impairment of long-lived assets | |
The Company assesses the impairment of long-lived assets when events or changes in circumstances indicate that the carrying value of the assets or the asset group may not be recoverable. Factors that the Company considers in deciding when to perform an impairment review include, but are not limited to significant under-performance of a business or product line in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in our use of the assets. An impairment analysis is performed at the lowest level of identifiable independent cash flows for an asset or asset group. The Company makes subjective judgments in determining the independent cash flows that can be related to a specific asset group based on our asset usage model and manufacturing capabilities. The Company measures the recoverability of assets that will continue to be used in our operations by comparing the carrying value of the asset group to our estimate of the related total future undiscounted cash flows. If an asset group’s carrying value is not recoverable through the related undiscounted cash flows, the impairment loss is measured by comparing the difference between the asset group’s carrying value and its fair value, based on the best information available, including market prices or discounted cash flow analysis. (see Note 3 — “Fair Value”). | ||
(m) | Revenue recognition | |
The Company manufactures semiconductor wafers for its customers based on the customers’ designs and specifications pursuant to manufacturing agreements and/or purchase orders. The Company also sells certain semiconductor standard products to customers. Revenue is recognized when persuasive evidence of an arrangement exists, service has been performed, the fee is fixed or determinable and collectability is reasonably assured. Sales to customers are recognized upon shipment and title transfer, if all other criteria have been met. The Company also provides certain services, such as mask making, testing and probing. Revenue is recognized when the services are completed or upon shipment of semiconductor products, if all other criteria have been met. | ||
Revenue is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods sold and services provided in the normal courses of business, net of discounts and sales related taxes. | ||
Customers have the right of return within one year pursuant to warranty and sales return provisions. The Company typically performs tests of its products prior to shipment to identify yield rate per wafer. Occasionally, product tests performed after shipment identify yields below the level agreed with the customer. In those circumstances, the customer arrangement may provide for a reduction to the price paid by the customer or for the costs to return products and to ship replacement products to the customer. The Company estimates the amount of sales returns and the cost of replacement products based on the historical trend of returns and warranty replacements relative to sales as well as a consideration of any current information regarding specific known product defects at customers that may exceed historical trends. | ||
The Company provides management services to certain government-owned foundries. Service revenue is recognized when persuasive evidence of an arrangement exists, service has been performed, the fee is fixed or determinable, and collectability is reasonably assured. (see Note 21 — “Transactions With Managed Government-Owned Foundries”). |
(n) | Capitalization of interest | |
Interest incurred during the active construction period is capitalized, net of government subsidies received. The interest capitalized is determined by applying the borrowing interest rate to the average amount of accumulated capital expenditures for the assets under construction during the period. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful life of the assets. Government subsidies, capitalized interest and net interest expense are as follows: |
For the year ended December 31, | |||||||||
2009 | 2008 | 2007 | |||||||
Total actual interest expense (non-litigation) | $41,421,385 | $70,735,520 | $72,686,950 | ||||||
Recorded in the consolidated statements of | |||||||||
operations | (24,699,336 | ) | (50,766,958 | ) | (37,936,126 | ) | |||
Gross capitalized interest | 16,722,049 | 19,968,562 | 34,750,824 | ||||||
Government subsidies | (11,617,950 | ) | (9,308,764 | ) | (27,083,604 | ) | |||
Net capitalized interest | $5,104,099 | $10,659,798 | $7,667,220 |
(o) | Government subsidies | |||
The Company received the following types of government subsidies: | ||||
(1) | Reimbursement of certain interest costs incurred on borrowings | |||
The Company received government cash subsidies of $11,617,950, $9,308,764, and $27,083,604 in 2009, 2008 and 2007, respectively, which were based on the interest expense on the Company’s budgeted borrowings. The Company records government subsidies as a reduction of interest expense on an accrual basis. | ||||
(2) | Government awards | |||
The Company received government awards of $31,855,697, $56,967,187, and $5,058,722 in the form of reimbursement of certain expenses in 2009, 2008 and 2007, respectively. These awards were recorded as reduction of expenses accordingly. | ||||
(3) | Government subsidy for fab construction | |||
Certain local governments provided subsidies to encourage the Company to participate and manage new plants relating to the integrated circuit industry. | ||||
In 2009, 2008 and 2007 the Company received government subsidies of $54,125,325, $7,324,792 and $nil, of which $57,257,456, $4,181,922 and $nil were used to offset the cost of fixed assets or construction in progress in 2009, 2008 and 2007, respectively. | ||||
(p) | Research and development costs | |||
Research and development costs are expensed as incurred and reported net of related government subsidies. |
(q) | Start-up costs | |
The Company expenses all costs incurred in connection with start-up activities, including preproduction costs associated with new manufacturing facilities and costs incurred with the formation of the new subsidiaries such as organization costs. Preproduction costs including the design, formulation and testing of new products or process alternatives are included in research and development expenses. Preproduction costs including facility and employee costs incurred in connection with constructing new manufacturing plants are included in general and administrative expenses. | ||
(r) | Foreign currency translation | |
The United States dollar (“US dollar”), the currency in which a substantial portion of the Company’s transactions are denominated, is used as the functional and reporting currency of the Company. Monetary assets and liabilities denominated in currencies other than the US dollar are translated into US dollar at the rates of exchange ruling at the balance sheet date. Transactions in currencies other than the US dollar during the year are converted into the US dollar at the applicable rates of exchange prevailing on the transaction dates. Transaction gains and losses are recognized in the statements of operations. | ||
The financial records of certain of the Company’s subsidiaries are maintained in local currencies other than the US dollar, such as Japanese Yen, which are their functional currencies. Assets and liabilities are translated at the exchange rates at the balance sheet date. Equity accounts are translated at historical exchange rates, and revenues, expenses, gains and losses are translated using the monthly weighted average exchange rates. Translation adjustments are reported as cumulative translation adjustments and are shown as a separate component of other comprehensive income (loss) in the statements of equity and comprehensive income (loss). | ||
(s) | Income taxes | |
Current income taxes are provided for in accordance with the laws of the relevant taxing authorities. | ||
As part of the process of preparing financial statements, the Company is required to estimate its income taxes in each of the jurisdictions in which it operates. The Company accounts for income taxes using the asset and liability method. Under this method, deferred income taxes are recognized for tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end, based on enacted laws and statutory tax rates applicable for the difference that are expected to affect taxable income. Valuation allowances are provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. | ||
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. |
(t) | Comprehensive income (loss) | |
Comprehensive income (loss) includes such items as net loss, foreign currency translation adjustments and unrealized income (loss) on available-for-sales securities. Comprehensive income (loss) is reported in the statements of stockholders’ equity and comprehensive income (loss). | ||
(u) | Fair value of financial instruments | |
When available, the Company measures the fair value of financial instruments based on quoted market prices in active markets, valuation techniques that use observable market-based inputs or unobservable inputs that are corroborated by market data. Pricing information the Company obtains from third parties is internally validated for reasonableness prior to use in the consolidated financial statements. When observable market prices are not readily available, the Company generally estimates the fair value using valuation techniques that rely on alternate market data or inputs that are generally less readily observable from objective sources and are estimated based on pertinent information available at the time of the applicable reporting periods. In certain cases, fair values are not subject to precise quantification or verification and may fluctuate as economic and market factors vary and the Company’s evaluation of those factors changes. See Note 3 — “Fair Value”, for further details. | ||
(v) | Share-based compensation | |
The Company grants stock options to its employees and certain non-employees. Share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized, net of expected forfeitures, as an expense over the employee’s requisite service period (generally the vesting period of the equity grant). | ||
The Company’s total share-based compensation expense for the years ended December 31, 2009, 2008 and 2007 was $10,145,101, $11,617,572, and $20,643,341 respectively. | ||
(w) | Derivative financial instruments | |
The Company’s primary objective for holding derivative financial instruments is to manage currency and interest rate risks. The Company records derivative instruments as assets or liabilities, measured at fair value. The Company does not offset the carrying amounts of derivatives with the same counterparty. The recognition of gains or losses resulting from changes in the values of those derivative instruments is based on the use of each derivative instrument and whether it qualifies for hedge accounting. | ||
(x) | Recently issued accounting standards | ||
In August 2009, the FASB issued Accounting Standards Update (“ASU”) 2009-05, “Fair Value Measurements and Disclosures (Topic 820) — Measuring Liabilities at Fair Value” (“ASU 2009-05”). ASU 2009-05 amends accounting guidance regarding the fair value measurement of liabilities. It provides clarification that in circumstances in which a quoted price in an active market for the identical liability is not available, a reporting entity is required to measure the fair value using (1) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities when traded as assets or (2) another valuation technique that is consistent with the principles of Topic 820. It also clarifies that when estimating the fair value of a liability, a reporting entity is not required to include a separate input or adjustment to other inputs relating to the existence of a restriction that prevents the transfer of the liability and that both a quoted price in an active market for the identical liability at measurement date and that the quoted price for the identical liability when traded as an asset in an active market when no adjustments to the quoted price of the asset are required are Level 1 fair value measurements. The provisions of ASU 2009-05 are effective for the first reporting period (including interim periods) beginning after issuance. Early application is permitted. The adoption of ASU 2009-05 does not have a material impact on the Company’s consolidated financial position or result of operations. | |||
In October 2009, the FASB issued ASU 2009-13, “Revenue Recognition (Topic 605) — Multiple-Deliverable Revenue Arrangements a consensus of the FASB Emerging Issues Task Force”. This guidance addresses the accounting for multiple-deliverable arrangements to enable vendors to account for products or services (deliverables) separately rather than as a combined unit. Specifically, this guidance amends the criteria for separating consideration in multiple-deliverable arrangements. This guidance establishes a selling price hierarchy for determining the selling price of a deliverable, which is based on: (a) vendor-specific objective evidence if available; (b) third-party evidence if vendor-specific objective is not available; or (c) estimated selling price if neither vendor-specific objective evidence nor third-party evidence is available. This guidance also eliminates the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement to all deliverables using the relative selling price method. In addition, this guidance significantly expands required disclosures related to a vendor’s multiple-deliverable revenue arrangements. This guidance is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. The Company will adopt this new guidance on January 1, 2011. The adoption of this new guidance is not expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows. | |||
In December 2009, the FASB issued ASU 2009-17, “Consolidations (Topic 810) — Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities” (“ASU 2009-17”) (previously SFAS 167, “Amendments to FASB Interpretation No. 46(R)”). The amendments in ASU 2009-17 replace the quantitative-based risks and rewards calculation for determining which reporting entity, if any, has a controlling financial interest in a variable interest entity with an approach primarily focused on identifying which reporting entity has the power to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance and (1) the obligation to absorb the losses of the entity or (2) the right to receive the benefits from the entity. ASU 2009-17 also requires additional disclosure about a reporting entity’s involvement in variable interest entities, as well as any significant changes in risk exposure due to that involvement. ASU 2009-17 is effective for annual and interim periods beginning after November 15, 2009. Early application is not permitted. The Company does not expect ASU 2009-17 to have a material impact on its consolidated financial statements. |
(x) | Recently issued accounting standards (continued) | |
In January 2010, the FASB issued ASU 2010-06, “Fair Value Measurements and Disclosures (Topic 820) — Improving Disclosures about Fair Value Measurements” (“ASU 2010-06”). The ASU amends ASC 820 (previously SFAS 157, “Fair Value Measurements”) to add new requirements for disclosures about (1) the different classes of assets and liabilities measured at fair value, (2) the valuation techniques and inputs used, (3) the activity in Level 3 fair value measurements, and (4) the transfers between Levels 1, 2, and 3. ASU 2010-06 is effective for the first reporting period beginning after December 15, 2009, except for the requirement to provide the Level 3 activity of purchases, sales, issuances, and settlements on a gross basis, which will be effective for fiscal years beginning after December 15, 2010, and for interim periods within those fiscal years. In the period of initial adoption, entities will not be required to provide the amended disclosures for any previous periods presented for comparative purposes. However, those disclosures are required for periods ending after initial adoption. Early adoption is permitted. ASU 2010-06 does not change the accounting treatment for fair value measurements and will change the Company’s disclosure for fair value measurements. | ||
(y) | Loss per share | |
Basic loss per share is computed by dividing loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding (excluding shares subject to repurchase) for the year. Diluted loss per ordinary share reflects the potential dilution that could occur if securities or other contracts to issue ordinary shares were exercised or converted into ordinary shares. Ordinary share equivalents are excluded from the computation in loss periods as their effects would be anti-dilutive. | ||
On January 1, 2009, the Company adopted the new accounting standard relating to noncontrolling interests (previously referred to as minority interests) that changed the accounting and reporting for noncontrolling interests in the consolidated financial statements. The noncontrolling interests as of December 31, 2009, 2008 and 2007 was comprised of redeemable convertible preferred shares in AT that were not owned by the Company. ASC810 is effective for the Company on a prospective basis, except for presentation and disclosure requirements that are applied retrospectively. The accretion of interests to noncontrolling interest are now included after “Net Loss” in the consolidated statement of operations. |
Fair Value Measurements | ||||||||
at December 31, 2009 Using | ||||||||
Quoted Prices in | Significant | |||||||
Active Markets | Other | Significant | ||||||
for Identical | Observable | Unobservable | ||||||
Instruments | Inputs | Inputs | Total Gains | |||||
(Level 1) | (Level 2) | (Level 3) | (Losses) | |||||
Assets: | ||||||||
Forward foreign exchange contracts | $— | $54,442 | $— | $3,961,279 | ||||
Interest rate swap contracts | — | — | — | 104,000 | ||||
Cross-currency interest swap contracts | — | 503,551 | — | 1,086,822 | ||||
Derivative assets measured at fair value | $— | $557,993 | $— | $5,152,101 | ||||
Liabilities: | ||||||||
Forward foreign exchange contracts | $— | $483,421 | $— | $(3,835,234 | ) | |||
Interest rate swap contracts | — | 529,712 | — | (127,336 | ) | |||
Cross-currency interest swap contracts | — | 388,913 | — | (519,099 | ) | |||
Commitment to issue shares and warrants | ||||||||
relating to litigation settlement | 120,237,773 | (30,100,793 | ) | |||||
Derivative liabilities measured at fair value | $— | $121,639,819 | $— | $(34,582,462 | ) |
Fair Value Measurements | ||||||||
at December 31, 2008 Using | ||||||||
Quoted Prices in | Significant | |||||||
Active Markets | Other | Significant | ||||||
for Identical | Observable | Unobservable | ||||||
Instruments | Inputs | Inputs | Total Gains | |||||
(Level 1) | (Level 2) | (Level 3) | (Losses) | |||||
Assets: | ||||||||
Forward foreign exchange contracts | $— | $665,584 | $— | $4,350,382 | ||||
Cross-currency interest swap contracts | — | 873,040 | — | 2,324,228 | ||||
Derivative assets measured at fair value | $— | $1,538,624 | $— | $6,674,610 | ||||
Liabilities: | ||||||||
Forward foreign exchange contracts | $— | 4,175,889 | $— | (10,809,932 | ) | |||
Cross-currency interest swap contracts | — | 1,233,129 | — | (1,670,195 | ) | |||
Derivative liabilities measured at fair value | $— | $5,409,018 | $— | $(12,480,127 | ) |
Fair Value Measurements | ||||||||
at December 31, 2009 Using | ||||||||
Quoted Prices in | Significant | |||||||
Active Markets | Other | Significant | ||||||
for Identical | Observable | Unobservable | ||||||
Instruments | Inputs | Inputs | Total Gains | |||||
Description | (Level 1) | (Level 2) | (Level 3) | (Losses) | ||||
Long-lived assets held and used | $— | $— | $28,424,849 | $(5,269,281 | ) | |||
Long-lived assets held for sale | — | — | 8,184,462 | (22,718,729 | ) | |||
$— | $— | $36,609,311 | $(27,988,010 | ) |
Fair Value Measurements | ||||||||
at December 31, 2008 Using | ||||||||
Quoted Prices in | Significant | |||||||
Active Markets for | Other | Significant | ||||||
Identical | Observable | Unobservable | ||||||
Instruments | Inputs | Inputs | Total Gains | |||||
Description | (Level 1) | (Level 2) | (Level 3) | (Losses) | ||||
Long-lived assets held and used | $— | $— | $916,958,304 | $(105,774,000 | ) | |||
$— | $— | $916,958,304 | $(105,774,000 | ) |
Debt instruments maturing in one year | ||||||||
Gross | Gross | |||||||
Amortized | unrealized | unrealized | ||||||
Cost | gains | losses | Fair value | |||||
December 31, 2008 | $19,928,289 | $— | $— | $19,928,289 | ||||
December 31, 2007 | $7,637,870 | $— | $— | $7,637,870 |
December 31, | ||||||
2009 | 2008 | 2007 | ||||
Forward foreign exchange contracts | $9,028,995 | $220,687,295 | $404,103 | |||
Interest rate swap contracts | 54,000,000 | — | — | |||
Cross-currency interest rate swap contracts | 24,699,730 | 36,731,630 | 51,057,531 | |||
$87,728,725 | $257,418,925 | $51,461,634 |
Notional | US dollar | |||||
Settlement currency | amount | equivalents | ||||
As of December 31, 2009 | ||||||
Euro | 14,825,188 | $21,265,249 | ||||
Renminbi | (83,496,523 | ) | (12,236,254 | ) | ||
$9,028,995 | ||||||
As of December 31, 2008 | ||||||
Euro | 21,979,034 | $31,144,291 | ||||
Renminbi | 1,294,294,400 | 189,543,004 | ||||
$220,687,295 | ||||||
As of December 31, 2007 | ||||||
Renminbi | 2,950,400 | $404,103 |
Notional | US dollar | ||||
Settlement currency | amount | equivalents | |||
As of December 31, 2009 | |||||
Euro | 17,219,555 | $24,699,730 | |||
As of December 31, 2008 | |||||
Euro | 25,922,110 | $36,731,630 | |||
As of December 31, 2007 | |||||
Euro | 34,624,665 | $51,057,531 |
December 31, | ||||||||
2009 | 2008 | 2007 | ||||||
Forward foreign exchange contracts | $(428,979 | ) | $(3,510,305 | ) | $530,354 | |||
Interest rate swap contracts | (529,712 | ) | — | — | ||||
Cross-currency interest rate swap contracts | 114,638 | (360,089 | ) | 1,003,275 | ||||
$(844,053 | ) | $(3,870,394 | ) | $1,533,629 |
2009 | 2008 | 2007 | ||||
Current | $160,802,634 | $108,109,977 | $249,489,644 | |||
Overdue: | ||||||
Within 30 days | 30,882,525 | 18,211,498 | 39,131,577 | |||
Between 31 to 60 days | 1,641,710 | 6,073,500 | 6,107,866 | |||
Over 60 days | 10,963,676 | 66,976,719 | 3,658,565 | |||
$204,290,545 | $199,371,694 | $298,387,652 |
2009 | 2008 | 2007 | |||||||
Balance, beginning of year | $5,680,658 | $4,492,090 | $4,048,845 | ||||||
Provision recorded during the year | 94,704,790 | 1,301,556 | 487,920 | ||||||
Write-offs in the year | (4,240,905 | ) | (112,988 | ) | (43,675 | ) | |||
Balance, end of year | $96,144,543 | $5,680,658 | $4,492,090 |
2009 | 2008 | 2007 | ||||
Raw materials | $57,279,287 | $76,299,347 | $83,645,656 | |||
Work in progress | 102,538,543 | 53,674,794 | 139,959,481 | |||
Finished goods | 33,887,365 | 41,662,727 | 24,704,628 | |||
$193,705,195 | $171,636,868 | $248,309,765 |
2009 | 2008 | 2007 | |||||
Buildings | $293,225,129 | $292,572,075 | $283,153,927 | ||||
Facility, machinery and equipment | 552,373,720 | 534,251,063 | 470,434,074 | ||||
Manufacturing machinery and equipment | 5,398,887,677 | 5,367,843,256 | 5,035,366,468 | ||||
Furniture and office equipment | 74,206,691 | 76,210,542 | 67,835,774 | ||||
Transportation equipment | 1,890,082 | 1,768,949 | 1,750,734 | ||||
6,320,583,299 | 6,272,645,885 | 5,858,540,977 | |||||
Construction in progress | 230,867,305 | 348,049,839 | 274,505,450 | ||||
Less: accumulated depreciation | (4,299,836,387 | ) | (3,657,309,884 | ) | (2,930,088,762 | ) | |
$2,251,614,217 | $2,963,385,840 | $3,202,957,665 | |||||
The
Company recorded depreciation expense of $746,684,986, $760,881,076 and
$705,391,171 for the years ended December 31, 2009, 2008 and 2007,
respectively.
The
Company sold equipment and other fixed assets:
|
|||||||
2009 | 2008 | 2007 | |||||
Sale price | $1,698,639 | $8,136,361 | $51,375,045 | ||||
Carrying value | 5,530,949 | 5,948,053 | 26,920,427 | ||||
(Loss)/gain | $(3,832,310 | ) | $2,188,308 | $24,454,618 |
2009 | 2008 | 2007 | |||||
Technology, Licenses and Patents | |||||||
Cost: | $346,792,269 | $323,457,444 | $322,435,363 | ||||
Accumulated Amortization and Impairment: | (164,098,164 | ) | (123,398,338 | ) | (90,240,231 | ) | |
Acquired intangible assets, net | $182,694,105 | $200,059,106 | $232,195,132 | ||||
The
Company entered into several technology, patent and license agreements
with third parties whereby the Company purchased intangible assets for
$23,334,825, $1,022,081 and $187,573,251 in 2009, 2008 and 2007,
respectively.
The
Company recorded amortization expense of $35,064,589, $32,191,440 and
$27,070,617 in 2009, 2008 and 2007 respectively. The Company will record
amortization expenses related to the acquired intangible assets of
$28,481,881, $29,689,207, $24,817,808, $22,523,470 and $19,062,559 for
2010, 2011, 2012, 2013 and 2014, respectively.
In 2009,
2008 and 2007, the Company recorded impairment losses of $5,630,236,
$966,667 and $nil respectively, for licenses related DRAM products that
are no longer in use. (See to Note 10 — “Impairment of Plant and
Equipment”).
|
December 31, 2009 | ||||
Carrying | % of | |||
Amount | Ownership | |||
Equity method investment (unlisted) | ||||
Toppan SMIC Electronics (Shanghai) Co., Ltd. | $7,380,625 | 30.0 | ||
Cost method investments (unlisted) | 2,467,523 | Less than 20.0 | ||
$9,848,148 | ||||
On July 6,
2004, the Company and Toppan Printing Co., Ltd (“Toppan”) entered into an
agreement to form Toppan SMIC Electronics (Shanghai) Co., Ltd. (“Toppan
SMIC”) in Shanghai, to manufacture on-chip color filters and micro lenses
for CMOS image sensors.
In 2005,
the Company injected cash of $19,200,000 into Toppan SMIC, representing
30% equity ownership. In 2009, 2008 and 2007, the Company recorded
$1,782,142, $444,211, and $4,012,665, respectively, as its share of the
net loss of the equity investment.
The
Company assesses the status of its equity investments for impairment on a
periodic basis. As of December 31, 2009, the Company has concluded that no
impairment exists related to equity
investment.
|
2009 | 2008 | 2007 | ||||
Current | $174,834,213 | $126,149,360 | $223,527,856 | |||
Overdue: | ||||||
Within 30 days | 25,335,474 | 26,524,678 | 46,571,502 | |||
Between 31 to 60 days | 8,269,941 | 9,510,883 | 10,226,533 | |||
Over 60 days | 20,443,176 | 23,733,618 | 21,666,848 | |||
$228,882,804 | $185,918,539 | $301,992,739 |
December 31, 2009 | ||||
Discounted | ||||
Maturity | Face value | value | ||
2010 | $80,000,000 | $78,608,288 | ||
2011 | 30,000,000 | 28,559,709 | ||
2012 | 30,000,000 | 27,767,557 | ||
2013 | 30,000,000 | 26,997,375 | ||
Total | 170,000,000 | 161,932,929 | ||
Less: Current portion of promissory notes | 80,000,000 | 78,608,288 | ||
Non-current portion of promissory notes | $90,000,000 | $83,324,641 |
2009 | 2008 | 2007 | ||||
Short-term borrowings from commercial | ||||||
banks (a) | $286,864,063 | $201,257,773 | $107,000,000 | |||
Long-term debt by contracts (b): | ||||||
Shanghai USD syndicate loan | $127,840,000 | $266,050,000 | $393,910,000 | |||
Shanghai USD & RMB loan | 99,309,612 | — | — | |||
Beijing USD syndicate loan | 300,060,000 | 300,060,000 | 500,020,000 | |||
EUR loan | 50,227,567 | 72,037,070 | 51,057,531 | |||
Tianjin USD syndicate loan | 179,000,000 | 259,000,000 | 12,000,000 | |||
$756,437,179 | $897,147,070 | $956,987,531 | ||||
Long-term debt by repayment schedule: | ||||||
2010 | $205,784,080 | |||||
2011 | 334,995,270 | |||||
2012 | 215,657,829 | |||||
Total | 756,437,179 | |||||
Less: current maturities of long-term debt | 205,784,080 | |||||
Non-current maturities of long-term debt | $550,653,099 |
(a)
|
Short-term borrowings from
commercial banks
As of December 31, 2009, the Company had 19 short-term credit agreements that provided total credit facilities of up to $337 million on a revolving credit basis. As of December 31, 2009 the Company had drawn down $287 million under these credit agreements and $50 million is available for future borrowings. The outstanding borrowings under the credit agreements are unsecured, except for the amount of $20.4 million, which is secured by term deposits. The interest expense incurred in 2009 was $11,250,052, of which $2,752,239 was capitalized as additions to assets under construction. The interest rate is variable and determined as LIBOR +1.5% to 2.75%, which ranged from 1.11% to 8.75% in 2009. As of
December 31, 2008, the Company had 10 short-term credit agreements that
provided total credit facilities of up to $268 million on a revolving
credit basis. As of December 31, 2008, the Company had drawn down $201
million under these credit agreements and $67 million is available for
future borrowings. The outstanding borrowings under the credit agreements
are unsecured. The interest expense incurred in 2008 was $9,411,024, of
which $1,103,335 was capitalized as additions to assets under
construction. The interest rate is variable and determined as LIBOR +0.5%
to 1.75%, which ranged from 1.18% to 8.75% in 2008.
As of
December 31, 2007, the Company had 15 short-term credit agreements that
provided total credit facilities of up to $484 million on a revolving
credit basis. As of December 31, 2007, the Company had drawn down $107
million under these credit agreements and $377 million is available for
future borrowings. The outstanding borrowings under the credit agreements
are unsecured. The interest expense incurred in 2007 was $4,537,200, of
which $1,909,602 was capitalized as additions to assets under
construction. The interest rate is variable and determined as LIBOR +0.7%
to 1%, which ranged from 5.37% to 6.44% in
2007.
|
(b)
|
Long-term
debt
Shanghai USD Syndicate Loan In June 2006, SMIS entered into the Shanghai USD syndicate loan with an aggregate principal amount of $600,000,000 with a consortium of international and PRC banks. The principal amount is repayable beginning December 2006 in ten semi-annual installments. The interest rate is variable and determined as LIBOR+1.00%. The total
outstanding balance of SMIS’s long-term debt is collateralized by its
equipment with an original cost of $1.8 billion as of December 31,
2009.
The
Shanghai USD syndicate loan contains covenants relating to the minimum
consolidated tangible net worth, limits total borrowings compared to
tangible net worth and EBITDA for the prior four quarters, and requires
minimum debt service coverage ratios. SMIC Shanghai is exempted from the
covenants by the lenders. Furthermore, the Company is currently working
with the lenders to refinance the remainder of the USD loan and expects
the completion of this restructuring within the near future from the date
of this report.
Shanghai USD & RMB
Loan
In June 2009, SMIS entered into the Shanghai USD & RMB loan, a two-year loan facility in the principal amount of $80,000,000 and RMB200,000,000 (approximately $29,309,612), respectively with The Export-Import Bank of China. This
facility is secured by the manufacturing equipment located in SMIS 12-inch
fab. This two-year bank facility will be used to finance future expansion
and general corporate needs for SMIS’ 12-inch fab. The interest rates for
US tranche and RMB tranche are variable at LIBOR+2.00% and fixed at 4.86%,
respectively.
The total
outstanding balance of the facilities is collateralized by its equipment
with an original cost of $362 million as of December 31,
2009.
Beijing USD Syndicate
Loan
In May 2005, SMIB entered into the Beijing USD syndicate loan, a five-year loan facility in the aggregate principal amount of $600,000,000, with a syndicate of financial institutions based in the PRC. The principal amount is repayable beginning December 2007 in six equal semi-annual installments. On June 26, 2009, SMIB amended the syndicated loan agreement to defer the commencement of the three remaining semi-annual payments to December 28, 2011. The amendment includes a provision for mandatory early repayment of a portion of the outstanding balance if SMIB’s financial performance exceeds certain pre-determined benchmarks. The amendment has been accounted for as a modification as the terms of the amended instrument are not substantially different from the original terms. The interest rates before and after the amendment were decided by LIBOR+1.60% and LIBOR+2.20%, respectively. The total
outstanding balance of the Beijing USD syndicate loan is collateralized by
its plant and equipment with an original cost of $1.3 billion as of
December 31, 2009.
The
Beijing USD syndicate loan contains covenants to maintain minimum cash
flows as a percentage of non-cash expenses and to limit total liabilities,
excluding shareholder loans, as a percentage of total assets. SMIB has
complied with these covenants as of December 31,
2009.
|
(b)
|
Long-term debt (continued)
EUR Loan On December 15, 2005, the Company entered into the EUR syndicate loan, a long-term loan facility agreement in the aggregate principal amount of EUR 85 million with a syndicate of banks with ABN Amro Bank N.V. Commerz Bank (Nederland) N.V. as the leading bank. The proceeds from the facility were used to purchase lithography equipment to support the expansion of the Company’s manufacturing facilities. The drawdown period of the facility ends on the earlier of (i) the date on which the loans have been fully drawn down; or (ii) 36 months after the date of the agreement. Each drawdown made under the facility shall be repaid in full by the Company in ten equal semi-annual installments starting from May 6, 2006. The interest rate is variable and determined as EURIBOR+0.25%. The total
outstanding balance of the facility is collateralized by certain plant and
equipment with an original cost of $22 million for SMIT and $115 million
for SMIS as of December 31, 2009.
Tianjin USD Syndicate
Loan
In May 2006, SMIT entered into the Tianjin USD syndicate loan, a five-year loan facility in the aggregate principal amount of $300,000,000, with a syndicate of financial institutions based in the PRC. This five-year bank loan was used to expand the capacity of SMIT’s fab. The Company has guaranteed SMIT’s obligations under this facility. The principal amount is repayable starting from 2010 in six semi-annual installments and the interest rate is variable and determined at LIBOR+1.25%. The total
outstanding balance of the facility is collateralized by its plant and
equipment with an original cost of $631 million as of December 31,
2009.
The
Tianjin USD syndicate loan contains covenants to maintain minimum cash
flows as a percentage of non-cash expenses and to limit total liabilities
as a percentage of total assets. SMIT has complied with these covenants as
of December 31, 2009.
|
(b)
|
Long-term debt (continued)
Tianjin USD Syndicate Loan (continued) Details of the drawn down, repayment and outstanding balance of the abovementioned long-term debts are summarized as follows: |
|
Shanghai | ||||||||||
USD | Shanghai | Beijing USD | Tianjin USD | |||||||
Syndicate | USD & RMB | Syndicate | Syndicate | |||||||
Loan | Loan | Loan | EUR Loan | Loan | ||||||
2009 | ||||||||||
Drawn down | — | $99,309,612 | — | — | — | |||||
Repayment | $138,210,000 | — | — | $22,694,080 | $80,000,000 | |||||
Outstanding Balance | $127,840,000 | $99,309,612 | $300,060,000 | $50,227,567 | $179,000,000 | |||||
2008 | ||||||||||
Drawn down | — | — | — | $38,929,954 | $247,000,000 | |||||
Repayment | $127,860,000 | — | $199,960,000 | $17,950,415 | — | |||||
Outstanding Balance | $266,050,000 | — | $300,060,000 | $72,037,070 | $259,000,000 | |||||
2007 | ||||||||||
Drawn down | $207,000,000 | — | — | $41,863,894 | $12,000,000 | |||||
Repayment | $87,510,000 | — | $99,980,000 | $8,173,357 | — | |||||
Outstanding Balance | $393,910,000 | — | $500,020,000 | $51,057,531 | $12,000,000 |
December 31, 2009 | ||||
Discounted | ||||
Maturity | Face value | value | ||
2010 | $23,766,666 | $23,233,386 | ||
2011 | 5,200,000 | 4,779,562 | ||
28,966,666 | 28,012,948 | |||
Less: Current portion of long-term payables | 23,766,666 | 18,562,691 | ||
Long-term portion of long-term payables | $5,200,000 | $4,779,562 |
1) | SMIS | |
Pursuant to the preferential tax policy available under the FEIT law as well as other related tax regulation, SMIS was subject to a preferential income tax rate of 15%. According to Circular Guofa (2000) No. 18 — New Policy Implemented for Software and Semiconductor Industries (“Circular 18”) issued by the State Council of China, SMIS is entitled to a 10-year tax holiday (5-year full exemption followed by 5-year half reduction) for FEIT rate starting from the first profit-making year after utilizing all prior years’ tax losses. The tax holiday enjoyed by SMIS took effect in 2004 when SMIS utilized all the accumulated tax losses. | ||
In accordance with Guofa [2007] No. 39, SMIS was eligible to continue enjoying 10% income tax rate in 2009 and 11%, 12%, 12.5% and 12.5% in the remaining tax holiday through its expiry in 2013. | ||
2) | SMIB and SMIT | |
In accordance with the Circular 18 and Circular No. 1, SMIB and SMIT are entitled to the preferential tax rate of 15% and 10-year tax holiday (5-year full exemption followed by 5-year half reduction) subsequent to their first profit-making years after utilizing all prior tax losses. Both entities were in loss positions as of December 31, 2009 and the tax holiday has not yet taken effect. | ||
3) | SMICD | |
Under the FEIT Laws, SMICD was qualified to enjoy a 5-year tax holiday (2-year full exemption followed by 3-year half reduction) subsequent to its first profit-making year after utilizing all prior tax losses or 2008 in accordance with the New EIT Law. SMICD was in a loss position and the tax holiday began as of December 31, 2008 at the statutory rate of 25%. | ||
4) | Energy Science | |
Energy Science is a manufacturing enterprise located in the Shanghai Pudong New Area. Pursuant to the preferential tax policy granted to the Pudong New Area under the FEIT Law, Energy Science was subject to a preferential tax rate of 15% and qualified to enjoy a 5-year tax holiday (2-year full exemption followed by 3-year half reduction in FEIT rate) subsequent to its first profit-making year after utilizing all prior tax losses or 2008 in accordance with the New EIT Law. The tax holiday was triggered in 2007 and is eligible to continue until 2011. The tax rate for 2007, 2008 and 2009 was 0%, 0% and 10%, respectively and will be 11% and 12% for the remaining tax holiday through its expiry in 2011. |
2009 | 2008 | 2007 | ||||
Japan subsidiary | $— | $405,000 | $1,149,983 | |||
US subsidiary | 252,000 | 223,812 | 163,604 | |||
European subsidiary | 141,431 | 128,010 | 181,451 |
December 31, | |||||||
2009 | 2008 | 2007 | |||||
PRC | |||||||
Current | $40,949 | $15,106 | $19,602 | ||||
Adjustments on deferred tax assets and | |||||||
liabilities for enacted changes in tax rate | (32,403,299 | ) | 20,542,716 | (20,542,716 | ) | ||
Deferred | (23,818,794 | ) | (9,506,907 | ) | (10,691,699 | ) | |
Other jurisdictions | |||||||
Current | $9,556,902 | $15,382,078 | $1,495,038 | ||||
Deferred | — | — | — | ||||
$(46,624,242 | ) | $26,432,993 | $(29,719,775 | ) |
December 31, | |||||||
2009 | 2008 | 2007 | |||||
PRC | $(793,668,370 | ) | $(291,664,135 | ) | $51,906,337 | ||
Other jurisdictions | (213,651,272 | ) | (113,838,901 | ) | (99,937,852 | ) | |
$(1,007,319,642 | ) | $(405,503,036 | ) | $(48,031,515 | ) |
2009 | 2008 | 2007 | |||||
Deferred tax assets: | |||||||
Allowances and reserves | $13,019,352 | $4,732,017 | $— | ||||
Start-up costs | 159,707 | 929,991 | 53,698 | ||||
Net operating loss carry forwards | 109,384,792 | 55,476,943 | — | ||||
Unrealized exchange loss | 6,006 | 33,228 | — | ||||
Depreciation and impairment of fixed assets | 79,104,144 | 59,224,163 | 75,886,896 | ||||
Subsidy on long lived assets | 479,818 | 479,817 | 479,817 | ||||
Accrued expenses | 1,936,337 | — | — | ||||
Total deferred tax assets | 204,090,156 | 121,479,433 | 76,420,411 | ||||
Valuation allowance | (101,558,305 | ) | (75,792,963 | ) | (19,505,239 | ) | |
Net deferred tax assets — non-current | $102,531,851 | $45,686,470 | $56,915,172 | ||||
Deferred tax liability: | |||||||
Capitalized interest | (1,035,164 | ) | (411,877 | ) | (604,770 | ) |
2009 | 2008 | 2007 | |||||||
Applicable enterprise income tax rate | 15.0% | 15.0% | 15.0% | ||||||
Expenses not deductible for tax purpose | (2.2% | ) | (1.8% | ) | (0.9% | ) | |||
Effect of tax holiday and tax concession | (0.8% | ) | 0.0% | 48.7% | |||||
Expense (credit) to be recognized in future | |||||||||
periods | (6.3% | ) | (8.2% | ) | (19.2% | ) | |||
Changes in valuation allowances | (0.7% | ) | (15.6% | ) | 9.3% | ||||
Effect of different tax rate of subsidiaries | |||||||||
operating in other jurisdictions | (3.6% | ) | (7.2% | ) | (33.8% | ) | |||
Changes of tax rate | 3.2% | (5.1% | ) | 42.8% | |||||
Effective tax rate | 4.6% | (6.5% | ) | 61.9% | |||||
The aggregate amount and per share effect of the tax holiday are as follows: | |||||||||
2009 | 2008 | 2007 | |||||||
The aggregate dollar effect | $7,979,279 | $10,572 | $23,415,370 | ||||||
Per share effect — basic and diluted | $0.00 | $0.00 | $0.00 |
Reconciliation of the Noncontrolling Interest | |||
Balance at January 1, 2007 | $ | 38,800,666 | |
Redemption | (1,000,000 | ) | |
Net loss | (2,856,258 | ) | |
Balance at December 31, 2007 | $ | 34,944,408 | |
Net income | 7,850,880 | ||
Balance at December 31, 2008 | $ | 42,795,288 | |
Redemption | (9,013,444 | ) | |
Accretion of interest | 1,059,663 | ||
Balance at December 31, 2009 | $ | 34,841,507 |
Ordinary shares | Weighted | ||||||||||
Average | |||||||||||
Weighted | Remaining | ||||||||||
Number of | average | Contractual | Aggregated | ||||||||
options | exercise price | Term | Intrinsic Value | ||||||||
Options outstanding at | |||||||||||
January 1, 2009 | 1,124,155,994 | $ | 0.12 | ||||||||
Granted | 386,983,895 | $ | 0.04 | ||||||||
Exercised | (6,453,800 | ) | $ | 0.03 | |||||||
Cancelled | (94,543,259 | ) | $ | 0.10 | |||||||
Options outstanding at | |||||||||||
December 31, 2009 | 1,410,142,830 | $ | 0.10 | 6.21 years | $18,478,165 | ||||||
Vested or expected to vest | |||||||||||
at December 31, 2009 | 1,398,875,834 | $ | 0.10 | 6.15 years | $16,862,913 | ||||||
Exercisable at December 31, | |||||||||||
2009 | 523,202,733 | $ | 0.13 | 4.22 years | $3,785,120 |
2009 | 2008 | 2007 | ||||
Average risk-free rate of return | 1.18% | 2.13% | 3.98% | |||
Expected term | 2–4 years | 1–4 years | 1–4 years | |||
Volatility rate | 55.95% | 46.82% | 35.28% | |||
Expected dividend yield | — | — | — |
Restricted share units | Weighted Average | ||||||||||
Weighted | Remaining | ||||||||||
Number of | Average | Contractual | Aggregated | ||||||||
Share Units | Fair Value | Term | Fair Value | ||||||||
Outstanding at January 1, | |||||||||||
2009 | 95,620,762 | $ | 0.12 | ||||||||
Granted | 787,797 | $ | 0.04 | ||||||||
Exercised | (39,500,430 | ) | $ | 0.15 | |||||||
Cancelled | (3,282,352 | ) | $ | 0.11 | |||||||
Outstanding at December 31, | |||||||||||
2009 | 53,625,777 | $ | 0.11 | 7.55 years | $ | 5,827,170 | |||||
Vested or expected to vest at | |||||||||||
December 31, 2009 | 43,128,948 | $ | 0.10 | 7.81 years | $ | 4,473,686 |
2009 | 2008 | 2007 | |||||||
Loss attributable to Semiconductor | |||||||||
Manufacturing International Corporation | |||||||||
ordinary shares holders | $(963,537,205 | ) | $(440,231,120 | ) | $(19,468,147 | ) | |||
Basic and diluted: | |||||||||
Weighted average ordinary shares | |||||||||
outstanding | 22,359,237,084 | 18,682,585,932 | 18,505,650,171 | ||||||
Less: Weighted average ordinary shares | |||||||||
outstanding subject to repurchase | — | (41,066 | ) | (3,709,682 | ) | ||||
Weighted average shares used in computing | |||||||||
basic and diluted income per share | 22,359,237,084 | 18,682,544,866 | 18,501,940,489 | ||||||
Basic and diluted loss per share | $(0.04 | ) | $(0.02 | ) | $(0.00 | ) |
December 31, | ||||||
2009 | 2008 | 2007 | ||||
Outstanding options | ||||||
to purchase ordinary shares | 96,282,204 | 128,361,312 | 72,685,282 | |||
Outstanding unvested restricted share units | 17,172,046 | 61,117,195 | 75,302,939 | |||
113,454,250 | 189,478,507 | 147,988,221 |
(a) | Purchase commitments | |
As of December 31, 2009 the Company had the following commitments to purchase machinery, equipment and construction obligations. The machinery and equipment is scheduled to be delivered at the Company’s facility by December 31, 2010. |
Facility construction | $69,012,026 |
Machinery and equipment | 77,493,442 |
$146,505,468 |
(b) | Royalties | |
The Company has entered into several license and technology agreements with third parties. The terms of the contracts range from three to 10 years. The Company is subject to royalty payments based on a certain percentage of product sales, using the third parties’ technology or license. In 2009, 2008 and 2007, the Company incurred royalty expense of $20,836,511, $18,867,409 and $13,118,570, respectively, which was included in cost of sales. | ||
The Company has entered into several license agreements with third parties where the Company provides access to certain licensed technology. The Company will receive royalty payments based on a certain percentage of product sales using the Company’s licensed technology. In 2009, 2008 and 2007, the Company earned royalty income of $498,270, $1,192,537 and $1,428,603, respectively, which was included in sales. Royalty income is recognized one quarter in arrears when reports are received. | ||
(c) | Operating lease as lessor | |
The Company owns apartment facilities that are leased to the Company’s employees at negotiated prices. The apartment rental agreement is renewed on an annual basis. The Company also leases office space to non-related third parties. Office lease agreements are renewed on an annual basis as well. The total amount of rental income recorded in 2009, 2008 and 2007 was $ 6,331,248, $5,818,655 and $6,937,107, respectively, and is recorded in other income in the statement of operations. |
2009 | 2008 | 2007 | |||||||
Total sales: | |||||||||
United States | $632,047,071 | $767,966,660 | $657,603,189 | ||||||
Europe | 20,806,685 | 92,572,683 | 328,710,235 | ||||||
Asia Pacific* | 35,625,352 | 40,849,450 | 49,217,344 | ||||||
Taiwan | 157,624,333 | 185,848,747 | 183,113,880 | ||||||
Japan | 9,685,012 | 37,706,875 | 152,364,336 | ||||||
Mainland China | 214,598,650 | 228,766,884 | 178,756,304 | ||||||
$ | 1,070,387,103 | $ | 1,353,711,299 | $ | 1,549,765,288 |
Net revenue | Accounts receivable | |||||||||||
Year ended December 31, | December 31, | |||||||||||
2009 | 2008 | 2007 | 2009 | 2008 | 2007 | |||||||
A | 22% | 22% | 16% | 21% | 23% | 14% | ||||||
B | 14% | 14% | * | * | * | * | ||||||
C | 13% | 13% | * | 11% | * | * | ||||||
D | * | * | 18% | * | * | 15% | ||||||
E | * | * | * | * | * | 13% | ||||||
F | * | * | * | * | 16% | * | ||||||
G | * | * | * | * | 18% | * | ||||||
H | * | * | * | 10% | * | * | ||||||
Receivable from sale of | ||||||||||||
Other current assets | manufacturing equipment | |||||||||||
December 31, | December 31, | |||||||||||
2009 | 2008 | 2007 | 2009 | 2008 | 2007 | |||||||
F | * | 50% | 29% | * | 83% | 100% | ||||||
G | * | * | * | * | 17% | * |
1) | Entry of judgment and mutual release of all claims that were or could have been brought in the pending lawsuits; | |
2) | Termination of SMIC’s obligation to make remaining payments under the 2005 Settlement Agreement between the parties (approximately US$40 million); | |
3) | Payment to TSMC of an aggregate of US$200 million (with US$15 million paid upon execution, funded from SMIC’s existing cash balances, and the remainder to be paid in installments over a period of four years); | |
4) | Commitment to grant to TSMC of 1,789,493,218 shares of SMIC (representing approximately 8% of SMIC’s issued share capital as of October 31, 2009) and a warrant exercisable within three years of issuance to subscribe for 695,914,030 shares of SMIC, at a purchase price of HK$1.30 per share Both the shares and the warrant would allow TSMC to obtain total ownership of approximately 10% of SMIC’s issued share capital after giving effect to the share issuances and are subject to receipt of required government and regulatory approvals; and | |
5) | Certain remedies in the event of breach of this settlement. |
1) | Settlement of litigation via entry of judgment and mutual release of all claims in connection with pending litigation; | |
2) | TSMC’s covenant not-to-sue with respect to alleged misappropriation of trade secrets; and | |
3) | Termination of payment obligation of the remaining payments to TSMC under the 2005 Settlement Agreement of approximately $40 million. |
2009 | 2008 | 2007 | ||||||
Loss (income) from operations is arrived | ||||||||
at after charging (crediting): | ||||||||
Auditors’ remuneration | $1,291,969 | $1,584,925 | $1,698,293 | |||||
Amortization of land use rights | 1,497,008 | 927,746 | 886,293 | |||||
Foreign currency exchange loss (gain) | (3,122,135 | ) | (8,195,569 | ) | 3,117,962 | |||
Bad debt expense | 115,825,752 | 1,301,556 | 486,920 | |||||
Inventory write-down | 14,147,068 | 17,766,628 | 6,570,137 | |||||
Staff costs inclusive of directors’ remuneration | $197,421,911 | $190,942,366 | $151,447,470 |
David | Gao | Yang | Jiang | Wang | ||||||||||||||||||||||||||||
N.K. | Chen | Yong | Edward | Zhou | Richard Ru | Tsuyoshi | Yuan | Ta-Lin | Lip-Bu | Henry | Fang | Albert | Shang | Zheng | ||||||||||||||||||
Wang | Shanzhi | Gang | S Yang | Jie | Gin Chang | Kawanishi | Wang | Hsu | Tan | Shaw | Yao | Y. C. Yu | Zhou | Gang | Total | |||||||||||||||||
2009 | ||||||||||||||||||||||||||||||||
Salaries and other benefits | $— | $— | $— | $— | $— | $273,029 | $— | $— | $— | $— | $— | $— | $— | $— | $— | $273,029 | ||||||||||||||||
Stock Option Benefits* | $— | $— | $— | $8,149 | $— | $47,299 | $8,149 | $8,149 | $— | $8,149 | $— | $— | $— | $8,149 | $— | $88,044 | ||||||||||||||||
Total | $— | $— | $— | $8,149 | $— | $320,328 | $8,149 | $8,149 | $— | $8,149 | $— | $— | $— | $8,149 | $— | $361,073 | ||||||||||||||||
2008 | ||||||||||||||||||||||||||||||||
Salaries and other benefits | $— | $— | $— | $— | $— | $218,398 | $— | $— | $— | $— | $— | $— | $— | $— | $— | $218,398 | ||||||||||||||||
Stock Option Benefits* | $— | $— | $— | $— | $— | $144,300 | $4,285 | $4,285 | $4,285 | $4,285 | $4,285 | $— | $12,489 | $— | $— | $178,214 | ||||||||||||||||
Total | $— | $— | $— | $— | $— | $362,698 | $4,285 | $4,285 | $4,285 | $4,285 | $4,285 | $— | $12,489 | $— | $— | $396,612 | ||||||||||||||||
2007 | ||||||||||||||||||||||||||||||||
Salaries and other benefits | $— | $— | $— | $— | $— | $195,395 | $— | $— | $— | $— | $— | $— | $— | $— | $— | $195,395 | ||||||||||||||||
Stock Option Benefits* | $— | $— | $— | $— | $— | $172,203 | $17,189 | $17,189 | $17,189 | $17,189 | $17,189 | $— | $50,094 | $— | $— | $308,242 | ||||||||||||||||
Total | $— | $— | $— | $— | $— | $367,598 | $17,189 | $17,189 | $17,189 | $17,189 | $17,189 | $— | $50,094 | $— | $— | $503,637 |
2009 | 2008 | 2007 | ||||
Number of | Number of | Number of | ||||
directors | directors | directors | ||||
HK$nil to HK$1,000,000 ($128,620) | 11 | 8 | 9 | |||
HK$2,500,001 ($321,550) to | ||||||
HK$3,000,000 ($385,860) | 1 | 1 | 1 |
2009 | 2008 | 2007 | ||||
Salaries and other benefits | $1,147,923 | $941,001 | $586,065 | |||
Bonus | — | — | 237,969 | |||
Stock option benefits | 182,730 | 232,296 | 283,125 | |||
Total emoluments | $1,330,653 | $1,173,297 | $1,107,159 |
2009 | 2008 | 2007 | ||||
Number of | Number of | Number of | ||||
individuals | individuals | individuals | ||||
HK$1,500,000 ($192,930) | 1 | 1 | — | |||
HK$1,500,001 ($192,930) to | ||||||
HK$2,000,000 ($257,240) | 3 | 3 | 3 | |||
HK$2,000,001 ($257,240) to | ||||||
HK$2,500,000 ($321,550) | 1 | 1 | 1 | |||
HK$2,500,001 ($321,550) to | ||||||
HK$4,500,000 ($578,790) | — | — | 1 |
31. |
DIFFERENCES BETWEEN
US GAAP AND INTERNATIONAL FINANCIAL REPORTING
STANDARDS
|
(i) | In regard to accounting treatment for share-based payments, IFRS 2, “Share Based Payment”, was issued to specify recognition, measurement and disclosure for equity compensation. IFRS 2 requires all share-based payment to be recognized in the financial statements using a fair value measurement basis. An expense should be recognized when goods or services received are consumed. IFRS 2 was effective for periods beginning on or after January 1, 2005. | |
Had the Company prepared the financial statements under IFRS, the Company would have adopted IFRS 2 retrospectively for the fiscal year beginning on January 1, 2005 and compensation expenses on share-based payments to employees would have been calculated using fair value based method for the years prior to January 1, 2006. | ||
Under US GAAP, prior to January 1, 2006, the Company was able to account for stock-based compensation issued to employees using either intrinsic value method or fair value based method and the Company adopted the intrinsic value method of accounting for its stock options to employees. | ||
Under the intrinsic value based method, compensation expense is the excess, if any, of the fair value of the stock at the grant date or other measurement date over the amount an employee must pay to acquire the stock. Compensation expense, if any, is recognized over the applicable service period, which is the vesting period. | ||
Effective January 1, 2006, the Company began to recognize share-based compensation based on the grant date fair value of the award similar to IFRS 2. In addition, the Company no longer recorded deferred share-based compensation related to unvested share options in equity, consistent with IFRS 2. Upon the adoption of this accounting principle, the Company has recorded a cumulative effect of $5,153,986 in the year 2006 under US GAAP, which is not required under IFRS2. |
31. |
DIFFERENCES BETWEEN
US GAAP AND INTERNATIONAL FINANCIAL REPORTING STANDARDS (CONTINUED)
|
(ii) | Under IFRS, noncontrolling interest is presented in the equity section while under US GAAP noncontrolling interest is presented outside of equity, between liabilities and equity. | |
Under IFRS, the portion of profit and loss attributable to the noncontrolling interest and to the parent entity is separately disclosed on the face of the income statement. Under US GAAP, amounts attributable to the noncontrolling interest are presented as a component of net income or loss. | ||
(iii) | Under US GAAP, a beneficial conversion feature refers to the preferential price of certain convertible equity instruments an investor receives when the effective conversion price of the equity instruments in lower than the fair market value of the common stock to which the convertible equity instrument is convertible into at the date of issuance. US GAAP requires the recognition of the difference between the effective conversion price of the convertible equity instrument and the fair market value of the common stock as a deemed dividend. | |
Under IFRS, this deemed dividend is not required to be recorded. | ||
(iv) | Under IFRS, leases of land and buildings are classified as operating or finance leases in the same way as leases of other assets. However, a characteristic of land is that it normally has an indefinite economic life and, if title is not expected to pass to the lessee by the end of the lease term, the lessee normally does not receive substantially all of the risks and rewards incidental to ownership, in which case the lease of land will be an operating lease. A payment made on entering into or acquiring a leasehold that is accounted for as an operating lease represents lease prepayments that are amortized over the lease term in accordance with the pattern of benefits provided. For balance sheet presentation, the prepayment of land use rights should be disclosed as current and non-current. | |
Under US GAAP, land use rights are also accounted as operating leases and represent lease pre-payments that are amortized over the lease term in accordance with the pattern of benefits provided. Current and non-current asset classification is not required under US GAAP. |
31. |
DIFFERENCES BETWEEN
US GAAP AND INTERNATIONAL FINANCIAL REPORTING STANDARDS (CONTINUED)
|
(v) | IFRS requires an enterprise to evaluate at each balance sheet date whether there is any indication that a long-lived asset may be impaired. If any such indication exists, an enterprise should estimate the recoverable amount of the long-lived asset. Recoverable amount is the higher of a long-lived asset’s net selling price and its value in use. Value in use is measured on a discounted present value basis. An impairment loss is recognized for the excess of the carrying amount of such assets over their recoverable amounts. A reversal of previous provision of impairment is allowed to the extent of the loss previously recognised as expense in the income statement. | |
Under US GAAP, long-lived assets and certain identifiable intangibles (excluding goodwill) held and used by an entity are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of a long-lived asset and certain identifiable intangibles (excluding goodwill) may not be recoverable. An impairment loss is recognized if the expected future cash flows (undiscounted) are less than the carrying amount of the assets. The impairment loss is measured based on the fair value of the long-lived assets and certain identifiable intangibles (excluding goodwill). Subsequent reversal of the loss is prohibited. Long-lived assets and certain identifiable intangibles (excluding goodwill) to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. | ||
The Company considered the operating loss in SMIB to be an impairment indicator for its long-lived assets in SMIB and evaluated whether or not such assets have been impaired at December 31, 2007. The undiscounted expected future cash flows are in excels of the carrying amount of the relevant long-lived assets and no impairment loss was required to be recognized under US GAAP in 2007. However, under IFRS, the estimated recoverable value derived from a discounted expected cash flow is less than the carrying value of those long-lived assets. As such, the Company has recognized an impairment loss of US$105,774,000 for the year ended December 31, 2007 under IFRS. | ||
The Company reached an agreement with certain customers to discontinue production of DRAM products and subsequently the Company’s Board of Directors decided to exit the commodity DRAM business as a whole. The Company considered these actions to be an indicator of impairment in regard to the plant and equipment in the Company’s Beijing facility. Based on a detailed analysis, the Company recorded an impairment loss of $105,774,000, equal to the excess of the carrying value over the fair value of the associated assets under US GAAP in 2008. | ||
The difference in timing of recognition of impairment loss under US GAAP and IFRS give rise to the difference in depreciation charges on long-lived assets after impairment allocation, which would be gradually reversed in future periods when the long-lived assets are fully depreciating. | ||
(vi) | Under US GAAP, income (loss) from equity investment is presented as a separate item before net income (loss) on net of tax basis. | |
Under IFRS, the income (loss) from equity investment is presented as a component of income (loss) before income tax benefit (expense). |
31. |
DIFFERENCES BETWEEN
US GAAP AND INTERNATIONAL FINANCIAL REPORTING STANDARDS (CONTINUED)
|
2009 | 2008 | 2007 | ||||||||||
Net loss under US GAAP | $(962,477,542 | ) | $(432,380,240 | ) | $(22,324,405 | ) | ||||||
IFRS adjustments: | ||||||||||||
i) | Reverse of cumulative effect of a change in | |||||||||||
accounting principle for share-based payment | — | — | — | |||||||||
ii) | Presentation of noncontrolling interest | — | 3,055,592 | (2,856,258 | ) | |||||||
v) | Impairment of long-lived assets | — | 105,774,000 | (105,774,000 | ) | |||||||
v) | Depreciation of long-lived assets | (2,569,243 | ) | 4,633,535 | — | |||||||
Net loss under IFRS | $(965,046,785 | ) | $(318,917,113 | ) | $(130,954,663 | ) | ||||||
Net loss per share under IFRS | $(0.04 | ) | $(0.02 | ) | $(0.01 | ) | ||||||
Equity as reported under | ||||||||||||
US GAAP | $1,796,240,383 | $2,749,364,501 | $3,012,519,022 | |||||||||
ii) | Presentation of noncontrolling interest | — | — | 34,944,408 | ||||||||
v) | Impairment of long-lived assets | — | — | (105,774,000 | ) | |||||||
v) | Depreciation of long-lived assets | 2,064,292 | 4,633,535 | — | ||||||||
Equity under IFRS | $1,798,304,675 | $2,753,998,036 | $2,941,689,430 | |||||||||
Current liabilities as reported under | ||||||||||||
US GAAP | $1,031,522,572 | $899,772,911 | $930,190,120 | |||||||||
ii) | Presentation of Series A shares | 34,841,507 | 42,795,288 | — | ||||||||
Under IFRS | $1,066,364,079 | $942,568,199 | $930,190,120 | |||||||||
Land use rights, net — current portion as | ||||||||||||
reported under US GAAP | $— | $— | $— | |||||||||
IFRS adjustment | ||||||||||||
iv) | Current portion adjustment | |||||||||||
for land use right | 1,540,271 | 1,442,730 | 1,054,777 | |||||||||
Under IFRS | $1,540,271 | $1,442,730 | $1,054,777 | |||||||||
Land use rights, net | ||||||||||||
As reported under US GAAP | $78,111,788 | $74,293,284 | $57,551,991 | |||||||||
IFRS adjustments | ||||||||||||
iv) | Current portion adjustment for land use | |||||||||||
right | (1,540,271 | ) | (1,442,730 | ) | (1,054,777 | ) | ||||||
Under IFRS | $76,571,517 | $72,850,554 | $56,497,214 | |||||||||
Plant and equipment | ||||||||||||
As reported | $2,251,614,217 | $2,963,385,840 | $3,202,957,665 | |||||||||
IFRS adjustments | ||||||||||||
v) | Impairment of long lived assets | — | — | (1,054,777 | ) | |||||||
v) | Depreciation of long lived assets | 2,064,292 | 4,633,535 | — | ||||||||
Under IFRS | $2,253,678,509 | $2,968,019,375 | $3,097,183,665 |
31. | DIFFERENCES BETWEEN US GAAP AND INTERNATIONAL FINANCIAL REPORTING STANDARDS (CONTINUED) |
2009 | 2008 | 2007 | |||||||||
Additional paid-in capital | |||||||||||
as reported under US GAAP | 3,499,723,153 | 3,489,382,267 | 3,313,375,972 | ||||||||
IFRS adjustments | |||||||||||
i) | Retrospective adjustment on adoption of | ||||||||||
IFRS 2 | 30,388,316 | 30,388,316 | 30,388,316 | ||||||||
i) | Reverse of cumulative effect of a | ||||||||||
change in accounting principle | 5,153,986 | 5,153,986 | 5,153,986 | ||||||||
iii) | Carry forward prior year’s adjustment | ||||||||||
on deemed dividend | (55,956,051 | ) | (55,956,051 | ) | (55,956,051 | ) | |||||
Under IFRS | $3,479,309,404 | $3,468,968,518 | $3,292,962,223 | ||||||||
Accumulated deficit | |||||||||||
as reported under US GAAP | (1,712,046,962 | ) | (748,509,757 | ) | (308,278,637 | ) | |||||
IFRS adjustments | |||||||||||
i) | Carried over impact under IFRS 2 | (30,388,316 | ) | (30,388,316 | ) | (30,388,316 | ) | ||||
i) | Reverse of cumulative effect of a | ||||||||||
change in accounting principle | (5,153,986 | ) | (5,153,986 | ) | (5,153,986 | ) | |||||
iv) | Carry forward prior year’s adjustment | ||||||||||
on deemed dividend | 55,956,051 | 55,956,051 | 55,956,051 | ||||||||
v) | Impairment of long-lived assets | — | — | (105,774,000 | ) | ||||||
v) | Depreciation of Long-lived assets | 2,064,292 | 4,633,535 | — | |||||||
Under IFRS | $(1,689,568,921 | ) | $(723,462,473 | ) | $(393,638,888 | ) | |||||
Cost of sales | |||||||||||
as reported under US GAAP | 1,184,589,553 | 1,412,851,079 | 1,397,037,881 | ||||||||
IFRS adjustments | |||||||||||
v) | Depreciation of Long-lived assets | 2,569,243 | (4,633,535 | ) | — | ||||||
Under IFRS | $1,187,158,796 | $1,408,217,544 | $1,397,037,881 | ||||||||
Operating expenses | |||||||||||
as reported under US GAAP | 849,714,341 | 317,797,068 | 188,659,217 | ||||||||
IFRS adjustments | |||||||||||
v) | Impairment of long-lived assets | — | (105,774,000 | ) | 105,774,000 | ||||||
Under IFRS | $849,714,341 | $212,023,068 | $294,433,217 | ||||||||
Interest expenses | |||||||||||
as reported under US GAAP | 24,699,336 | 50,766,958 | 37,936,126 | ||||||||
IFRS adjustments | |||||||||||
ii) | Impairment of long-lived assets | 1,059,663 | 4,795,288 | — | |||||||
Under IFRS | $25,758,999 | $55,562,246 | $37,936,126 | ||||||||
Income (loss) before tax | |||||||||||
as reported under US GAAP | (1,007,319,642 | ) | (405,503,036 | ) | (48,031,515 | ) | |||||
IFRS adjustments | |||||||||||
v) | Impairment of long-lived assets | — | 105,774,000 | (105,774,000 | ) | ||||||
v) | Depreciation of long-lived assets | (2,569,243 | ) | 4,633,535 | — | ||||||
vi) | Presentation of income (loss) from | ||||||||||
equity investment | (1,782,142 | ) | (444,211 | ) | (4,012,665 | ) | |||||
ii) | Accretion of interest on Series A shares | (1,059,663 | ) | (4,795,288 | ) | — | |||||
Under IFRS | $(1,012,730,690 | ) | $(300,335,000 | ) | $(157,818,180 | ) |
31. | DIFFERENCES BETWEEN US GAAP AND INTERNATIONAL FINANCIAL REPORTING STANDARDS (CONTINUED) |
(a) | Inventory valuation | |
Inventories are carried at cost under both US GAAP and IFRS. However, if there is evidence that the net realisable value of goods, in their disposal in the ordinary course of business, will be less than cost, whether due to physical obsolescence, changes in price levels, or other causes, the difference should be recognized as a loss of the current period. This is generally accomplished by stating such goods at a lower level commonly known as “market”. | ||
Under US GAAP, a write-down of inventories to the lower of cost or market at the close of a fiscal period creates a new cost basis that subsequently cannot be reversed based on changes in underlying facts and circumstances. Market under US GAAP is the lower of the replacement cost and net realizable value minus normal profit margin. | ||
Under IFRS, a write-down of inventories to the lower of cost or market at the close of a fiscal period is a valuation allowance that can be subsequently reversed if the underlying facts and circumstances changes. Market under IFRS is net realizable value. | ||
(b) | Deferred income taxes | |
Deferred tax liabilities and assets are recognized for the estimated future tax effects of all temporary differences between the financial statement carrying amount of assets and liabilities and their respective tax bases under both US GAAP and IFRS. | ||
Under IFRS, a deferred tax asset is recognized to the extent that it is probable that future profits will be available to offset the deductible temporary differences or carry forward of unused tax losses and unused tax credits. Under US GAAP, all deferred tax assets are recognized, subject to a valuation allowance, to the extent that it is ‘’more likely than not” that some portion or all of the deferred tax assets will be realized. “More likely than not” is defined as a likelihood of more than 50%. | ||
With regard to the measurement of the deferred tax, IFRS requires recognition of the effects of a change in tax laws or rates when the change is “substantively enacted”. US GAAP requires measurement using tax laws and rates enacted at the balance sheet date. | ||
Under US GAAP, deferred tax liabilities and assets are classified as current or non-current based on the classification of the related asset or liability for financial reporting. Under IFRS, deferred tax assets and liabilities are always classified as non-current. |
31. | DIFFERENCES BETWEEN US GAAP AND INTERNATIONAL FINANCIAL REPORTING STANDARDS (CONTINUED) |
(c) | Research and development costs | |
IFRS
requires the classification of the costs associated with the creation of
intangible assets by research phase and development phase. Costs in the
research phase must always be expensed. Costs in the development phase are
expensed unless the entity can demonstrate all of the following:
Under US
GAAP, research and development costs are expensed as incurred except
for:
The
general requirement to write off expenditure on research and development
as incurred is extended to research and development acquired in a business
combination.
|
Semiconductor Manufacturing International Corporation | |||
Date: May 11, 2010 | By: | /s/ Dr. David N.K. Wang | |
Name: | Dr. David N.K. Wang | ||
Title: | President, Chief Executive Officer, Executive Director |